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ABSTRACT 
Scaffolds in tissue engineering play a crucial role in guiding cell growth and 
tissue generation. Fibrous materials have been shown advantageous as tissue 
engineering scaffolds because of the large surface area, high porosity and 
excellent pore interconnectivity. However, fibrous materials are typically 
unstable in pore size and morphology due to the lack of effective bonding 
between fibres, and they also have difficulty in pore size controlling. This 
remains a big challenge in scaffold fabrication. The functional surface of 
scaffolds could further enhance cell performance. For example, nano-scaled 
topography surface could assist in cell attachment, adhesion, proliferation and 
even differentiation; scaffolds with a bioactive surface assists in cell-substrate 
interaction; antibacterial agents could be employed in scaffolds to protect cells 
and tissues from infection. So it is important to pursue a suitable surface for 
successful scaffold in clinical application also.  
This PhD project focuses on establishing a three-dimensional (3D) fibrous 
tissue scaffold that has controlled pore size and inter-bonded fibrous structures, 
and examining the effects of the 3D fibrous matrices and functional fibre 
surfaces on the cell growth behaviour.      
To realize it, the 3D fibrous matrices were prepared by combining melting 
bonding of synthetic fibres with a template leaching technique. Short 
polycaprolactone (PCL) fibres were used for decreasing fibre-fibre 
entanglement and conferring isotropic structures. Sugar powder was used as 
the template to create large pores in the fibrous structure. The as-prepared 3D 
fibrous inter-bonded structure was proved to have desirable pore structures 
combining small pores and large pores. Pore size and porosity could be 
variable with different processing parameters, and the pores were well-
interconnected. The mechanical properties and stability also were superior to 
normal nonwoven mat. Permeability of media inside the scaffolds was 
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excellent as well. In-vitro cell culture experiments showed that Chinese 
hamster ovary (CHO) and fibroblast cells healthily grew inside the scaffolds.   
 
Nano-scaled surface was created on the 3D inter-bonded scaffolds for 
improvement of cell functions. Layer-by-layer electrostatic self-assembly 
technique was used to form a nano-structured surface on the scaffolds. 
Experimental results revealed that the surface wettability increased after 
coating silica nanoparticles on the PCL fibre surface, and the surface roughness 
was also improved with the increase of coating layers. This nano-structured 
surface dramatically enhanced cell attachment and cell proliferation. Alkaline 
phosphatase (ALP) activity study also showed that the nano-structured surface 
improved osteoconductivity and osteoindustivity.  
To obtain a bioactive surface, apatite was applied to the 3D inter-bonded 
fibrous scaffolds through pre-treating the scaffolds with vacuum plasma 
followed by soaking them in simulated body fluid (SBF) solution. The plasma 
treatment increased the surface reactivity, offering surface with good water 
absorptive ability. Thus when the scaffold was soaked in SBF solution, the 
plasma treatment was found to speed up the apatite nucleation and deposition. 
The apatite-coated scaffolds showed improvement in cell attachment. 
Osteoblastic cells were observed to proliferate and differentiate better in the 
apatite-coated 3D fibrous scaffold compared to the untreated control.  
In the last part, silver and polyhexamethylene biguanide hydrochloride (PHMB) 
were chosen as antibacterial agents to increase the anti-infection ability. Using 
electroless plating and layer-by-layer electrostatic self-assembling methods, 
silver and PHMB could be respectively applied to the fibrous matrices. The 
treated scaffolds showed ability to effectively kill bacteria. However, silver-
treated scaffolds were only good for short time cell growth. The PHMB treated 
samples can support the normal growth of cells for 2 weeks.  
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Overall, in this thesis, a novel fibrous scaffold was established for potential 
tissue engineering application. The fibrous scaffold with a functionalised 
surface enhanced cell performance.
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C H A P T E R  O N E  
Introduction  
1.1 Significance and research problems 
Tissue engineering is a modern tissue replacement and therapy technology 
involving using scaffolds to support cell growth in vitro which is then 
implanted into body for possible tissue replacement. The success of tissue 
engineering is highly dependent on materials, cell culture, engineering, and 
biological technologies. Tissue scaffolds as a key component of tissue 
engineering must meet the structure (e.g. shape, pore size, porosity, pore 
interconnectivity), mechanical (e.g. load bearing or non-load bearing), surface 
and functional criteria so that the cells can grow as if they are in the native 
environment.  
The future trends of tissue engineering will be based on using biodegradable 
polymer-based scaffolds because they can be biodegraded in the body while 
the new tissue is formed, which avoids the immune-reaction in the long-term 
implantation. They also show advantages in areas such as easy processing and 
property optimization.  
Recently, fibrous materials have been studied extensively in the tissue 
engineering field. In comparison with other porous tissue scaffolds, fibrous 
materials have unique features such as high surface area, large porosity, and 
well-interconnected pore structures. The main issues for the fibrous scaffolds 
are the lack of strength for load bearing tissue applications, and the insufficient 
thickness for 3D scaffolding applications.  
Nonwoven materials have good pore interconnectivity and porosity. Their 
large surface area also assists in cell attachment. Moreover, the nonwoven 
technique is cost-effective compared to other fibre processing techniques. 
Some nonwovens have been used in tissue engineering therapy. However, the 
existing nonwoven technique meets problems with controlling the pore size, 
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forming stable pore structure and having adequate mechanical strength in all 
matrix directions.   
The key to forming stable pores in nonwoven is to make fibres bond together. 
This is relatively easy to be achieved through melt or solvent bonding of the 
fibres. Conventionally, the pore size and porosity of a nonwoven can be 
adjusted in a very small range through the control of fibre diameter and 
nonwoven material density.   
Particle leaching is another technology to prepare porous materials. The porous 
structure in this technology is constructed through adding particulate materials 
to a polymer, followed by leaching off the particles after the polymer material 
is solidified. The pore size and porosity are controllable through particle size 
and the ratio between particulate template and polymer. However, the main 
issue for particle leaching technique is that the porous structures produced have 
low pore-interactivity. The first question of this thesis is: 
Research question 1: Whether the pore size, porosity and isotropic 
mechanical strength of a nonwoven tissue scaffold can be controlled by 
combining conventional nonwoven with a particle leaching technology?    
Surface topography of a scaffold has close relationship with the cell attachment, 
adhesion, proliferation and differentiation. Topography itself also has an 
indirect influence on surface wettability, which affects protein absorption and 
media accessibility. It is believed that nano-scaled structure can mimic native 
extracellular matrix, which could be more effective in cell function. Nano- 
scaled topography surface can improve not only the cell attachment and 
adhesion, but also the cell spreading and sometimes proliferation. Nano-sized 
patterns on the surfaces could direct the cell elongation and growth as well.  
Many technologies have been used to modify the surface to understand the 
influence of surface roughness and biochemistry characteristic on cell growth, 
however, most of the studies are based on 2D films or membranes. The 
understanding of nano-surface in 3D tissue scaffold structures is still limited.   
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Layer-by-layer electrostatic self-assembly has been used widely in the 
biomedical field for incorporation of bio-molecules into scaffolds. This 
technique offers the possibility to control the coating quantity and coating 
thickness. The second question to be answered in this thesis is:  
Research question 2: Can layer-by-layer self-assembly technique be used 
to deposit nano-structured coating on 3D fibrous scaffold and how the self-
assembled coating influences the cell growth? 
As mentioned, the surface chemistry plays a key role in determining the cell-
substrate interaction and associated cell attachment, adhesion and proliferation. 
Surface biochemistry activity also affects the tissue integration into the target 
body during the implantation.  How to get a bioactive surface or improve the 
scaffold bioactivity for 3D scaffold is still a hot topic in tissue engineering.  
Hydroxyapatite is a bioactive component to enhance biocompatibility, 
bioactivity and osteoconductivity. Introducing apatite to scaffold surface can 
effectively enhance the integration between scaffold and host tissue. Among all 
the techniques on introducing apatite to surface, soaking in a simulated body 
fluid (SBF) solution is the best because it leads to amorphous apatite similar to 
the natural bone. The problem for SBF soaking method is that it usually 
requires a long soaking time to get a layer of sufficient apatite thickness on the 
polymer surface.  
Plasma technique can be used to modify surface properties. After plasma 
treatment, the surface changes not only in chemical component, but also in 
electrical charges. The surface wettability can also be improved. Plasma 
treatment can introduce active groups onto polymer surface, which can be used 
to further graft functional molecules. In this project, plasma technique was 
used to accelerate the processing of apatite nucleation generation when dipping 
into SBF solution.  
Then it comes to the third research question: 
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Research question 3: Can vacuum plasma technique be used to speed up 
the apatite deposition on 3D fibrous matrices? How does the plasma 
induced apatite coating affect the growth of osteoblastic cells within 3D 
fibrous matrices?  
Infection is a fatal factor leading to failure of implantation. The importance of 
bacterial infection has not been realised in the tissue engineering area. Normal 
sterilising methods including 70% ethanol, UV irradiation or ionizing radiation 
are either time consuming/costly, or not suitable for polymer scaffolds, and 
they may not be able to prevent bacteria from invading the matrix.   
Surface antibacterial treatment is a convenient method to prevent cells from 
infection. For this purpose, antibacterial agents could be useful. So the last 
research question of this PhD project is: 
Research question 4: Could antibacterial agent be applied to 3D fibrous 
scaffolds? How do the antibacterial agents influence the cell culture 
performance?  
In general, this PhD project aims to develop better 3D fibrous tissue scaffolds 
and understand the interactions of 3D fibrous structure, surface structure and 
activity and cell growth attributes. The ultimate aim is to find ideal artificial 
scaffolds mimicking the native extracellular matrix in both structure and 
function to best support cell growth and function.  
1.2 Specific aims 
Soft fibres are difficult to mix uniformly with particles because the fibre-fibre 
entanglement prevents the fibres from blending efficiently with particles. The 
fibre-fibre entanglement can be reduced by shortening the fibre length.  It has 
been established that when the fibre length is reduced to less than 2 mm, the 
fibre entanglement is diminished considerably. When short fibres are mixed 
with particles, the fibres could also orient in any possible directions. If such a 
short fibre-particle mixture is heated to a certain extent, the fibre component 
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could be melt, while the particle component still stays in a solid state. The 
fibres will be bonded together only in the contacting parts, therefore forming 
an inter-connected fibrous network. By dissolving the particles from the melt 
bonded mixture, a nonwoven fibrous structure could be produced, and the pore 
size and porosity could be controlled through the particle size and the 
fibre/particle ratio. The first aim of this PhD research project is: 
Specific aim 1: Development of pore-stabilised 3D nonwoven fibrous tissue 
scaffolds by using short synthetic fibres and soluble particles as materials, 
and controlling the pore size and porosity through particle size and 
fibre/particle ratio. 
In this project, Polycaprolactone (PCL) will be used as a model polymer to 
build 3D fibrous scaffolds. Sugar powder will be used as template materials. 
The reasons for using PCL and sugar as fibre and template materials are that 
PCL is thermoplastic and biodegradable polymer, which allows melt 
processing and being degraded for scaffolds fabrication and application. Sugar 
is a non-toxic chemical, thus it wouldn’t bring any side-effect to scaffolds even 
with incomplete removal.  
The surface features from 3D fibrous matrices can be modified for cell 
attachment. If a hydrophobic polymer is used, the water repellent porous 
feature makes it difficult for nutrients to be introduced. Silica nanoparticles are 
known to have very good water wettability. If silica nanoparticles are applied 
on to the surface of hydorphobic fibres, surface wettability of the whole matrix 
could be improved. Since silica nanoparticles can be coated on the fibre surface 
by a layer-by-layer electrostatic self-assembly method, the coating thickness 
and surface roughness could be controlled through the assembly layers. In this 
way, the silica nanoparticles could be used to assemble nano-structured surface 
on 3D fibrous matrix.  
Specific aim 2: Application of silica nanoparticles on PCL fibrous matrices 
via the electrostatic self-assembly technique, and studying the influence of 
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this treatment on osteoblast cell attachment, proliferation and 
differentiation.  
Apatite has been proved to be excellent in biocompatibility, bioactivity and 
osteoconductivity. Scaffolds with this surface could be easily integrated with 
human bone during implantation. However, for PCL fibre matrices, it may take 
a long time to form apatite on the surface due to the lack of reactive groups on 
the surfaces. To speed up the process, vacuum plasma treatment, followed by 
forming apatite coating in SBF solution could be a simple and efficient option.  
Specific aim 3: Using plasma treatment to activate the surface of fibres so 
that a layer of apatite coating can be formed efficiently on the 3D fibrous 
scaffold and demonstrating the existence of the apatite coating and its 
benefit to the attachment, proliferation and differentiation of bone cells.  
Silver, as the most effective antibacterial agent since ancient time, can kill over 
650 disease-causing organisms in the body, even at low concentrations. 
Electroless plating method is often used to form a thin layer of silver on 
substrates.  
Polyhexamethylene biguanide (PHMB) is another effective antibacterial agent 
to gram-positive and gram-negative bacteria, fungi, yeast and even HIV-1. 
What makes it particularly good for biomedical application is that it has a very 
low tissue response and minimal patient discomfort. Thus, it is an ideal 
antibacterial agent for tissue scaffold. In this project, these antibacterial agents 
will be applied onto 3D tissue scaffolds and their effects on the cell growth 
performance will be examined.  The last aim of this research project is:  
Specific aim 4: Applying Ag or PHMB to 3D fibrous matrix, and 
examining the effects of the antibacterial coating on cytotoxicity and cell 
culture performances.  
1.3 Thesis outline 
This thesis is divided into eight chapters.  
  
-7- 
Chapter 2 reviews existing literatures on 3D tissue scaffolds and their 
requirements especially for fibrous scaffolds. The state-of-the-art in this area is 
also discussed in terms of the fabrication methods, the scaffold structures and 
their advantages and disadvantages for tissue engineering.  
Chapter 3 describes the materials, scaffold fabrication and the characterisation 
techniques.   
In Chapter 4, the preparation method of inter-bonded 3D fibrous matrices is 
introduced. Four kinds of matrices with different pore structures have been 
successfully obtained and their properties including pore structure, surface 
wettability, water permeability, water binding ability, mechanical properties 
are examined. Furthermore, cell culture study has been undertaken to 
investigate their potential for biological applications. 
Chapter 5 presents a novel strategy to improve the surface property of PCL 
fibrous scaffolds by layer-by-layer coating of silica nanoparticles on fibre 
surface.  This special surface treatment has very little influence on the nutrient 
and waste exchange within the fibrous structure. The as-prepared scaffold with 
novel surface has been tested for its cell compatibility, including cytotoxicity, 
cell proliferation and cell differentiation. 
In Chapter 6, bone-like apatite is introduced on the 3D fibrous PCL scaffolds 
by pre-treating the PCL scaffolds with vacuum plasma and then immersing 
them into simulated body fluid (SBF).  The apatite formation has been 
characterised and the possibility of using this scaffold for bone tissue 
engineering is also explored.  
Chapter 7 deals with 3D fibrous PCL scaffolds having antibacterial surface 
coating (Ag or PHMB) and their antibacterial properties and cytotoxicity.  
Chapter 8 finally summarises the entire work performed on the 3D inter-
bonded fibrous scaffolds. Suggestions for further research in this area are also 
given.  
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C H A P T E R  2   
Literature Review 
2.1 Tissue Engineering and Scaffolds 
As first described by Langer and Vacanti [1], tissue engineering is an 
interdisciplinary field that applies the principles of engineering and life 
sciences towards the development of biological substitutes that restore, 
maintain, or improve tissue function or a whole organ. It is aimed at the 
development of biological alternatives for harvested tissues, implants and 
prostheses. The basic idea for tissue engineering is to take cells from human 
body and culture them on “scaffolds” into a tissue construct which is finally 
transferred to human body for replacement or therapy purposes (Fig. 2.1).  
 
Fig.2.1. Schematic illustration of  tissue engineering [2] 
Tissue scaffolds play a central role in tissue engineering. Scaffolds are 
designed to provide anchorage for cells to attach, proliferate, differentiate, and 
grow on, furthermore to form an extracellular matrix (ECM)” [3], from which 
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the important function of scaffold is outlined. They act as a supporting 
template for cell growth. This is especially important for cells, which are 
anchorage-dependent and require a specific environment to grow.  
 
The success in tissue engineering requires not only an understanding of the 
cells response towards the outer scaffolding environment, and designing 
suitable scaffolds for a specific application, but also successful integration of 
the scaffold construct into the human body without any immune reaction, 
which are the focuses of research on scaffolds for tissue engineering.  
 
The parameters influencing cell performance are complex and have not yet 
been fully understood. It is believed that the scaffold structure, culture method 
and medium component affect cell functions tremendously [4]. Parameters 
concerning the matrix material itself, including mechanical strength (e.g. 
stiffness, elasticity, tension), surface characteristic (e.g. surface chemistry, 
topography, wettability, electricity) and pore architecture (e.g. pore size, 
porosity, pore shape and interconnectivity), are important in regulating cell 
growth and proliferation.  Many research efforts have been devoted in the past 
decades to understand these parameters. However, most of them were focused 
on 2D structures, which cannot mimic the native tissue or cells in the body. 
Since the cell growth in human body is in 3D environment, which is different 
from that on 2D structure, 3D structures are expected to positively impact on 
the cellular phenotype and functions, especially cell electrophysiological 
properties, relative cell distribution, expression profiles and responsiveness to 
exogenous signals [5]. 
 
It has been found that the criteria for an ideal scaffold vary depending on the 
tissue type and location in the human body. Generally, the ideal 3D scaffolds 
need to satisfy the requirements below [6]:  
1) Biocompatibility; 
2) Biodegradability and /or bioresorbability; 
3) Suitable mechanical properties; 
  
-10- 
4) Suitable pores and appropriate pore surface to induce desired cellular 
activities and to guide 3D tissue regeneration; 
5) Adequate physiochemical properties to direct cell-material interactions 
matching the tissue to be replaced; 
6) Ease in regaining the original shape of the damaged tissue and the 
integration with the surrounding environments.  
Other aspects such as hemocompatibility and anti-infection are also 
prerequisites to any treatment therapy [7-8].  
 
With the development of nanotechnology, nano-structured materials have been 
taken into consideration for tissue scaffold design. It is usually believed that 
nanostructure is good to interface with individual cell [9], because materials on 
nano-scale are compatible to extra cellular matrix [10]. Scaffolds made of 
nanostructure, or with nano-structured surface have been shown to improve 
cell performance or activity somehow [11-13].  
 
Because of the complex and tissue specific requirements, challenges still 
remain in development of tissue scaffolding materials mimicking the structures 
and functions of native scaffolds.   
2.2 Current Developments in 3D Polymer Scaffolds 
 
Three-dimensional scaffolds from metal, polymers and ceramics have been 
used for surgical implantation over the past century. However, two main 
drawbacks, non-biodegradablity and limited processing ability [14], have 
prevented metal and ceramic scaffolds from wide applications in the tissue 
engineering field. In contrast, polymer scaffolds are free of these issues. They 
can be biodegradable and the degradability can be controlled easily through 
tailoring the polymer structure or using polymer blend. Polymer materials can 
be processed into 3D structures without using high temperature and expensive 
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machinery. In the following part, a general review will be given on the state of 
the art in 3D polymer scaffolds.  
  
2.2.1 Cell lines 
The human body comprises about 100 trillion cells with about 260 different 
phenotypes, that divide, differentiate and self-assemble over time and space 
into an integrated system of tissues and organs, and precise replication of a 
functionally viable tissue is not a mean task [15]. However, not every kind of 
cells can be separated from human body. There are two main kinds of cells 
used now for tissue engineering: somatic cells and stem cells. They have 
significantly different self-renewal and differentiation abilities. Somatic cells 
are usually separated from special organ or tissue and are cultured in special 
media for tissue/organ regeneration. They are often used in tissue engineering 
study, therefore not limited to healthy patient. Stem cells provide a multi-
potential cell source for tissue engineering. Stem cells are usually divided into 
hematopoietic stem cells (HSCs), which can give rise to all the blood cells, and 
bone marrow stromal cells (mesenchymal stem cells, MSCs), which 
differentiate into skeletal muscle cells. HSCs may differentiate into other three 
major cells: brain cells, skeletal and cardiac muscle cells, and liver cells. MSCs 
may also differentiate into osteoblasts, multilayered epidermis-like cells, 
chondrocytes, adipocytes, and other myocytes like cardiac muscle cells [16]. 
The phenotype of the cells is stable throughout culture and there is no loss in 
osteogenic, chondrogenic or aipogenic potential. Due to these advantages, 
much research attention has been paid to stem cells, although there are 
challenges on controlled differentiation [17] and debates as to whether the cells 
can be differentiated and grown rapidly enough in vitro to provide sufficient 
populations to meet clinic need due to their low division frequency [18]. 
2.2.2 Cell seeding and culture methods 
Seeding of cells into scaffolds might play a crucial role in determining the 
progression of tissue formation [19-20]. The original cell distribution on the 
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scaffolds and the fate of further tissue development are decided by seeding 
methods.  
 
Methods to seed cells into scaffolds are normally divided into static and 
dynamic seeding methods. Static seeding method was initially established for 
2D scaffolds. It involves dropping cell/ media suspension manually onto 
scaffolds. The cell distribution is dependent on the scaffold structure and the 
operator. For a flat scaffold, the cell-media can spread evenly. For 3D 
scaffolds, cell distribution depends on the locations of where the cell medium 
reaches, and also most of the cells only attach on the superficial layers of the 
3D scaffolds. Although it is easy to operate, it faces challenges to seed cells on 
3D scaffolds of large volume.   
 
Dynamic cell seeding has been used to overcome the drawbacks of the static 
seeding method. Dynamic seeding can be subdivided into the following 
methods: 
1) Spinning flask (Fig.2.2-a) [21-22] 
2) Filtration method (Fig.2.2-b) [23] 
3) Rotary method (Fig.2.2-c) [24] 
4) Ultrasonic assisted method (Fig.2.2-d) [25] 
5) Centrifugation force assisted method (Fig.2.2-e) [26-27] 
6) Vacuum assisted cell seeding method (Fig.2.2-f) [28] 
7) Magnetic force assisted cell seeding method (Fig.2.2-g) [29]  
8) Perfusion bioreactors (Fig.2.3) [32] 
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Fig.2.2. Schematic Diagram of basic dynamic seeding methods, a) spinner flask, b) filtration 
method, c) rotary method, d) ultrasonic assisted method, e) centrifugation force assisted 
method, f) vacuum assisted method and g) magnetic force assisted method. 
Bioreactor devices came into use since the formation of 3D scaffolds. It can 
effectively seed a large number of cells into the scaffolds uniformly [30-31]. 
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As shown in Fig.2.3 [32], bioreactor devices have two basic models: perfusion 
system and pulsatile flow reactor. Except being excellent for seeding cells into 
3D scaffolds, bioreactors are good candidates for cell culture as they can 
precisely control the environment and operation condition, such as pH value, 
temperature, nutrient supply and waste removal. However, dynamic seeding 
always needs large volume of fresh media, and an extra shear force might exist 
on cells during the seeding time.   
 
Fig.2.3.Schematic diagram of bioreactor culture system, a) perfusion system, b) pulsatile flow 
system.[32]  
After being cultivated on the scaffolds, the cells are undertaken a period of 
culturing. The culture environment may have a greater impact on cellular 
behaviour than the intrinsic origin of the cells [33-34]. The culture can be 
divided into static or dynamic modes. Static culture refers to that the seeded 
scaffolds were statically cultured under a certain temperature and O2 and CO2 
content. Dynamic culture usually deals with culturing the seeded scaffolds in a 
reactor, as mentioned in Fig.2.3. Pressures make it possible to refresh media 
and take out waste. It has been pointed out that by using a perfusion reactor, 
the central oxygen concentration can sustain at a level near 4% after 5 days 
compared to static culture, (0% for the same culture period), which prevents 
cell from death and forms more homogeneous tissue eventually [35-36]. In 
addition, the uniformity of cell distribution might affect cell cycle [28, 37]. 
Despite the great potential for dynamic culture to produce high-throughput 
artificial tissues, the process has been a challenging one. For example, the 
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flow-induced shear stress has an impact on cell growth. The collagen 
synthesised from the fibroblasts cultured on 3D scaffolds is hardly retained 
within the construct during culturing due to the severe extraction by the media 
solution [38].  
2.2.3 Materials  
In terms of scaffold itself, material is a basic element to determine the success 
of tissue engineering. Polymers have their own characteristics like 
bioresorbability, biodegradability, easy processing comparing to metals and 
ceramics as mentioned previously. They can come from different sources such 
as natural polymers and synthetic polymers. They can be classified into 
biodegradable and non-degradable/biostable polymers according to the 
degradation ability [39].  Although each polymer has its own feature, one 
polymer usually cannot meet all requirements for making an ideal tissue 
scaffolds. Synthesis of complex polymer with as many as possible necessary 
properties and blending different polymers to get improved performance have 
been the common strategies of developing scaffold materials over recent years 
[40].  Reviews on polymeric biomaterials can be found in the literatures [39, 
41].  
 
Natural polymers  
The commonly used natural polymers for tissue scaffolds are collagen, 
chitosan, starch, alginate and elastin [6, 42-45]. They can be naturally isolated 
from native tissues, thus easily mimic the native cellular milieu, but problems 
related to variation between different batches, poor mechanical property, and 
less controlled biodegradability still exist.  
 
Collagen is an important natural biopolymer, which can be found from most of 
the body organs like skin, bone, tendon, cartilage, and blood vessels. In human, 
collagen comprises one third of the total proteins, accounting for three quarters 
of the dry weight of skin, and is the most prevalent component of the 
extracellular matrix (ECM) [46-47]. It has effective biological properties for 
tissue engineering applications and is widely used as a biomaterial already [48-
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49]. The concerns on using collagen are antigenicity and immunogenicity, 
potential pathogen transmission and immune reactions [39].   
 
Chitosan is a copolymer of glucosamine and N-acetylglucosamine units 
obtained by deacetylation of chitin with a percentage of N-acetyl-glucosamine 
lower than 50% [50-51]. It is often used for wound healing, drug delivery 
system, and tissue engineering because of its unique nontoxic and anti-
microbial properties [52]. However, it is only soluble in acetic acid solution 
hindering the effective fabrication of 3D scaffolds [6, 53].  
 
Starch emerges as a frequently applied material since it has great processing 
versatibility [54]. It is a polysaccharide produced by mostly higher order plants 
as a means of storing energy, and it consists of two polymers of D-glucose: 
amylase (lightly branched polymer) and amylopectin (highly branched 
polymer), which make its property variable and tunable [55], conferring the 
scaffolds with different properties for different applications [44, 56-57]. 
Alginate, a natural anionic polysaccharide composed of blocks, (1-4)-linked β-
de-mannuronic acid and α-l-guluronic acid, which can be extracted from brown 
algae[45], has gained popularity in biomedical applications because of the 
gelling ability in the presence of divalent cations (such as calcium and barium), 
stability and viscosity in aqueous solutions [58]. However, the low mechanical 
property and slow degradability limit their wide applications [59]. 
Elastin is the main protein component found in extracellular matrix. It is 
synthesised during the growth of tissues. Elastin is composed of cross-linked 
insoluble tropoelastin molecules that make it stable for a long time. Elastin is 
usually applied in biomaterials because of the combination in both mechanical 
strength and flexibility [42]. However, the immune responses and the 
insolubility limit its applications in some tissue engineering fields [60].  
 
Synthetic polymers 
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Synthetic polymers can be synthesised on large scales and have a repeatable 
property. This overcomes the aforementioned problems associated with natural 
polymers and offers wide uses as tissue scaffolding materials. Many 
biodegradable polymers such as polylactic acid (PLA), polyglycolic acid 
(PGA) and polycaprolactone (PCL), have been approved by Food and Drug 
Administration (FDA) in United States.  
 
PGA, obtained from polymerisation of glycolide, is a highly crystalline 
polymer with crystallinity ranging of 35-75%. It has relatively low melting 
temperature, about 185 °C to 225°C [61], and exhibits good mechanical 
properties with low solubility in most organic solvents. Its melting properties 
make it possible to process scaffolds using thermal techniques. Many different 
structures of tissue scaffolds have been developed from this material [62-64].  
This polymer also has very good degradable properties. It is known to lose 
strength after implantation in body over several weeks, and break down into 
glycine that can be absorbed in about 4-6 months. The high degradation rate 
has been a concern to some specific applications [65].  
 
PLA is very similar to PGA but the presence of a pendant methyl group on the 
alpha carbon. It has a chirality structure of L, D, and DL isomer for the alpha 
carbon. According to the molecular weight and polymer processing parameters, 
distribution of L- and D-lactide units could be variable. There are two 
dramatically different crystallinities for PLLA and PDLLA. PLLA is a semi-
crystalline polymer (~35%) with a melting temperature of 170~180°C [66]. It 
is a slow degrading polymer, capable of degrading between 2 and 6 years 
depending on the molecular weight [67].  But its high mechanical strength 
gives it possible for usage in many fields [68-70]. Poly (dl-lactide) (PDLLA) is 
an amorphous polymer. Its amorphous nature permits it losing mass in 12~16 
months, but gives its very low mechanical strength [65].  The possibility to 
polymerise copolymers having different crystallinities, molecular weights 
through adjusting the composition allows for optimising this polymer for 
specific tissue engineering applications [71-73].  
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Polycaprolactone (PCL) is another semicrystalline polymer and having a 
number of advantages to be used as tissue engineering materials. It can be 
easily polymerised by a cheap monomer, ε-caprolactone through ring-opening 
polymerisation reaction. The melting temperature of this polymer is near 
58~60 °C, which has low requirement for thermal processing techniques, and 
other active chemical could also be processed without much concern of 
degradation during the scaffold fabrications. Also, it can be solved in most of 
organic solvents, which is fantastic for processing.  The semicrystallinity 
makes it degradable and water and carbon dioxide are the main degradation 
products, which is nontoxic to cells, tissues/organs, and even the whole body. 
PCL also has reasonable mechanical strength, especially high elongation at 
breakage [61]. More importantly, such a polymer has excellent 
biocompatibility. Except the degradation rate is relatively slow (2-3 years), 
PCL has no reactive groups, which is often necessary for scaffolds application. 
However, it is still an ideal material for tissue scaffolds especially for bone 
regeneration and other long term implanting applications [74-78].  
 
Polyhydoxyalkanoates (PHA), poly 3-hydroxybutyrate (PHB), copolymers of 3-
hydroxybutyrate and 3-hydroxyvalerate (PHBV), poly 4-hydroxybutyrate 
(P4HB), copolymers of 3-hydroxybutyrate and 3-hydroxyhexanoate (PHBHHx) 
and poly 3-hydroxyoctanoate (PHO) are termed as bacterial polymers because 
they are produced by microorganisms under unbalanced growth conditions [79-
80]. Similar to other biopolymers, they are biodegradable and thermo-
processable. But their drawbacks are limited availability and time-consuming 
extraction procedure from bacterial cultures [81-82]. As a model polymer, 
PHB in this series is introduced below.  
PHB is firstly produced in 1920 by bacteria Bacillus megaterium [83-84]. The 
polymer has a melting temperature between 160~180 ˚C. It is soluble in a wide 
range of solvents. PHB is also a piezoelectric material, which could be a nice 
property for scaffolding application because cells are known to react with 
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electricity. PHB has good toughness and the mechanical property can be 
adjusted by copolymer, like PHBV.  PHB has a very low degradation rate due 
to its high crystallinity, but its copolymer PHBV has a low crystallinity 
resulting in much better degradation behaviour[85].  
Polyurethane is usually synthesised by polycondensation of diisocyanates with 
alcohols and/or amines, which is regarded as toxic components to human body. 
It is biostable and biocompatible, thus has been investigated as long-term 
medical implants. Biodegradable polyurethanes have also been developed 
using biocompatible aliphatic diisocyanates. Degradable poly (ester urethanes) 
were developed by reacting lysine diisocyanate with polyester diols or triols 
based on D,L-lactide, caprolactone and other co-polymers  with a wide range 
of properties [86]. Either biostable polyurethane or biodegradable poly (ester 
urethanes) has been widely used in tissue engineering field recently [87-91].  
Poly (propylene fumarate) (PPF) is an unsaturated linear polymer, and it is 
injectable and biodegradable for orthopaedic applications [92-94]. Due to the 
unsaturated fumarate groups on the polymer backbone, the polymer property 
can be improved by further crosslinking [95-97]. The degradation products of 
this polymer are biocompatible and readily removed from the body [98]. It has 
already been used in bone tissue engineering [99-102].  
With the well development of polymer science, a huge number of polymers 
have been emerged for applications as biomaterials. Here only some commonly 
appeared polymers are described. Intensive reviews on biopolymers can be 
found in the literatures [65, 103]. Although the properties of synthetic 
biopolymers can be tailored to meet specific applications, pre-inflammatory 
could be a problem affecting the fate of neo-tissue form in tissue engineering 
[104-109].  
2.2.4 Scaffold fabrications and structures 
Many 3D scaffold structures have been developed, by using either traditional 
technique (e.g. template-leaching, gas foaming, fibre bonding, phase 
separation) (Fig. 2.4), or model processing technique such as solid freeform 
  
-20- 
fabrication (SFF) (e.g. stereolithography, selective laser sintering, fused 
deposition modeling, 3D printing). However, every technique has its own pros 
and cons. It is not easy for one technique to meet all requirements of 3D 
scaffolds. Therefore, two or more techniques were often combined together to 
take the advantages of each technique. Here the main techniques are 
summarized on basis of literature reports.  
 
Fig.2.4. Conventional methods to fabricate 3D scaffolds, a) salt leaching, b) phase separation, 
c) gas foaming.[110]  
Salt leaching technique: this method usually works together with solvent 
casting or freeze-drying method. Polymer solution containing porogen 
materials is castor freeze-dried to shape into 3D objects and get rid of the 
solvent. The porogen particles are then leached away to form a 3D scaffold 
[111-113]. The porogen material plays functions in forming pores inside the 
scaffolds. The pore size and shape are dependent on the porogen. This method 
is easy to undertake, but it is limited to produce very thin film or membrane 
samples [114-117]. Although the scaffold thickness can be increased by using 
multiple layers, the use of solvent in the processing is still a problem. If the 
solvent is not removed completely, cytotoxicity could occur [110].  
Fibre related method: this technique uses fibres to build different 3D structures. 
Textile technologies of braided, nonwoven, weaving or knitting are normally 
the main fibre construction methods [68-69, 112, 118-126]. New emerging 
techniques such as electro-spinning, is also employed. Textile techniques are 
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matured in producing different fibrous structures. The pores in the fibre 
scaffolds are in irregular shapes, which are much different from those in 
particle leaching ones. The pore size can be controlled through fibre diameter, 
fibrous structure and processing parameters. Also, the pores in fibrous 
materials have excellent interconnectivity. Furthermore, the large surface area 
provided by fibrous materials makes fibrous scaffolds an ideal candidate for 
cell attachment and expansion. The issues for fibrous scaffolds are their weak 
mechanical property [127].  
Electrospun nanofibre mesh has been used as tissue engineering scaffolds 
because it has a similar fibrous morphology to the native extracellular matrix 
(ECM) and can provide fibrous scaffolds with instructive surface properties to 
direct cell faith [128-129]. Its powerful ability to produce different structures, 
such as side-by-side [130],  core-sheath [131-132] and aligned nanofibre mats 
[133], surface-nanofibre tubes [134-135], makes it one of the most promising 
techniques in this century. However, electrospun nanofibre mats are typically 
regarded as 2D scaffolds since cells cannot grow and penetrate easily into the 
scaffolds [136-137]. To solve these problems, multiple-layered electrospun 
mat, or mixing electrospun mat and dual-porosity nanofibrous mat have been 
prepared [138-139]. Cell seeding has also been combined with electrospinning 
to directly form layered 3D scaffolds seeded with living cells [140].  
Thermal induced phase separation (TIPS) applies the mechanism of lowering 
system free energy to separate a homogenous multi-component polymer 
system into several phases: polymer-rich phase and polymer-lean phase. Once 
the solvent is removed, the pores can be generated [141-142]. This technique 
generates pores with different morphologies [143-144]. Phase separation can 
be divided into solid-liquid, and liquid-liquid phase separations. For solid-
liquid phase separation, the solvent for the polymer solution is crystallized 
under certain temperature. After removing the crystals, pores are formed. The 
solid phase is discontinuous, except the liquid phase [145-146]. Unlike the 
solid-liquid phase separation, liquid-liquid phase separation has an upper 
critical and a lower critical solution temperature. The two phases (polymer-rich 
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and polymer-lean) are both continuous. An open pore structure can be 
produced when the solvent is removed [144].  Phase separation technique 
involves the use of solvent, which may be a reason for the limited applications. 
Also, solid-liquid method usually produces pores up to tens of microns, which 
limits its applications in some specific biological fields [147].   
Gas foaming technique is an alternative technique to eliminate using organic 
solvent in the 3D scaffold preparation, which is thought to be an improvement 
in scaffold fabrication technique. CO2 gas from high pressure to low pressure 
changes results in the formation of porous scaffolds [148]. Pores in such 
scaffolds are usually interconnected and are hundreds of microns in size [149]. 
The honeycomb pores also can be prepared from this method [150]. The high 
pressure required in this technique limits many biopolymers’ applications in 
3D scaffolds [151].  
The above conventional scaffold fabricating methods face challenges in 
fabricating 3D tissue constructs resembling the native tissue microvasculature 
and micro-architectures. New techniques like rapid prototyping, 3D bioprinting 
or bioplotting, self-assembling, hydrogel technique, as well as the hybrid 
techniques have appeared in recent years. 
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Fig.2.5. Schematic diagrams of setups of different rapid prototyping techniques, a) 
sterolithography, b) 3D printing, c) selective laser sintering, d) fused deposition modelling. 
[152] 
Rapid prototyping (RP) techniques, also termed solid freeform fabrication 
(SFF), is the most promising technique to fabricate scaffolds because it can 
effectively control the scaffold structure, and design the exact shape of 
complex scaffold for tissue replacement via computer-aided design (CAD). It 
is also named as 3-D printing (3DP), fused deposition modelling (FDM) and 
selective laser sintering (SLS), 3D fibre deposition, and so on. Fig. 2.5 shows 
some of the setups.  For every technique, it has its own distinct advantages and 
limitations, which have been reviewed in several papers [152-156]. 3DP 
technique is the most commonly used SFF technique for scaffold fabrication. It 
uses powder as raw material to form 3D structure via ink jet printing method, 
which allows processing of a wide range of powders from polymers, metals to 
ceramics. Additionally, the unprocessed powders are easily trapped in the 
  
-24- 
small inner holes and affect the functions of 3D scaffolds. FDM technique uses 
polymer melt as the material to form a series of material roads deposited layer-
by-layer by a nozzle with a small orifice. The deposition direction, the filament 
thickness and road intervals can be easily modified to obtain different 
structures. Due to the requirement of melting state of polymer, this technique 
narrows its application in tissue scaffolds. The feedstock materials of 3D fibre 
deposition technique can be in pellet or granule forms, and the material flow 
can be regulated by applying pressure to the syringe. The 3D structure can be 
regulated by fibre thickness and orientation.  SLS system also uses powders as 
raw materials. However CO2 laser is used to selectively sinter polymer 
powders into thin-layered structures. During the SLS processing, the laser 
selectively scans the powders, making the powder temperature rise to glass 
transition and then fusing them together.  3D structure is built up by layer-by-
layer deposition of the polymer melt. This processing route must use powders 
as material, and the exposure of the powder material to a high energy laser 
beam might degrade the t polymer chains.  Stereo-lithography (SLA) has also 
been exploited for 3D scaffold fabrication. A UV laser vector is used to scan 
over the top of a bath of a photo polymerisable liquid polymer material. Once 
the polymerisation is initiated, the laser beam can create the first solid layer. 
Again, a layer-by-layer 3D structure can be formed by tracking the laser beam. 
After the model is complete, it is cured in an UV oven to smoothen the surface. 
Undoubtedly, the raw materials need to be UV photo-polymerisable, and 
compatible to UV curing. A relatively new 3D printing technique, modified by 
using cryogenic plotting system, can impart fibres with a rough surface and 
hydrophilic properties [43]. Overall, the RP techniques make it possible to 
produce 3D structure automatically, rapidly, and accurately. But they still have 
limitations in terms of raw material selection, processing conditions, and 
expensive machinery. 
Indirect 3D printing is based on solid freeform fabrication technique. It uses 
the 3D rapid prototyping technique to get a negative mould, and then polymer 
solution is casted into the mould to get a 3D scaffold after the mould removal 
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[157-158]. This technique can overcome the limitations in polymer selection, 
solvent use, and incorporation of localised pores [157, 159-160].  
3D hydrogel technique  
3D hydrogel porous structure has a high content of water (> 30%) and is 
capable of incorporating cells homogenously throughout the gel network. Its 
fantastic 3D structure allows the nutrient transport and the injectable gel state 
broadens its application in tissue engineering [161-162]. So far, hydrogel has 
become one of focuses in tissue scaffolding research. The methods to prepare 
hydrogel scaffolds are mostly based on bottom-up technique, including direct-
write assembly [163], protein self-assembly [60], photo-initiated cross-linking 
[164-166], thermal cross-linking [166], and physical or chemical cross-linking 
of hydrophilic polymers [167-168]. The application varies from muscle cell 
culture, cartilage tissue replacement, space filling scaffold, cell-delivery 
scaffold, to bioactive molecule delivery scaffolds [169-171].  There are still 
many aspects for 3D hydrogel scaffolds to improve, such as the weak 
mechanical property [172-173], and sometimes the use of toxic cross-linker 
[174-175].  
3D cell printing is based on the concept of building tissue or organ layer by 
layer from individual cell-containing components. There are usually two cell 
printing methods, one is called structural cell printing, and the other is 
conformal cell printing. They both build 3D cell constructs with heterogeneous 
cell and biomolecular distribution inside the 3D structure. The difference is 
that the ink for 3D structural cell printing concludes scaffolding, cells and 
biomolecules simultaneously, but the ink for 3D conformal cell printing 
contains cell only. In this way, cells are printed into thin layers of prefabricated 
cell scaffold (See Fig.2.6) [176]. Most of the 3D printing technique can be 
utilized for 3D structural cell printing [177-179].  
 But the application of harsh or organic solvents prevents many good choices 
of polymer materials in the live cell deposition process. Many non-toxic 
“bioinks” (hydrogels of gels) have been found, but they often lack rigidity and 
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structural integrity [180-181]. The “contradiction” between building up 3D 
structure and the deposition of individual cells is another issue. On the 
contrary, the 3D conformal cell printing has no issue related to toxic solvent, 
and the printing resolution can also reach a single-cell level [182-183]. The 
shining point of 3D cell printing to tissue scaffolds is that cells can be 
distributed uniformly inside and outside the scaffold structure, and therefore 
can grow into homogeneous tissue or organs.  Since the whole process deals 
with cells, a sterilised environment is necessary.  
 
Fig.2.6. Schematic representations of a) structural cell printing where both scaffold and cells 
are printed simultaneously or serially, and b) conformal cell printing where cells alone are 
printed onto thin layers of prefabricated scaffold. [176] 
Hybrid technology for fabricating hybrid scaffolding structures is an appealing 
method in tissue engineering. Making use of the pros of different techniques is 
critical to make hybrid scaffolds. Here some recent hybrid techniques are 
introduced.  
The electron beam and photolithography methods have been utilized together 
to get a tubular scaffold with micro- and nano-structure in the 3D scaffolds to 
enhance the scaffolding performance. The nano-pits or nano-pillars are created 
using electron beam lithography, while micro-pattern structures are generated 
by photolithography (Fig. 2.7) [184].   
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Fig.2.7. a) Flow chart for fabrication of a polymer tubular scaffold, b) a cross-sectional view of 
the hybrid scaffolding construct. Scale bar is 100μm. [184] 
A direct polymer melt deposition method has been combined with 
electrospinning to produce a 3D structure with dual scaled pores. The 
microfibre diameter can be accurately controlled by computer-aided design, 
and the electrospun nanofibre mat has been coated on the microfibre surface 
and between microfibres to enhance the cell attachment and adhesion for cell 
growth (Fig. 2.8) [185].  
 
Fig.2.8. a) A hybrid process combining direct polymer melt deposition and electrospinning, b) 
Photograph of the overall 3D structure, c) the hybrid basic unit layer composed of microfibres 
and nanofibres, d) and e) images in higher magnifications. [185]  
Other rapid prototyping techniques also can be combined with electrospinning 
to get a dual pore size 3D structure. The 3D microstructure enables cell 
penetration and nutrient transport, while the electrospun mat provides a nano-
scaled surface, which enhances cell attachment, proliferation and 
differentiation. Another example is given in Fig. 2.9 [186].  
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Fig.2.9. A setup combining 3D plotting and electrospinning systems [186] 
The 3D prototyping technique has also been used to produce a mould for 3D 
structure, followed by pouring a polymer solution into it to form a nanofibrous 
structure through thermal phase separation. Thus this kind of scaffold ensures 
both 3D and nanofibrous structures. The scaffolds having complex geometry 
have been proved to be a good candidate for bone tissue engineering [160].  
Melt electrospinning and wet electrospinning techniques have been applied 
together to produce a 3D scaffold with microfibres as support and nanofibres 
as filling for cell attachments. This nano-/micro-fibre scaffolds with a porosity 
of 91.2% and a mean pore size of 93.9 μm have shown great potential for 3D 
organisation and guidance of cells (Fig.2.10 ) [187].  
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Fig.2.10. a) Schematic diagram of a hybrid electrospinning process, b) and c) photographs of 
the hybrid structure from (b) front view and (c) side view, d) and e) surface (d) and cross-
section (e) morphologies of the hybrid fibrous structure [187] 
Electrospun nanofibres have been deposited into water and then freeze-dried to 
obtain a hybrid 3D structure, in which nanofibres can either assemble into a 
loose 3D structure or form a dense 3D structure, dependent on the freeze-
drying condition. This method results in a structure consisting of nanofibres 
completely (Fig. 2.11) [188].  
 
Fig.2.11. a) Schematic diagram of the hierarchical organisation of 3D structures, b) 3D PCL  
mesh dried at room temperature, c) 3D PCL  mesh prepared by freeze drying  in a cylinder 
with visible pores, d) SEM image of dense yarn scaffolds, e) SEM image of 3D scaffold 
surface with distinctly isolated yarns made out of aligned nanofibres. [188]  
A hybrid structure combining the advantages of collagen micro-sponge for its 
cell affinity with the good mechanical property from knitted PLGA mesh has 
been developed by dipping knitted fabric into collagen solution, followed by a 
freeze drying procedure. The hybrid structure has a much better cell 
distribution and extra cellular matrix deposition ability (Fig. 2.12) [189].  
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Fig.2.12. a) Schematic illustration of three PLGA/collagen hybrid scaffolds. Black; PLGA 
knitted mesh; Gray: type I collagen sponge. b) SEM observation of THIN, SEMI, and 
SANDWICH PLGA/collagen hybrid scaffolds. A, B, C: top view of the THIN scaffolds; D, G: 
top view of the SEMI and SANDWICH scaffolds, respectively; E, H: bottom view of the 
SEMI and SANDWICH scaffolds, respectively; F, I: cross-sectional view of the SEMI and 
SANDWICH scaffolds, respectively. [189]  
Porous scaffolds with macro- and micro-pores have been prepared by a 
combination of gas foaming (GF) and selective polymer extraction (PE) from 
co-continuous blends. This special scaffold has both macro-porosity suitable 
for rapid cell colonisation and tissue in-growth, and micro-porosity serving as 
preferential route for fluid transport (Fig. 2. 13) [190].  
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Fig.2.13. Schematic illustration of macro- and micro- porous 3D scaffolds a) SEM image of 
the co-continuous blend after selective extraction of one component, b) SEM image of the 
structure after gas foaming,c) SEM image of the scaffold prepared by the selective extraction 
of one component from the foamed structure. [190]   
Most hybrid techniques used recently for tissue engineering have been tried to 
get ideal scaffold structures with macro-, micro-, and nano-scales inside. These 
structures combine at least two levels of scale characteristics to achieve 
enhanced properties. Macro-scale pores can assist tissue in-growth during the 
implantation, the micro-pores are effective for mass transport of nutrients and 
waste, and the nano-scaled pores are perfect for cell attachment, extra cellular 
matrix formation, and cell–matrix interaction. Hybrid techniques are likely to 
be the focus of future research in this area.  
 2.2.5 Applications 
So far, some commercial tissue engineering products, for example, artificial 
bone, cartilage, man-made skin have appeared [191]. Tissue scaffold can be 
put into as many possible uses as one can imagine: ligament [192-193], liver 
[194-195], tendon [196-197], muscle [168, 198], nerve [137, 199], joints [200-
201], bladder [202-203], vascular [36, 204], blood vessels [205-207], cornea 
[208-209], skeleton [210-211], orthopaedic [11, 212], trachea [213],  and so on. 
The requirement for every specific application is quite different. In this thesis, 
the focus is on bone tissue scaffolds.  
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2.2.6 Complications 
To make successful tissue engineering therapy, the engineered 3D scaffolds 
should meet the requirements as previously mentioned in Section 2.1.  There 
are many attempts to get scaffolds with these characteristics. However, many 
difficulties still exist, some of which are given below:  
1) Controlling the biodegradation rate so it is about the same as neo-tissue 
formation rate. The scaffold has to serve as a supporting construct in the early 
stage, with the time, it needs to be degraded and totally absorbed by human 
body without any toxic reaction. 
2) Controlling the structure with good mechanical property, and appropriate 
pore size and porosity to guide cellular activities and 3D tissue formation. 
3) Low-cost, easy-processing, repeatable and controllable technique to make 
3D scaffolds. The technique also needs to avoid using toxic solvent.  
4) Uniform cell distribution, easily cell penetration, and homogeneous tissue 
regeneration. 
5) Adequate surface physiochemical properties to direct cell-material 
interactions. 
6) Ease for scaffold to integrate with the surrounding environment. 
7) Disinfection characteristic after implantation into the body.  
Once these aspects/difficulties are solved, the 3D scaffolds will constitute an 
ideal environment to foster the formation of new tissue and to integrate with 
the host environment.  
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2.3 Fibre-based Tissue Scaffolds 
 
Fibre based structures have been applied in tissue engineering field due to their 
many unique features compared to other types of scaffolds. For example, they 
have high surface area, high porosity, interconnected pore structures, and 
controlled pore size as well.  The huge choices of fibre and different processing 
routes (eg. woven, knitting, and nonwoven) provide for a wide range of 
materials and structures.  
2.3.1 Classification of fibre-based scaffolds 
The structures from traditional textile processing techniques, including fibres, 
yarns, ribbons, woven, knitted and non-woven fabrics, have already been 
studied extensively for tissue scaffolding applications for several decades.  
Similar structures from emerging techniques, such as electrospinning, self-
assembling, and rapid prototyping also are appealing candidates.  In this part, a 
review on different fibrous scaffolds is given. 
 
Fibres/Yarns/Braided/Twisted structures 
Fibres are usually braided or twisted into yarns for suture or anterior cruciate 
ligament applications. For example, a commercial PCL suture was made on a 
computer-aided embroidery machine and was coated with collagen I for end 
use [214]. PLLA microfibre scaffolds with tunable mechanical properties were 
fabricated by braiding or braiding-twist technique for anterior cruciate 
ligaments (ACL) [215].  
 
Woven structure 
Woven structures are produced on a weaving machine or loom, using warp and 
weft yarns. The three basic weaves are plain weave, satin weave, and twill 
weave [216].  Woven structures have been used in liver cell culture [194], 
cartilage constructs [217], rotator cuff repair [218-219], heart repair [220], and 
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tendon regeneration [221].  Because they are usually in plain fabric form with a 
thickness less than two yarn diameters, simple woven structures cannot meet 
complex shape requirements. To overcome this limitation, 3D woven structures 
have been developed, initially for applications in the composite area [222-223]. 
The fibres are not only in the warp (x) or weft direction (y), but also in a third 
direction (z) to form a real 3D structure. 3D fibrous woven structure was 
proved suitable for tissue engineering for the first time in 2007 by Franklin et 
al [121] (Fig. 2.14).  
 
Fig.2.14. a) Fibre architecture of an orthogonally woven 3D structure. 3D structures were 
woven by interlocking multiple layers of two perpendicularly oriented sets of in-plane fibres 
(x- or warp direction, and y- or weft direction) with a third set of fibres in the z-direction. a) 
Schematic diagram, b) surface view of the X–Y plane (scanning electron microscope), c) cross-
sectional view of the Y–Z plane, d) cross-sectional view of the X–Z plane [121] 
3D rapid prototyping technique described previously can form 3D structure by 
a computer-aided design. The structure is very similar to that of woven 
structure except that in woven structure the warp and weft yarns are woven 
together, but here the fibres are simply deposited together. Usually yarns 
consist of many thin fibres. For 3D fuse deposition the fibre is very thick 
relatively. Fig. 2.15 shows a 3D rapid prototyping structure in the cross-
section, and 3D micro-CT images for the fibre parts and the void parts.  
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Fig.2.15. a) A cross-section view of rapid prototyping structure and its traditional 3D micro-
CT structure of b) fibre and c) void. 
Knitted structure 
Knitting is different from weaving in that the intermeshing of yarn loops forms 
its fabric. As shown in Fig. 2.16, there are two knitting methods: weft knitting 
and warp knitting [216]. Knitted structures tend to have very good elastic 
property, which makes them particularly suitable for bladder reconstruction, 
artery replacement, and tendon or ligament tissue regeneration. Some of these 
applications are listed below.  
Knitting fabrics can be used as human urinary bladder reconstruction material 
because of its various advantages, such as high elasticity, porosity, good 
mechanical property and drape. Poly (ethylene terephthalate) (PET) knitting 
fabrics have already been studied extensively. Biodegradabe PLA/PLLA/PGA 
knitting fabrics have been used to engineer artificial bladders [224].  
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Fig.2.16. Illustration of a) weft knitting and b) warp knitting structures [224] 
The stability under dynamic stress and the good elasticity are also important 
for tissue-engineered artery.  Poly (L/D) lactide 96/4 warp knitted fabric has 
also been used for artery replacement [225].  
Knitted PLGA scaffolds also give better tendon tissue regeneration than 
braided fibre scaffolds in terms of the new tissue in-growth and the mechanical 
property [196].  
Knitted PLGA and PLLA scaffolds can be used to reconstruct anterior cruciate 
ligament (ACL) [226], and the hybrid structure based on silk knitted fabric has 
also been used in ligament tissue engineering. The hybrid contains silk fibres 
for providing mechanical strength, a knitted structure aiming to improve the 
internal connective space and a collagen matrix assisting and modulating 
neoligament tissue in-growth [192, 227]. To avoid the cell-gel separation from 
composite scaffolds of fibrin gel/PLGA knitted structure [228-229] , a bMSCs 
sheet was assembled directly into a knitted PLLA scaffold for ligament 
engineering [226]. Silk warp knitted fabric cultured with mesenchymal stem 
cells has also been investigated for treatment of stress urinary incontinence, 
with promising results from animal trials [230-231].  
Another hybrid scaffolds have been fabricated by using PLA warp-knit textile 
to enhance a gel, in which the gel can act as a cell carrier, but the textile can 
provide the necessary mechanical property for the hybrid scaffold for 
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cardiovascular tissue engineering [232]. Other application for vascular tissue 
engineering also uses gel to fill a knitted valve structure, like using fibrin gel to 
fill PCL knitting structure [233].  
Hybrid structures based on knitted fabrics have been surface coated with 
electrospun nanofibres to get micro-nano scaffold system for ligament/ tendon 
tissue engineering [196], and with hydroxyapatite to form hybrid structure for 
bone scaffold [234].  
Nonwoven structure 
Fibres in a nonwoven structure are neither woven nor knitted. In industry, 
nonwoven structures are normally made from continuous filaments or from 
staple fibre webs strengthened by bonding using various techniques. The 
bonding techniques include adhesive bonding, mechanical interlocking by 
needling or fluid jet entanglement, thermal bonding and stitch bonding. 
Electrospinning usually produces a nonwoven structure also. In Fig. 2.17, 
conventional nonwoven processing, as well as some new fibre-mat formation 
methods are introduced.   
Nonwoven structure was proved to be compatible to blood in 1969, and 
became an alternative to woven and knitted fabrics in tissue engineering [235]. 
It was initially used as cartilage scaffold by Langer and Vacanti [236]. Since 
then, nonwoven scaffolds have been developed for a wide range of medical 
applications, such as wound dressing [237-238], dermal equivalents [126], 
bone tissue engineering (femoral shaft [239], cartilage [240-242]), ligament 
tissue [243], smooth muscle tissue [244], blood compatible interfaces [245], 
intestinal mucosa [246], and heart valve [247-248] .   
Commercial fibres (usually nonbiodegradable) from polymer materials such as 
poly(ethyleneterephthalate) (PET) [249], Polypropylene (PP) [250], nylon 
[251], polyester (polytetramethyleneterephthalate) [245, 252-253], and 
cellulose (regenerated, oxidized) [254-256] have been used in nonwovens. 
Fibres specially designed for biomedical uses (usually biodegradable) such as 
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from PGA [112, 239-242, 257], poly(L-lactic acid) (PLLA)[258-259], 
Poly(L/D) lactide 96/4 [260], PGA and PLLA 50/50 or PGA/PLA 90/10 [261], 
chitosan(CS)/chitin or composite of chitosan and PLGA [262-263], 
starch/polycaprolactone (SPCL) [264], silk firoin [126], hyaluronan esters 
(Hyafft derivatives) [265-267],  alginate [268], extracted PEA-derived [269-
270], poly (3-hydroxybutyrate(P3HB) [271], and benzyl ester of hyaluronic 
acid (Hyaff-11) [272]  have also been employed.  
To meet the requirements of wettability, tomography or bio-signals for cell 
growth, studies on nonwoven scaffolds have been focused on the surface 
modification. To change surface energy and get a hydrophilic surface, surface 
treatments include chemical methods (e.g. boiling in base [273-275] or strong 
acid [276-278] solution, inducing diethyllaminoethyl (DEAE) groups [249]), 
physical methods (e.g. γ-ray or UV lightradiation [237], low-temperature 
plasma [260], microwave discharge treatment [245] or direct-current pulsed 
plasma treatment [279]), combined methods (e.g. plasma followed by grafting 
thermally with acrylic acid (AA) [279], grafted with AA or NIPAAm and then 
immobilised with collagen and chitosan [237-238, 279]), coating with 
bioactive molecules such as insulin, RGD, heparin, hydroxycarbonated apatite, 
or growth factor [253, 277-278, 280-282]. These treatments help to improve 
the surface biocompatibility, so the scaffold/cell composites can easily 
integrate with the surrounding environments.  
Schmelzisen’s group has succeeded in using PLGA nonwoven scaffold to 
tissue-engineer bone chips in low-load bearing areas [283-284]. Many 
problems related to nonwoven tissue engineering have still not been solved 
effectively. Nonwoven structures are not as stable as woven or knitted 
structures. Deformation, delaminating or cranking happens at macro levels, 
while the fibre slippage within nonwoven scaffold occurs at micro-levels. 
These have a deadly influence on the cell fate. The control of porosity, pore 
size between the fibres can be achieved by changing the fibre diameter, and 
web-laying speed [252, 285]. But a highly porous structure is still hard to 
obtain. For electrospun nonwoven fabrics, which have been used in scaffold 
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fabrication [128-129], the key issue is still poor cell penetration [136-137]. 
There have been many attempts to address this issue [125, 127].  Fibres can be 
disentangled from nonwoven with tweezers manually [252], which is difficult 
to obtain uniform matrices. Hydroentangled nonwoven was cultured with cells 
in each layer, and these layers were then assembled into a 3D structure to 
overcome the cell penetration problems or cell in-growth limitation [286]. New 
nonwoven techniques to modulate the pore structures, including porosity, pore 
size and pore interconnectivity are needed.  
 
Fig.2.17. a) Traditional nonwoven fabric processings. An oriented multifilament yarn was 
produced by polymer extrusion, then the yarns was crimped, cut, carded into a lofty web, and 
further form nonwoven mesh. To improve the dimensional stability, barbed needles, high 
pressure water, or heat was used to entangle the fibres and lock them together; b) wet spinning 
technique: polymer solution was spun into a coagulation bath to form nonwoven structure 
scaffold simultaneously. This method was used to fabricate starch-base nonwoven scaffolds 
[287]; c) melt spinning directly to web. Polymer pellets were fed into the die, the polymer melt 
was then extruded into thin polymer fibres under the heat and air flow. The thin fibres arrange 
randomly to form nonwoven mat without further processing [285, 288]; d) Electrospinning 
process, polymer solution was extruded into micro-fibre mat though the force between high 
voltage and low voltage. By changing the process condition, such as the concentration of 
polymer solution, the applied voltage, the collect distance, various structures can be produced.  
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2.3.2 Issues of fibre-based scaffolds 
Fibrous scaffolds are usually not strong enough for load bearing tissue 
regeneration. The chemical property of polymer fibres may affect cell 
attachment, even though the fibres themselves are usually nontoxic to cells. 
Further surface modification is necessary.  For fibre bundles, yarns, braided or 
twisted structures, their morphologies limit their applications in sutures, 
ligaments or tendons. Circular knitted tube/solid structure is suitable for 
specific applications like artery, ligament and tendon. Plain woven or knitted 
structures are usually thin and flat and cannot be used as 3D tissue engineering 
structures. Nonwoven fabrics face a similar challenge. Further developments in 
3D woven, knitted, and nonwoven structures are needed. The nonwoven 
process is particularly attractive due to its relatively low production cost.  
2.4 Role of nano-structured functional surfaces on cell 
performance of polymer scaffolds 
 
Surface design of polymer scaffolds that can promote tissue regeneration has 
become a focus of tissue engineering research. Surface architecture 
(morphology and topography) and surface chemistry may have great effects on 
cellular responses in the initial stage of cell attachment, and further cell 
proliferation, differentiation, and even neo-tissue integration with human body.   
 
Surface topography patterns at different scales can direct cell growth [289]. 
Patterns at the single-cell scale (0.1-100μm) can provide contact guidance, 
which limits cell adhesion to specific locations and influence cell shape and 
orientation [290-293]. Patterns in nano-scales are important for cell attachment 
[294]. Surface topography is also directly related to ECM formation [295-296]. 
Surface topography can indirectly affect the surface wettability, thus controls 
protein absorption and cell attachment [297].  
Surface chemistry is playing a profound role in cell growth and gene 
expression. Numerous surface treatment or functionalisation techniques have 
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been developed to confer specific surface for cell-related scaffold therapy. 
Surface can be loaded with bioactive components for better cell-surface 
interaction [298]. Surface can be modified to enhance cell attachments [299].  
Conductive property can also be imparted to the surface for controlling neural, 
muscle or ligament cells orientation [300]. Surface can have anti-bacterial 
property for reducing infection during the implantation [301].  
In the rest of this part, nano-structured surface for improvement of cell 
performance, bioactivity, antibacterial property of 3D polymer scaffolds is 
introduced.  
2.4.1 Nano-structured surface for enhancement of cell 
performance 
Cell interaction with the environment has been examined for a long time. It has 
already been proved that material surface topology in micrometer-range 
features such as grooves, ridges, and wells have a strong influence on the cell 
attachment, adhesion and proliferation [10]. Cells even can align, grow and 
migrate along a defined topography orientation. This was explained by contact 
guidance [302].  It was found that micrometre surface features might influence 
cells in morphology, orientation, cytoskeleton and focal contact arrangement, 
motility and gene expression [303-305]. The nano-scaled surface architecture 
can mimic and provide physiological conditions similar to native extracellular 
matrix (ECM) for proper growth of engineered tissue [306]. The increase in 
nano-roughness can alter the surface energy, and then increase protein 
absorption and bioactivity. Subsequently, the cells attachment, adhesion, 
proliferation and long term extracellular matrix will be enhanced. Cell response 
to nano-patterned surface has been reviewed [306-307]. Cell performance on 
the nano- or micro-structured surface depends on cell types, because different 
cell lines might favour different surface roughness. For example, endothelial 
cells and osteoblast cells preferentially adhere onto both nano-structured and 
sub-micron structured titanium surfaces rather than smooth titanium surfaces 
[308]. Macrophage-like cells respond to smaller surface features 30 nm in 
height, and endothelial cells react to larger surface features such as those with a 
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height greater than 100 nm [309-310].  More recently, it was proposed that 
disordered nano-patterns might increase cellular adhesion better, and 
osteoblastic/osteospecific differentiations as well in contrast to ordered nano-
patterns [311-313].  
The techniques for modification of surface roughness can be classified into 
three categories: physical method, chemical method and their combinations. 
The surface can be featured as ordered or disordered patterns. The nano-scale 
features can be nano-rods, nano-ridges, nano-wires, nano-pits, nano-dots, nano-
particles, nano-crystals, and nano-fibres (See in Fig. 2.18).  
 
Fig.2.18. Various nano-structured surfaces, a) nanopits [314], b) nanoparticles [315], c) 
nanowires [316], d) nanogrooves, e) nanoridges, f) sharp-tip nanoridges, g) nanocrystals [317], 
h) nanorods, and i) nanofibres [318].   
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Plasma etching: high energy plasma can etch the substrate surface, causing the 
formation of rough surfaces. It was used to produce disordered nano features 
on scaffold surface many years ago. For example, atmospheric pressure plasma 
treatment on PLLA can induce formation of nano-patterned surface for cell 
growth (Fig. 2.19) [13]. Plasma etching method is mainly suitable for thin 
films or membranes, because the plasma cannot penetrate into the thick 
scaffolds [319-320]. For this reason, it is not quite suitable for surface 
modification on 3D scaffolds.  
 
Fig.2.19. PLLA film treated with different plasma voltages, a) plain surface; b), c) and d) 
plasma treatment to form 70 nm to 100 nm nano-featured surfaces. [13] 
Template method: The procedure of using template to make a nano/micro-
structured surface is very simple, cost effective and there is no need for 
expensive facility. This method was widely used in tissue engineering (Fig. 
2.20) [321]. Silicon and AAO are good template candidates due to their porous 
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structure, but they are not suitable for 3D porous scaffold surface 
modifications.  
 
 
Fig.2.20. Scheme of template methods, a) Overturning method to form nanopits, b) directly 
deposition method to form concaves [321]  
Lithography: includes photo-nanolithography, colloidal lithography, 
nanoimprint lithography, electro-beam lithography, focused-ion beam 
lithography, dip-pen lithography, transfer lithography and interference 
lithography. This series of methods are modern tool to modify surface. Fig. 
2.21 illustrates one of the novel lithography systems, reflective electron beam 
lithography. It can greatly improve the throughout per hour [322]. Photo-
nanolithography needs photo-masks and the polymer should be photo-active, 
which narrows the selection of polymers [323]. Ion implantation method can 
introduce a severe compositional and chemical modification to the polymer 
surface. But the shallow penetration depth and the relatively high machine cost 
prevent its wide use in 3D polymer scaffolds [324-325]. Other lithography face 
similar challenges: it requires costly special equipments, and the processing 
procedure is time-consuming. This treatment is limited to small area.  
 
  
-45- 
 
Fig.2.21. Diagram of REBL nano-writer concept [322] 
Electrospinning: can generate porous fibrous structure for better cell growth. 
The weak points of this technique are that it is not able to provide thick 3D 
structure, and the surface nano-features cannot be controlled exactly [17].  
Although novel fabrication method can make electrospun mat form 3D tissue 
scaffolds, the nanofibre mat is actually situated between the micro-pores, but 
not on the surface of individual pore [186].  
Wet chemistry methods including chemical etching, polymer demixing, LBL 
coating, sputter coating and sandblasting may solve the problem of poor 
penetration. It also can modify surfaces throughout the whole scaffolds [326-
327].  
Chemical etching: is the basic method to get nano-textured surface. Acid or 
base etching method is usually used in metal, ceramic scaffold [328-329], and 
sometimes polymer surfaces [330]. For example, PU and PLGA were etched 
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by HNO3 and NaOH separately to get nano-structured surfaces (Fig.2.22) [12].  
However, strong acid and base are not suitable for polymer-related scaffolds, 
because they might de-composite polymer and influence the mechanical 
property of scaffolds.   
 
Fig.2.22. Chemical etching to get submicro-or nano-structured surfaces [308]  
Polymer demixing method: for nano-patterned surfaces relies on the 
spontaneous phase separation of polymer blends (uniform in one solvent). 
Polymer demixing can get island structure having the exact same component as 
the body polymer, and this method can also control the island height from 10-
100 nm (Fig. 2.23) [331].  
  
-47- 
 
Fig.2.23. AFM images of islands formed using different polymer blends, a) 20% w/w poly(p-
bromostyrene): 80% w/w poly(styrene), b) 60% w/w poly(p-bromostyrene): 40% w/w 
poly(styrene,c) 80% w/w poly(p-bromostyrene): 20% w/w poly(styrene), d) AFM image of 45 
nm high PS/PBrS islands,e) AFM image of 50 nm high PS/PnBMA islands [331] 
Layer by layer electsostatic self-assembly (ESA): is often used in biomedical 
field for incorporation of specific biomacromolecules or bioactive molecules 
onto scaffold surface, due to its ability to control the coating quantity and 
coating thickness [332-333].  Layer by layer coating can be used to get nano-
patterned surface by coating nanoparticles or nanorods on the surface. Silica 
nanoparticles have been used to coat fabrics to obtain buoyancy properties by 
this method (Fig. 2.24) [334].  
 
Fig.2.24. SEM images of untreated cotton fabric (a and b) and cotton fabrics assembled with 
(PAH/SiO2)n multilayers: (c) n = 1, (d) n = 3, (e) n = 5, and (f) n=7 [334].  
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Issues on nano-patterned surfaces 
1) It is often difficult to separate the influences between the surface 
chemistry and the surface topography, because the surface chemistry 
usually changes with the modification of surface topography. 
2) Nanoparticles modified surface may induce allergic or inflammatory 
reactions or influence hemolysis and blood coagulation [335-338].  
3) Whist many methods are available for achieving nano-surface features, 
achieving fully ordered and controlled surface structures for 3D 
scaffolds remains a challenge.  
 
2.4.2 Bioactivity improvement for bone tissue engineering 
The natural bone is a composite consisting of inorganic apatite nanocrystals 
and collagen fibres, and the inorganic apatite nanocrystals deposit on collagen 
fibres to form a three dimensional structure [339]. Apatite is proved to be 
excellent in biocompatibility, bioactivity and osteoconductivity [340]. It can 
reduce the interface energy between human bone mineral and the surface 
apatite layer on scaffold when implantation. Considerable efforts have been 
spent on enhancing bioactivity by coating with bone-like apatite, calcium 
phosphate ceramic or hydroxyapatite on the surface of metal or polymer 
through plasma spraying [341], ion sputtering [342], laser deposition [343], 
sol-gel deposition [340], and dip coating sintering [344]. They usually required 
high temperature or specific pH condition. The prepared apatite is not similar 
to that in human body, and lacks bioactivity.  It was believed that via soaking 
in SBF solution, the apatite formed a low crystallinity and nano-crystal size, 
which is more similar to natural bone and easy to degrade [345]. Fig. 2.25 
shows various CaP surface structures [346]. Usually the polymer surface was 
modified to have functional groups like carboxylic acid, hydroxyl groups, Si-
OH, Ti-OH, Zr-OH, Nb-OH and Ta-OH which were effective to induce apatite 
nucleation by capturing calcium and phosphate ions from SBF solution [347-
348]. With time, bone-like apatite layer was easily formed on polymer surface.  
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Fig.2.25. Apatite coatings with different morphologies, a) and b) apatite precursor spheres, c) 
and d) plate-like apatite, e) and f) small plate-like apatite formed, g) and h) conventional 
apatite formed after immersing in SBF for 1 and 14 days, respectively.[346]  
The common problem for those methods is that the deposition is time-
consuming. For example it took 60 days to form apatite on PCL film surface. 
So to speed up the apatite formation on polymer surface, many methods have 
been tried.  
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1) Pre-dipping in Ca2+ and PO43- solution to achieve nucleation of CaP on the 
surface, and then soaking in SBF solution.  These procedures were repeated 
several times for better nucleation [349].  
2) Surface was functionalised with special groups for effectively controlling 
the nucleation procedure. NaOH treatment of PCL was used to induce the 
formation of –COOH groups for speeding up the nucleation procedure [350]. 
NaOH is a strong base, which may cause decomposition of polymer bone 
scaffold.  
Plasma technology was used to modify the surface chemical properties in an 
environment-friendly way. It could offer polymer surface with active groups 
such as carboxylic acid, RUhydroxyl groups by simple atmosphere treatment 
[319]. O2 or argon plasma pre-treatment to introduce functional groups on 
polymer surface has exhibited significant improvement in CaP formation on 
polymer surface [351-352].  
3) Soaking in high concentration SBF 
Soaking can be done in a solution of high SBF concentration, for example 
using 2×, 3×, 5×, or 10× times of SBF. The 10×SBF is very unstable, and hard 
to prepare, CO2 gas was used to improve the stability of 10×SBF [353-354]. 
Another problem for the high concentration SBF is that apatite formed from a 
high concentration SBF may have different component to that of human bone. 
This may affect the vivo experiment or implantation [355].  
Among these methods, the nucleation induced by surface functionalisation is 
the most effective, and the time for the formation of a sufficient CaP layer can 
be shortened significantly.  
2.4.3 Antibacterial scaffolds  
The main failure of tissue implantation is caused by infection [356], like many 
cases from dental implantation [357-358] and in vitro fertilization cycles [359]. 
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Such an issue has not received much attention, presumably because most of the 
studies are focused on how to improve cell attachment, growth and even 
proliferation.  
The usually used disinfection method includes UV irradiation, autoclave, 
dry/wet heat, ionizing radiation or 75% ethanol disinfection, which is either 
time-consuming or not cost-effective. More importantly, they have limitation 
in certain scaffolds and might decrease the mechanical properties. Alcohol 
sterilisation is not always effective for bacteria. After the implantation, the 
tissue scaffold in the body is also facing a great risk of infection. Moreover, the 
tissue implanted often resists antibiotics resulting in failure of implantation 
[360].  
If scaffolds were coated with one antibacterial layer, it would be able to stop 
bacterial infection. Actually, there are already many applications of 
antibacterial coatings in the biomedical area, such as valves [361], pins [362], 
vascular [363], catheter [364] and prostheses [365-366]. The antibacterial 
agents that have been considered for biomedical uses range from metal ions, 
metal compounds and organic agents. They can kill microorganisms but are 
somewhat toxic too. One useful article defined a biocompatibility index to 
compare the safety of antibacterial agents in biomedical use [367]. Results 
indicated that silver nitrate (AgNO3) is the most toxic one to murine fibroblast, 
followed by octenidine dihy- drochloride (OCT), silver (I) sulfadiazine (SSD), 
benzalkonium chloride (BAC), cetylpyri- dinium chloride (CPC), 
chlorhexidine digluconate (CHX), triclosan (TRI), polyhexamethylene 
biguanide (PHMB), mild silver protein (MSP), iodine in solution [PVP-I(s)] 
and povidone iodine in ointment [PVP-I(o)]. When taking the antibacterial 
properties into account, the OCT and PHMB are the best candidates for cell-
related antibacterial agents.  
Nano-Silver:Silver has been recognised for its excellent antibacterial activity 
since ancient time against a broad range of microorganisms, over 650 disease-
causing organisms in the body, even at low concentrations [368]. More 
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recently, it was identified to interrupt HIV cellular replication [369]. With the 
development of nanotechnology, Ag is favoured due to its small size and large 
surface to volume ratio. This can increase the contact chance to microbes and 
then vastly improve its antimicrobial activity [370]. It differs from bulk 
materials in many aspects, like possessing high extinction coefficient, high 
surface Plasmon resonance and anti-microbial properties that are less toxic 
than bulk form [371-372]. It also has been proved to kill several pathogenic 
bacteria that have resistance to various antibiotics [373]. Silver has been 
applied as biocide widely in daily life, such as bandage [374], food packing 
[375], water or air treatment [376-377]. In biomedical area, Ag based wound 
dressing [372, 378] and Ag coated medical devices have been extensively used 
as well [362-363, 365].   
To date, the mechanism of Ag killing bacteria is explained as: 1) Ag caused 
leakage of the ROS outside the cell leading to apoptosis [186]; 2) Ag interacted 
with thiol groups to prevent the cell proteins from forming correctly and DNA 
replication [379]; 3) Attachment to the cell surface, altering the function of the 
cell membrane [380].The antibacterial property of Ag depends on the size, 
shape and charge. For example, size ranging from 1 to 10 nm has better 
bactericidal activity because of more chances to contact with bacteria [381]. 
Truncated triangular shaped is the best among other shapes like tubes, rods, 
triangles, wires and aligned wires [380, 382].  
Although many researchers have raised concern that Ag might have potentially 
negative influence to health, some cell culture experiments have shown Ag 
nanoparticles are cytotoxic to rat liver cell line [383], lung epithelial cells [384], 
keratinocytes and fibroblast cell lines [385], and PC-12 neuroendocrine cell 
line [386] and brain ultrastructrue [387]. Ag in most studies is suggested to be 
non-toxic to mammalian systems [388-389]. In comparison to the surgery 
failure due to the infection, Ag is much less toxic to human body. If only the 
concentration, size and status for optimum antimicrobial activity is known, Ag 
would be perfect for disinfection of scaffolds for implantation applications 
[390].   
  
-53- 
Till now, the Ag coating on bio-devices or fabrics for antibacterial function has 
been through wet chemical and physical methods. Generally, it is to make the 
silver salt to reduce into nAg particles. Most of the physical methods (e.g. 
microwave irradiation [391], UV irradiation, γ-irradiation [392-393], ultrasonic 
[394-395] and plasma coating) are best for film surface treatment and need 
expensive devices. However, wet chemical modification provides easy, 
convenient treatment to both film and 3D structure, and no expensive devices 
are necessary. Sol-gel method has been widely applied in the textile industry. 
A disadvantage of this method is that it is hard to get uniformly distributed Ag 
nanoparticles throughout the whole fabric [396-397]. Layer by layer coating 
method makes it possible to coat 3D matrix evenly, but it involves multi-step 
and complicated treatment [398-399].  
PHMB:Polyhexamethylene biguanide (PHMB), also known as polyhexanide 
and polyaminopropyl biguanide, was firstly found to have good antibacterial 
property in mid 1970s.  As another very popular biocide,it is a mixture of 
polymeric biguanides (Fig. 2.26, where n=2–40), with a mean size of n=11, 
giving a molecular mass range of approximately 400–8000, with various 
combinations of amino, guanide or cyanoguanide as end-groups.  PHMB can 
be synthesised using the following simple method. Firstly, 
hexamethylenediamine reacts with sodium dicyandiamide to get 
hexamethylene biscyanoguanidine. Secondly, the resultant products react neat 
with hexamethylenediamine hydrochloride at 160-185 °C for 4 hours under 
constant stirring to form oligomeric molecules of PHMB [400-401].   
 
Fig.2.26. Structure of PHMB 
PHMB is effective to a broad spectrum of gram-positive and gram-negative 
bacteria, fungi, yeast, and even HIV-1 [402]. Many researches focus on the 
effectiveness of PHMB on bacteria from ophthalmic area (Acanthamoeba 
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polyphaga, A castellanii, and A hatchetti.), water systems (Legionella 
pneumophila.), biofilms (E coli and S epidermidis), and fungal infection 
(Trichophyton mentagrophytes).  
PHMB has been found diverse applications. For example, it was used to 
prepare antimicrobial fabrics in textile industry [403-404], food disinfection in 
food industry [405], and in many wound dressing products (e.g. AMD). It was 
used to avoid wound infection both in film and foam [406]. It was also widely 
used for contact lens disinfection solution in ophthalmology [407]. In hospital, 
it has been used as skin antiseptics clinically [408], commercial swimming 
pool cleaning agents also contain PHMB components [409].  
The action of PHMB on microbial is usually regarded as contact-killing. 
PHMB can attach itself to the bacterial cell membrane, disrupting microbial to 
kill the bacteria. PHMB interacts with the bacteria surface initially and then is 
transferred to the cytoplasm and cytoplasmic membranes. Another explanation 
is that the cationic biguanide functional group can react with negatively 
charged bacterial outer membrane, causing the increase in fluidity and 
permeability. As a result, the lipopolysaccharides are released from the outer 
membrane, and organism is killed. Some researchers believe that PHMB can 
cause the formation of the acidic phospholipids of the cytoplasmic membrane, 
resulting in the organism death eventually.  
Since PHMB has many active groups in the backbone, it is easy to bond 
PHMB to cotton fibre by multiple cationic groups, providing the stability 
between PHMB and cotton fibres. It is also easily applied to cotton fibre by a 
simple pad-dry-cure procedure. The PHMB can be exhausted on the fibre 
surface effectively. For synthetic fibre, self-crosslinkable resin and catalyst can 
assist the reaction between PHMB and fibres. For wound dressing application, 
PHMB can be introduced to the dressing fabric to protect against the 
development of wound infection by decreasing the bacterial load in the 
dressing and bacterial penetration through the dressing. PHMB is also 
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incorporated into the foam dressing during processing while the dense open-
cell foam matrix develops. 
When assessing the suitability of PHMB for use in the biomedical field, its 
cytotoxicity to mammalian cells must be taken into consideration.  It has a low 
toxicity to eye cells in very low concentration (about 0.0001%), and low tissue 
response and minimal patient discomfort [410].  When used for wound 
dressing, it didn’t elicit any skin reactions. As to other cells such as HaCaT 
cells, Human keratinocytes and fibroblasts [411-412], it showed very low and 
nearly no toxicity. 
Several researchers [210, 411] have studied the co-culture of bacterial and 
human mammalian cells on biocide-containing matrices. Many exciting results 
have been obtained. For example, PHMB has been proved to have ability to 
inhibit HIV-1 virus bonding to human health cells [402]. PHMB treatment can 
be useful for removing bacteria from cartilage if a defined predetermined 
concentration is applied [413]. PHMB has also been tested for protecting 
human keratinocytes from bacterial damages [411].  Nanosilver containing 
PHBV scaffolds has been proved to effectively inhibit the proliferation of 
Staphylococcus aureus (Gram-positive) and Klebsiella pneumoniae (Gram-
negative) bacteria, whereas the scaffolds do not show any in vitro cell 
cytotoxicity [301]. But there are also some opposite examples. The nano-silver 
contained ceramic scaffolds were proved to negatively affect osteoblast-like 
cell proliferation, meanwhile it can kill 99.9% Staphylococcus aureus [414]ˈ 
PHMB can result in severe damage to osteoblast cells hFOB [415]. 
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C H A P T E R  T H R E E  
Materials, Methods and Characterisation 
Technologies 
The materials, preparation and characterisation techniques used for all the 
experiments in this PhD study are listed in this chapter. 
3.1. Materials 
Poly(ε-caprolactone) (purity >99% Mn=80,000, Aldrich), anhydrous ethanol ( 
>99.5%, Aldrich), Tetraethoxysilane (TEOS), G418 solution, food-level 
ground sugar (sucrose, local supermarket), Dulbecco’s phosphate buffer saline 
powder (DPBS, Gibco), phenol-red-free media (RPMI, Invitrogen), 
glutaraldehyde (2.1%) in phosphate-buffered saline (PBS 10 mM, pH 7.4) 
(Whiteley medical, aidal plus), Osmium tetroxide (OsO4) (SPI suppliers, 2% in 
water), tannic acid (Aldrich), MTS-kit bioassay (Promega), phenazine 
methosulphate (PMS, Aldrich), sodium chloride (≥99.5%, Aldrich) and 
phosphate-buffered saline (PBS 10 mM, pH 7.4) were used as received. Milli 
Q water was always used in experiments. 
3.2. Fabrication and surface modification of fibrous 
scaffolds   
PCL filaments were extruded on a Wayne Bantam single screw extrusion line 
with a 12.5 mm screw diameter and 20:1 length to diameter ratio. The screw 
used had a 4:1 compression ratio. The screw speed was set at 25 rpm. An 18-
filament die was used for the extrusion. This extrusion unit has a 5-zone heated 
unit set at 93.3 ºC in the first zone ramping to 121 ºC in the final die zone. The 
extruded fibres were drawn from the spinneret die at 100 metres per minute. 
The PCL fibres were cut to 2 mm length prior to use. 
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Sucrose sugar powders were sieved (sieves 48 mesh and 28 mesh, Cole-
Parmer) to narrow the size in the range between 300 μm and 600 μm. The 
sieved sugar powders were then mixed with short PCL fibres in different ratios. 
To improve the sugar-fibre adhesion, a small volume of deionized water (1 ml 
per 10g of sugar-fibre mixture) was added during blending. 
The mixture was then cast into a capped metallic mould and placed into a 62 
ºC oven for 30 minutes to allow the fibres to bond with each other. After 
cooling down to room temperature, the heated fibre-sugar blend was washed 
extensively with deionized water to leach off the sugar. The matrices were then 
dried at room temperature for 24 hours. The thickness of the matrices was 
controlled to near 2 mm. In order to match the size of tissue culture wells, the 
matrices were cut into a thin disk shape (diameter 1.4 cm). 
Synthesis of silica nanoparticles  
Silica nanoparticles were synthesised according to the Stober method [416]. 
Briefly, 4.5 ml TEOS were dropwise added in a mixed solution with 3 ml 
water, 150 ml ethanol and 9 ml ammonia, and then stirred overnight, followed 
by centrifuging at 6000 rpm for 30 mins to collect the particle pallets. Then the 
nanoparticles could be washed twice with water and keep in distilled water for 
further use.  
Layer-by-layer electrostatic self-assembly of nanoparticles 
Electrostatic layer-by-layer coating method was conducted according to the 
following procedure: 1) PCL matrix was treated by 1M NaOH for 2h to form –
COOH on the surface, 2) then it was dipped into silica nanoparticle solution for 
5 mins to get a thick silica coating, 3) following it, the samples were dipped 
into 1% PAA solution to get a negative charge layer, 4) the samples were 
dipped into silica solution to get the first bilayer treated samples.  Between 
every step, the samples were thoroughly washed in distilled water and allowed 
getting rid of the extra components on the surfaces. Through repeat dipping 
into silica and PAA solution, multilayer silica can be applied on the surface. 
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With this method, the thickness of silica nanoparticles on the surface could be 
controlled effectively and the surface nano-morphology could also be 
manipulated easily.  
Plasma treatment of PCL scaffolds  
A lab-scale vacuum plasma system (Fig. 3.1) was used for plasma surface 
treatments. The energy used was 20W. Both the front and back surfaces of 
each specimen were treated for 3 min, separately.  
 
Fig.3.1. a) Vacuum plasma surface treatment unit, b) the plasma treatment zone 
Simulated Body Solution (SBF) soaking  
1×SBF solution was prepared following Kokubo’s methods [417]. Briefly, the 
SBF was prepared by dissolving NaCl, NaHCO3, KCl, K2HPO4•3H2O, 
MgCl2•6H2O, 1M HCl, CaCl2, and Na2SO4 in ultra-pure water and buffering to 
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pH 7.25 at 36.5 °C with tris(hydroxymethyl) aminomethane (final 
concentration of 50mM) and aqueous 1M HCl solution. The final solutions 
were filtered to eliminate impurities and stored at 4 ºC for several weeks 
without precipitation. 
For 10 times concentrated SBF (10×SBF), the preparation was according to 
document [418]. NaCl, KCl, CaCl2•2H2O, MgCl2•6H2O, Na2HPO4 were 
completely dissolved in MilliQ water in the given order at room temperature. 
The solution was then adjusted to pH near 4.35 and kept at room temperature 
for several months. NaHCO3 was added in to improve pH near 6.50 just before 
coating samples. The calculated ion concentrations of 1×SBF and 10×SBF 
solutions in comparison with those in human blood plasma (HBP) are listed in 
Table 3.1.   
Table 3.1. Ion Concentrations of the SBFs and Human Blood Plasma in Total and Dissociated 
Amounts 
Concentration/mM 
Ion 
Blood 
Plasma 
1×SBF 10×SBF 
Na+ 142.0 142.0 1020 
K+ 5.0 5.0 5.0 
Mg 2+ 1.5 1.5 5.0 
Ca2+ 2.5 2.5 25 
Cl- 103.0 147.8 1065 
HCO3- 27.0 4.2 10 
HPO42- 1.0 1.0 10 
SO42- 0.5 0.5 N/A 
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Samples after the vacuum plasma treatment were immediately immersed into 
1×SBF or 10×SBF at physiological pH of 7.4 and temperature of 37 °C for a 
certain time to deposit one layer of apatite. After that, the matrix disks were 
thoroughly washed by MilliQ water and dried overnight at room temperature 
for further use. 
Electroless plating  
Electroless plating was chosen to coat nano-Ag to the surface of 3D fibrous 
scaffolds. Two-part electroless Ag plating was prepared as follows:  
 
Solution A: 30g of NaOH were added to an AgNO3 aqueous solution 
containing 70g AgNO3 and 1200 ml water. Precipitation occurred instantly 
during the addition of the NaOH. Concentrated ammonia (35 wt %) was 
dropped into the Ag solution until it became clear. 5mg of L-cystine was then 
added into this solution to give the Solution A.  
 
Solution B: 90 g of D-glucose and 8 g of citric acid were dissolved into 200 ml 
ethanol and 2L water to give the Solution B. 
 
The cut circular discs were put into reaction beaker, and the two solutions were 
added into it together for a certain time (from 10 mins to 40 mins were 
examined in this study) 
 
Layer-by-layer coating of PHMB on 3D fibrous scaffolds 
3D PCL fibrous matrices were firstly treated with 1M NaOH for 2h to induce 
the formation of  –COOH groups on the surface, and then they were dipped 
into 1% PHMB solution (pH 8.0) to get a full negatively charged surface, 
following which was a continuous cycle of dipping between 1% PAA solution 
and 1% PHMB solution, both at pH 8.0.  It was marked as 1 layer PHMB for 
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the first dipping, and then 1bilayer PHMB for the first cycle, 3 bilayers PHMB 
for 3 cycles, and so on.  
3.3. Cell culture related technologies 
3.3.1 Sterilisation  
All the samples in this thesis used for biological experiments were sterilised by 
rinsing with 70% ethanol, saturated sodium chloride aqueous solution and 
MilliQ water (R=18.2MΩ). They were then placed individually in the wells of 
tissue culture plates and washed with sterile 70% ethanol for 30 min ~1.5 hr on 
an orbital shaker. The 3D scaffolds were rinsed with fresh 70% ethanol for 5 
minutes, dried in biohazard hood, and kept in clean and dry containers for 
further uses. 
3.3.2 Cell culture media 
The culture media for fibroblasts was prepared as mixture of 500 ml fibroblast 
media (RPMI + Glutamax) (Invitrogen) supplemented with 40 ml foetal bovine 
serum (FBS, Bovogen), 5 ml of penicillin and streptomycin solutions (10000 
U/ml penicillin, 10000 g/ml streptomycin, Sigma-Aldrich) and 2 ml amphostat 
B (Thermo Scientific). 
The culture media for CHO cells was prepared as mixture of 500 ml of CHO 
media (GIBCO + Glutamax) (Invitrogen) supplemented with 40 ml foetal 
bovine serum (FBS, Bovogen), 5 ml of penicillin and streptomycin solutions 
(10000 U/ml penicillin, 10000 g/ml streptomycin, Sigma-Aldrich) and 2 ml 
amphostat B (Thermo Scientific). 
The culture media for Saos-2 cells was prepared as mixture of 500 ml of Saos-
2  media (MEM+Glutamax TM-1) (Invitrogen) supplemented with 50 ml foetal 
bovine serum (FBS, Bovogen), 5 ml of penicillin and streptomycin solutions 
(10000 U/ml penicillin, 10000 g/ml streptomycin, Sigma-Aldrich) and 5 ml 
non-essential amino acid solution (NEAA) (Sigma-Aldrich). 
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The culture media for Hfob 1.19 cells were prepared as mixture of 500 ml of 
hFOB media (DMEM: F-12 Medium without phenol red) (Invitrogen) 
supplemented with 50 ml foetal bovine serum (FBS, Bovogen), 150 mg of 
G418 (Sigma-Aldrich). 
3.3.3 Cell lines 
Rat skin fibroblasts, Chinese hamster ovary (CHO) cells and Saos-2 osteoblast 
like cells were donated by Barwon Health hospital in Australia. 
Human Osteoblast cells (Cell line number CRL-11372) were purchased from 
American Type Culture Collection (ATCC). 
3.3.4 Subculture of cells 
The obtained rat skin fibroblast and CHO cells were subcultured firstly in 37 
°C incubators to get a steady growth for further cell culture study usage. Fig. 
3.2 indicated the healthy state of fibroblasts and CHO cells.  For fibroblasts, 
when growing on the flat tissue culture plates (TCP), they maintained a flat 
multipolygon shape. In contrast, CHO cells were spindle shaped and also grew 
nicely on the TCP surface.  
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Fig.3.2. Cell morphology of fibroblasts (a, and a’) on TCP under low and high magnification at 
37ºC and CHO (b) on coverslip.  
The original hFOB1.19 and Saos-2 cells were subcultured in 34 °C and 37 °C 
incubators separately, and they were ensured to grow healthily before doing 
any experiment further. The morphologies of hFOB 1.19 and Saos-2 cells used 
were shown in Fig. 3.3.  From the lower and the higher magnification of 
images, the cells attach to the TCP surface nicely and grow very well.   
 
Fig.3.3. Cell morphology of hFOB 1.19 (a, a’ and a”) and Saos-2 (b, b’ and b”) on TCP under 
low and high magnification at 34 ºC and 37 ºC 
3.3.5 Cell seeding 
In this thesis, different seeding methods were utilised. 
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1) Static seeding method: Briefly, 50 μl cell/media suspension was dropped 
onto the scaffold surface as uniformly as possible using a pipette. After 1.5 hr, 
other 950 μl media was topped up. On the second day of seeding, the matrices 
were washed with PBS and transferred to a new culture well. The number of 
cells attached on the matrices also was calculated by MTS assay described 
later. 
The seeding efficiency was calculated according to the equation (3.1): 
ሺΨሻ ൌ      
   
ൈ ͳͲͲ  (3.1) 
2) Dynamic seeding method using spinner flask: A certain volume of media 
was put into the spinner flasks, and it was magnetically stirred under a certain 
speed for a pre-set time.  In detail, 110 ml of seeding media was put into the 
spinner flasks, and the speed of spinner flasks was set in the range between 50 
rpm and 80 rpm. A seeding density of 1×106 cells/ml was used. 
3) Dynamic seeding method using small rotary vial: A certain volume of media 
was put into the small rotary vial, and it was put into the blood roller machine 
to rotate overnight to seed the cell uniformly onto the scaffolds. The seeding 
volume was only 2 ml, the rotating speed was between 23 rpm to 52 rpm, and 
the seeding density was 5×104 cells/matrix.  
4) Dynamic seeding method using orbital shaker:  Different seeding volumes 
ranging from 50, 100, 200, 500, to 1000μl were put into the well of tissue 
culture plates, and it was put onto orbital shaker to shake overnight at speed of 
0, 50, 75, 100, or 125 rpm.  The seeding density was controlled at 5×104 
cells/matrix.  
3.3.6 Cell culture 
All the samples after cell seeding experienced static cell culture. They were put 
into the standard incubator (37 ºC, 5% CO2). In the culture period, the media 
were first replenished after the first seven days and then every three days. 
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3.3.7 MTS assay 
MTS assay is a straightforward and simple method to detect the cell 
proliferation. The principle of the assay is that MTS tetrazolium compound is 
reduced in cells into a coloured formazan compound that is soluble in tissue 
culture media. This conversion occurs via dehydrogenase enzymes that are 
present in live cells. The colour then could be read in density to decide the live 
cell number [419]. 
During the culture period, matrices at different time points were chosen for 
MTS assay. The matrices were rinsed with PBS, to remove non-viable cells, 
and were transferred to new wells with 0.5 ml phenol-red-free RPMI media 
(Invitrogen). The original seeded well was also topped up with 0.5 ml phenol-
red-free media. Wells and matrices were let to react with 50 μl of 5 mg/ml 
MTS solution in phosphate buffered saline (PBS, Sigma Aldrich) for 4 hrs in 
37 qC incubator. As colour-development solution, 375 μl phenol red free media 
and 125 μl MTS and PMS in PBS solution (0.046 mg/ml PMS and 2 mg/ml 
MTS) were added. Samples were incubated in a 37 qC incubator for 1 hr, after 
which 100 μl of the solution was withdrawn to measure the absorption at 490 
nm on a microplate reader within the hour. 
MTS standard curves were obtained in a similar way by using a series of 
samples containing a known number of viable cells. The absorption was 
adjusted by subtracting the readings of the zero wells from all of the other 
readings. The cell numbers from the wells, the matrix or the sum of both were 
calculated based on the standard curve. All the cell culture related results were 
collected in triplicate and were presented in form of average and standard 
deviation. 
3.3.8 Cytotoxicity test 
A typical cytotoxicity test was implemented for 3 days [DS/EN ISO10993-5]. 
Sample scaffolds were seeded with rat skin fibroblasts (donated by Geelong 
Hospital, VIC, Australia) via static seeding into a 24-well tissue culture plates 
(Greiner, Interpath), using a calculated density of 1 × 104 cells/well. Cells were 
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cultivated in 1 ml of fibroblast media under standard culture conditions (i.e. at 
37 ºC, in a humidified atmosphere containing 5% CO2 and 95% air). The cell-
seeded scaffolds were maintained for 4 hrs in a 37 °C incubator prior to the 
addition of 1 ml culture medium into each well. The samples were then 
cultivated at 37 °C, in a humidified atmosphere containing 5% CO2 and 95% 
air. The cell number was determined by haemocytometer using a Trypan blue 
dye (Sigma-Aldrich) to exclude nonviable cells from the count. 
3.3.8 Stain of samples for microscopic observation 
After cell culture, cells on matrices were collected from the culture plates and 
washed three times with sterilized PBS, then immersed in a 2% para-
formaldehyde in PBS for 10 minutes at room temperature. After rinsing with 
PBS for three times, cells were stained with 1% toluidine blue in 2% borax and 
0.04% methylene blue. The stained samples now were ready for observation 
under microscope.  
3.3.9 Stain of samples for SEM observation 
Before SEM observation, cells on the scaffold samples were fixed by 
immersing the cell-carrying scaffolds in 2.1% wt/vol glutaraldehyde in 
phosphate-buffered saline (PBS 10mM, pH 7.4) for 4 hrs at room temperature. 
After rinsing with sequential dilutions of PBS in deionized water, the matrices 
were immersed in a 2% wt/vol solution of OsO4 in water for 20 minutes. The 
scaffolds were then immersed in a 1% wt/vol aqueous solution of tannic acid 
for 10 minutes, and then rinsed with 20% ethanol/water solution. The scaffolds 
were then freeze-dried in a freeze-drier (Labconco Freezone 2.0) 
3.3.10 Laser scanning confocal microscopy  
Laser scanning confocal microscopy (LSCM, Leica TCS SP5, Germany) 
equipped with Argon (458nm, 476nm, 488nm, 496nm and 514nm) and 405 
Diode (405 nm) lasers was used to observed all the cell-contained samples. 
After cell culture, the cell-carrying matrices were collected from the culture 
plates and washed three times with sterilised PBS to remove medium and 
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unviable cells. The matrices were then immersed in a 2% para-formaldehyde in 
PBS for 10 minutes at room temperature. After rinsing with PBS for three 
times, a permeabilisation solution (0.2% Triton X-100 in PBS, Sigma-Aldrich) 
was applied for 10 minutes at room temperature, and the matrices were rinsed 
again with fresh PBS for three times. Staining with DAPI (dilution ratio of 
1:100, Invitrogen) and Phalloidin Alexa 568 (dilution ratio of 1:100, 
invitrogen) was performed overnight at 4 °C in dark. After rinsing with PBS 
for three times to remove residuary fluorescent dye, the matrices were imaged 
under the confocal microscope (Fig. 3.4). The excitation wavelengths for DAPI 
and Phalloidin are 358 nm and 578 nm, respectively. The emission 
wavelengths for DAPI and Phalloidin are 461 nm and 600 nm, respectively. A 
series of slices were obtained as well by focusing different depth at certain step 
throughout thickness in the Z-axis. 
 
Fig.3.4. Confocal microscope unit 
3.3.11 Alkaline Phosphatase (ALP) assay 
ALP assay can quantitatively determine the alkaline phosphatase formed in 
cells. The principle of this method is that alkaline phosphatase catalyses the 
hydrolysis of p-nitrophenyl phosphate and liberating p-nitrophenol and 
phosphate. The rate of p-nitrophenol formation could be measured 
photometrically, which is proportional to the catalytic concentration of alkaline 
phosphatase [420].  
To determine the amount of ALP produced by the cells seeded on the 
scaffolds, scaffolds/cells constructs were washed with PBS for three times, 
moved to a new well, and then lysated by 1% Triton-100 under 37 °C for 1 hr 
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after pre-decided culture time. p-Nitrophenyl phosphate (pNPP) was added to 
the supernatant and incubated at room temperature for 1 hr. The enzyme 
reaction (conversion from p-nitrophenyl phosphate (pNPP) into p-nitrophenol 
(pNP)) was then stopped by a solution containing 2 M NaOH in distilled water. 
The absorption of p-nitrophenol (pNP) formed was determined at 410 nm. A 
standard curve was made using pNP values ranging from 0 to 300 U/l. The 
results were expressed as Units of pNP produced/l/hr. Each experiment was 
done in triplicate. 
3.3.12 Alkaline Phosphatase (ALP) staining for microscopy 
observation 
After a certain culture time, cell/scaffold composites were flushed with PBS 
and moved to a new well. They were then stained with 0.5% (v/v) Naphthol 
AS-MX Phosphate/N,N Dimetylformamide (DMF) solution and 0.6 mg/ml 
diazonium salt (fast red violet LB salts) in tris-hydrochloric acid buffer (pH 
8.74) and water solution at 37 °C for 30 minutes. The outcome of this is that 
enzyme activities were stain in colour from pink to red. After taking images, 
the cell/scaffold composites were rinsed in distilled water for three times, and 
Mayer’s hematoxylin was utilised to stain nucleus of hFOB cells for 1 minute, 
then taking images again to get figures with both nuclei and ALP stain. 
3.3.13Statistical analysis 
All experiments were conducted in triplicates and data are expressed as mean ± 
standard deviation. The cytotoxicity, MTS and ALP data were analysed on 
SPSS (SPSS statistics 17.0) by using ANOVA and post hoc multiple 
comparison tests. A p-value of less than 0.05 was considered statistically 
significant.  
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3.4 Bacterium related technologies 
3.4.1 Bacterial type 
Escherichia coli bacteria were purchased from American Type Culture 
Collection ( ATCC,Cat. No.35218). 
3.4.2 Bacterial culture media 
Modified tryptone soya broth (CM 0989B, approximate formular: Pancreatic 
digest of casein, 17 g/L, Papaic digest of soybean meal,3 g/L) and  tryptone 
soya agars (CM 0131B, Pancreatic digest of casein, 15 g/L, Enzymatic digest 
of soya bean, 5 g/L) were obtained from Oxoid Australia Pty Ltd. 
The culture media were prepared following the instruction of ATCC. For E. 
Coli: 16.5 g nutrient broth powders were dissolved in 500 ml distilled water by 
gently warming and stirring in a 1 L capped bottle. The broth was sterilised by 
autoclaving at 121 °C for 15 min. Then it was cooled down and kept in an 
incubator at 37 °C with constant shaking for further use. The culture agar for E. 
coli was prepared similarly instead by using 20 g agar powder in 500 ml 
distilled water. After cooling down to near 50 °C, the agar was mixed by hand 
shaking, and then directly poured into the plain plate to get agar plate with 
almost equal agar thickness (2.5mm). It took 25-35 min to solidify the agar 
medium. These agar plates can be kept stably in 4 °C for further use. 
3.4.3 Antibacterial testing 
The antibacterial assessment was tested based on a standard methodology: 1) 
static direct contact method and 2) dynamic shaking flask method. 
1) Static direct contact method. This was used to observe the antibacterial 
property of samples directly by adding bacterial solution to sample surface. 
Prepare the bacterial working solution by measuring the overnight bacterial 
culture at 550 nm after 10× dilution in nutrient broth, calculating the 
concentration of the culture according the OD value and diluting the solution 
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into 4 × 107 cells/mL. Seeding 107 cells onto the four stacked samples, and 
these samples with cells were kept in a sterile bottle for a certain time (e.g. 30 
min, 1 hr, 3hr, 5hr, 7hr, 24hr). After that, distilled water was added into the 
bottle and these bottles were vigorously shaken to elute bacteria. Plates were 
prepared for a series dilution of the elution and cultured at 37 ºC overnight. 
The second day, the number of colonies on the plates were counted and 
calculated for appropriate dilutions. In the experiments, samples without any 
anti-bacterial treatments were used as control. Then the reduction percentage of 
bacterial can be calculated by the equation below. 
%100(%) u 
A
ABreduction                                    (3.2) 
Where A is the colonies after incubation on the untreated samples, B is the 
colonies after incubation on the anti-bacterial treatment samples. If B>A, no 
reduction happens. 
The entire handling and testing procedure was done in front of a flame of a 
spirit lamp. 
 
Fig.3.5. Flow chart indicating static anti-bacterial study  
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2) Dynamic shaking flask method. This can well mimic the possible 
environment in future human body. Samples were in direct contact with 
bacteria solution under vigorous shaking for a desired time. Briefly, working 
solution was prepared by culture of E. coli from agar plates in sterilised 
nutrient broth for one day. Then the Ag-PCL matrices were introduced into 8 
mL of working solution in sterile tubes, which contains about 1.5x106 colony 
forming units (CFU) of E. coli. The mixtures were cultured at 37 °C in a 
shaking incubator (HD Scientific Suplies Pty Ltd) at 200 rpm for 1~8 hrs 
separately. Pure sterile broth with non-treated PCL matrix was also tested as a 
blank control. After the culture, the samples were vortexed for 1 min and 
diluted serially in sterile distilled water.  50 μl of each dilution was seeded onto 
LB agar using a surface spread plate technique duplicate. These plates were 
incubated at 37 °C static for 24 hrs. Then the numbers of bacterial colonies 
forming units (CFU) were counted. The counts were used to calculate the 
surviving number of bacteria. The antibacterial efficacy (Ab%) of the specimen 
was calculated according to the following equation: 
%100)1((%) u 
original
survive
CFU
CFUAb                             (3.3)  
Where CFUsurvive represents the colonies recovered from the samples; and 
CFUoriginal is colonies recovered from original working solution. The entire 
handling and testing procedure was done in front of a flame of a spirit lamp. 
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Fig.3.6. Flow chart showing dynamic anti-bacterial study  
3.5 Characterisation tools 
3.5.1 Photos 
Matrix disks and as-prepared other samples were imaged under a digital 
microscopy (Dino-lite plus, AnMo Electronics, China). 
3.5.2 Matrix thickness measurement 
The matrix thickness was measured under a load of 0.5N by digital MESDAN 
micrometer showed in Fig. 3. 7. 
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Fig.3.7. MESDAN micrometer for fabric thickness measurement 
3.5.3 Scanning electron microscopy  
Scanning electron microscopy was carried out with a Supra 55VP SEM (Carl 
Zeiss, Germany) microscope. It was used to investigate the surface 
morphology of PCL fibrous matrices, the surface treated-samples, and cell-
bearing samples. Samples were cut into small circle (1.4cm in diameter) and 
placed on SEM holders. Pictures were taken after sputter coating with gold 
using a Bal-tec SCD50 sputter coater at 40 mA for 60-90 seconds. All images 
were taken at a voltage of 10 keV and the magnification varied between 100 
times up to 10000 times. 
Electron microscopic images and energy-dispersive X-ray (EDX) mapping 
were taken on a scanning electron microscope (SEM) Leica S440 and analysed 
by ISIS software respectively. 
3.5.4 Micro-computed tomography 
The Micro XCT XRadia machine (XRadia Ine. USA) was used to scan samples 
to get X-ray micro-computed tomography images. It has a cone beam geometry 
that permits magnification regulation by adjusting the ratio of the distance 
between the X-ray source and the sample (Z1) to the distance between the X-
ray source and the detector (Z2). At the same time the magnification also can 
be controlled by magnification lens which are limited from h0.5 to h40. The 
limiting resolution is between 1 and 30­m. Detector system: CCD camera 
(Andor) combined with scintillara system to transfer X-ray to visible light. The 
camera is capable of acquiring X-ray images of 2048h2048 pixels with a 
depth of 16 bits per pixel. 
The scan procotol of this experiment included: X-ray source voltage was 
standerised at 40 kV and beam current at 150­A from tungshen as a target 
material. The distances were set to 125 mm for Z1 and 20 mm for Z2. The 
magnification factor from lens was h20. The samples were scanned at a 
rotation step of 0.25 degrees over 180 degrees. It took about 13 hours for every 
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sample to get a 10243 voxel tomogram of 1.0 G data and capture 721 
projections of 6.0 G data with a spatial resolution of 1.155­m and exposure 
time of 60s/projection. 
3.5.5 Processing of the micro-CT scanned series images 
3D reconstruction was performed using Mimics software (Materilise, 
Belgium). 100 sequential 200 × 200 pixel images were cropped from the serial 
images from the centre of each sample. Imported into mimics, these serial core 
images were reconstructed into 3D volumetric models. Thresholds were 
inverted to allow measurement of pore characteristics within the model. 
Subsequently, a region growing operation was performed to create a mask 
consisting only of interconnected pore spaces. Volume for this region-grown 
mask was determined and the ratio of region grown volume to the total volume 
was calculated. The percentage of this ratio is defined as the degree of 
interconnectivity. 
3.5.6 Mechanical property  
Uniaxial tensile testing of fibrous matrix was carried out at the ambient 
temperature with reference of ASTM D638-98. The quadrate strip sample with 
a size of 50h10h2mm was cut from fibrous mat and tested on an Tensile 
Tester (LR30K, Lloyd Instruments, UK) equipped with serrated vise grips and 
a 100 N load cell at a crosshead speed of 10 cm/min, gauge of 3 cm and no pre-
load. Maximum strength was determined as the strength values corresponding 
to 50% strain if, at this stage, the samples were not damaged. The thickness of 
every sample was pre-tested by a micrometer under pressure of 0.5 N. 
Measurements were done three times for one matrix in exactly the same setting 
to avoid errors from sample slippage and to get the average value and the 
standard deviation. Compression strength was tested with the same machine 
with sample in diameter of 37.55 mm. 
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Fig.3.8. Mechanical testing machine 
3.5.7 Water contact angle 
The water contact angles were measured using a KSV Model CAM101 Contact 
Angle Meter (KSV Instruments Ltd, Finland, Fig. 3.9). The instrument 
includes a video camera, a LED light source and electronics interface for the 
unit. Samples were cut into 1.4 cm diameter circle disk and stick on a glass 
slide. Then liquid drops of 1.20 mm diameter were placed on each sample 
surface with a syringe (diameter: 0.71 mm) and the image of each drop was 
captured at a rate of 1 per second after deposition onto sample surface and until 
the water drop penetrated to the sample. The final angle was the average of five 
testing results. 
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Fig.3.9. CAM101 KSV contact angle meter 
3.5.8 Water hydraulic permeability 
Hydraulic permeability was measured by a simple lab setup (Fig. 3.10), and the 
hydraulic permeability of the porous materials were calculated according to 
Darcy’s law [421] 
P
x
A
Qk '
'u 
                                                          (3.4) 
Where k is the hydraulic permeability of the porous material, A is the flushing 
area of the porous scaffold, Δx is the thickness of the scaffold, ΔP is the 
pressure difference driving the fluid flow across the scaffold. 
 
Fig.3.10. Setup for water hydraulic permeability testing 
3.5.9 Water binding ability 
The water binding ability of matrices was measured by weighing the dry mass 
and wet mass after immersing in 5 ml water for 24 hrs at room temperature. 
The binding ability was calculated by equation (3.5). 
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%100(%) u 
wet
wetdry
Mass
MassMass
abilitybindingWater
             (3.5) 
3.5.10 Fourier transform infrared spectroscopy 
Fourier transform infrared (FTIR) spectra were recorded on FTIR 
spectrophotometer (Bruker Vertex 70, Bruker Optik GmbH, Ettlingen, 
Germany) coupled to a Golden Gate single reflection ATR unit for PCL matrix 
and PCL surface treated samples. Routinely, background due to air was 
subtracted. The absorption spectra of the surfaces were obtained for each 
specimen and a total of 32 scans were accumulated at a resolution of 4 cm-1. 
All the tests were carried out in a controlled environment, at 20 ± 2 ºC 
temperature and 65 ± 2% relative humidity. The data was analysed using 
OPUS 5.5 software. 
 
Fig.3.11. Vertex 70 FTIR spectrophotometer 
3.5.11 Atomic force microscopy 
Atomic force microscope (AFM) images were taken by a DualScope DS 45-
40scanner (Danish Micro Engineering, Denmark) with a scan size of 5 × 5 μm. 
Applied load during testing was 0.15 nN. The scanning speeds on nanofibre 
membranes and polyester fibres were 100 and 5μm/s, respectively. The surface 
roughness was calculated using DualScope software. 
3.5.12 Dynamic light scattering 
Dynamic light scattering (DLS, Zetasizer 3000, Malvern Instruments) was 
utilised to measure the particle size distribution and zeta-potential of 
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nanoparticles. The Ag-PCL samples were dissolved into dichloromethane, and 
then tested. By measuring the intensity of light scattered from the samples, the 
particle size distribution was obtained.  
 
Fig.3.12. Malvern Zetasizer 3000 dynamic light scattering 
3.5.13 Transmission electron microscopy 
Transmission electron microscopy (TEM, JEOL JEM-2100) was used to 
confirm component layer formed outside the surface of PCL fibres after 
surface treatment. TEM samples were prepared by embedding the sample into 
epoxy resin followed by drying in a vacuum oven at 40 °C. The samples were 
then microtomed using a diamond knife on ultramictrotome machine. The thin 
slices (90 nm in thickness) were placed on 400 mesh copper grids for TEM 
observation. Images were obtained at an acceleration voltage of 200 kV. 
3.5.14 UV-VIS spectroscopy 
Absorption curves were measured on a UV-visible spectrophotometer (Varian 
cary 3) at room temperature using a quartz cell (10mm patch) for samples. 
Basically the Ag-PCL samples were dispersed in dichloromethane and scanned 
in the wavelength ranging from 400 nm to 800 nm. The spectra were 
subtracted by the background UV-vis spectra of PCL solvent mixture.  For the 
measurement of release of silver nanoparticles, samples were cut into a disc 
shape with 1.5 cm of diameter, and then eight pieces of samples were 
immersed into 50 ml of distilled water and stirred at 200 rpm for 1 day at 37 
°C. During this period, 1 ml of solution was drawn at pre-set time.  
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3.5.15 Wide angle X-ray diffraction 
X-ray diffraction (XRD) analyses were performed with a Philips Glancing 
Angle and Powder Diffractometer 1140/90 using CuK α radiation (λ=1.54056 
A) running at 40 kV and 40 mA. To determine the crystalline phases of the 
specimens, a 2θ scanning range from 20 to 60 degree was used with a scanning 
speed of 4 degrees per min. 
3.5.15 X-ray photoelectron spectrometer 
X-ray photoelectron spectra (XPS) were collected on a VG ESCALAB 220-
iXL spectrometer with a monochromated Al Kα source (1486.6 eV) using 
samples of ca. 3 mm2 in size. The X-ray beam incidence angle is 0 ° with 
respect to the surface normal, which corresponds to a sampling depth of ca. 3 
mm2. The obtained XPS spectra were analysed by the CasaXPS software.  
3.5.16 Inductively coupled plasma-atomic emission 
spectrometer 
After soaking the samples in SBF for certain days, 10 ml simulated body fluid 
(SBF) post-soaking solution was collected for inductively coupled plasma-
atomic emission spectrometer (ICP-AES) testing. 
3.5.17 Photo-spectroscopy 
Photo-spectroscopy was used to detect the colour change of the matrix in a 
very sensitive way. The spectrum could reflect the absorption peak of the 
specific colour.  
  
-80- 
 
Fig.3.13. DH-2000-BAL photo-spectroscopy 
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C H A P T E R  F O U R  
Inter-bonded 3D fibrous scaffolds and their 
cell culture performances 
In this chapter, the preparation of inter-bonded 3D fibrous matrices was 
introduced. The processing parameters influencing the formation of 3D 
structures were discussed. Four matrices with different structures were 
successfully prepared by controlling the ratio of fibre to sugar particles, and 
their properties including pore structure, surface wettability, water 
permeability, water binding ability and mechanical properties were examined. 
Rat skin fibroblast and Chinese hamster ovary (CHO) cells were cultured on 
the fibrous matrices. The cell growth performance was discussed in terms of 
the cell morphology and cell proliferation. Two cell seeding methods, dynamic 
and static seeding, were also compared.  
4.1 Experimental Procedure 
The fibrous matrices were prepared by the following procedure:  
Step 1: melt extrusion of PCL filaments; 
Step 2: cutting the long filaments into short fibres (a1.5 mm); 
Step 3: mixing the short fibres with particles of 300 μm a 600 μm in size;  
Step 4: putting the mixture in a mould and heating in an oven; 
Step 5: leaching off the particles to form fibrous scaffolds. 
The whole process is illustrated in Fig. 4.1.   
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Fig.4.1. Flow chart for preparation of fibrous matrices 
The fibrous scaffolds were then used to grow cells. Details on the cell culture 
experiments including cell subculture, cell seeding, cytotoxicity test, MTS 
experiment, cell morphology observation have been given in Chapter 3.  
4.2 Results and Discussion 
Many parameters influence the preparation of fibrous scaffolds, such as 
temperature, time, fibre length, fibre diameter, particle size, and the ratio 
between the fibre and sugar. Here, the process temperature in the range from 
60 ºC to 70 ºC, fibre diameter from 50 μm to 200 μm, fibre to sugar ratio from 
1:5 to 1:30 (w/w) were investigated. Fibre length was fixed at 1.5 mm or so.  
4.2.1 Length and diameter distribution of short fibres 
The fibre diameter was controlled by fibre extrusion conditions. Fig. 4.2a 
shows the fibre diameter and diameter distribution. The average fibre diameter 
is about 50 μm. In this thesis, the fibres with diameter of 100, 120, 150, 200 
μm have also been used.   
After obtaining the PCL filaments, staple fibres were obtained by manually 
cutting these filaments. As shown in Fig. 4.2b, the mean fibre length of the cut 
fibres is 1.5 mm. Due to the limitation of cutting machine, the fibre length in 
this thesis was fixed at 1.5 ± 0.3 mm.  
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Fig.4.2. Distribution of the as-prepared short fibre length and diameter, a) diameter distribution, 
b) length distribution  
4.2.2 Size and distribution of sugar powders 
The granular size of sucrose powders was regulated by sieving through a series 
of meshes with different sizes. The particles of size between 300 μm to 600 μm 
were collected. The size and distribution are shown in Fig.4.3.  
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Fig.4.3. Particle size distribution of sucrose powders 
4.2.3 Formation of 3D fibrous structures  
The main purpose of using this method to make fibrous matrices is to 
overcome disadvantages in the normal nonwoven structures. The basic 
fabrication process includes melt bonding synthetic fibres in the presence of 
particulate template (Fig.4.4). The short fibre makes it easy to mix with the 
powdery template, with very low fibre-fibre entanglement. Sugar template 
regulates the pore size and ensures the fibre bonding just at the initial contact 
points. When the melting temperature is near 60 ºC, the fibre contact points can 
melt together, but the sugar still stays in the solid state. The pressure can help 
to improve fibre-fibre contact points.  
One significant advantage of this method is using sugar as the template 
material, which is non-hazardous to cells [422]. It causes no cytotoxic effects 
even with incomplete removal from the matrix during the leaching process. 
Template makes it possible to form larger pores besides smaller pores formed 
by fibre-fibre interaction.  
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Fig.4.4. Scheme of fibrous structure formation 
4.2.4 Optimisation of processing parameters 
4.2.4.1 Influence of temperature  
Fig.4.5 shows the DSC curve of PCL materials. When the temperature is 
higher than 50 ºC, PCL starts melting, and at 55.10 ºC it reaches the peak. The 
shoulder of melting point of PCL is between 50 ºC to 62 ºC.  The only 
difference between PCL pellet, fibre and matrix is the width of shoulder, which 
is in the order: pellet >fibre >matrix.  
This suggests that in this temperature range, the polymer molecules move 
quickly and can rearrange their structure easily. The melt bonding temperature 
was thus chosen in the range between 50 ºC and 70 ºC.  
 
Fig.4.5. DSC curve of PCL pellets, fibres and inter-bonded fibrous matrices  
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Fig.4.6 shows the effect of processing temperature on the tensile strength of 
end matrices. All the matrices were fabricated under the same conditions (1.5 
mm short fibres, 1/15 (wt/wt) fibre/sugar ratio, 50 μm fibre diameter). At 60 
ºC, fibres in the matrix still remained loose. The matrix almost had no tensile 
strength. With increasing processing temperature, the matrix strength 
increased. At 65 ºC, the ultimate breaking strength reached the highest, 
however the matrix also showed the highest stiffness, which might not be good 
for the further cell culture work. At 62 ºC, the matrix had certain bonding 
between the fibres providing certain strength, but it was not too stiff. This 
temperature was chosen for further study.  
 
Fig.4.6. Tensile stress-strain curve of scaffolds with different processing temperatures 
With the increase in temperature, fibres tend to melt together on the contact 
positions. But when the temperature is very high, the short fibres would melt 
completely and become small powders, which no longer maintain the fibrous 
structure (Fig.4.7).  
As proved by microscope images, when the processing temperature was 70 ºC, 
many PCL particles were formed inside the matrix. Mode c (Fig. 4.7) was 
chosen as ideal fibre-bonding structure.  
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Fig.4.7. Fibre morphology changes with processing temperatures 
4.2.1.2 Influence of fibre diameter  
Fibre diameter played an important role in the formation of fibrous matrices. 
When fibre/sugar and processing temperature were fixed at1/7(wt/wt) and 62 
ºC, respectively, different fibre diameters resulted in different matrix tensile 
strengths. As shown in Fig.4.8, with decreasing the fibre diameter, the stiffness 
increased, and so did the ultimate stress.  
 
Fig.4.8. Stress-strain curves of fibrous matrices made from PCL fibres with different fibre 
diameters 
Under the fixed fibre length (1.5 mm), finer fibres have larger aspect ratio. 
With higher aspect ratio, the fibres cannot easily mix well with powders due to 
fibre-fibre entanglement. 
4.2.1.3 Influence of fibre to sugar ratio  
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By changing the fibre/sugar ratio, fibrous matrices with different densities were 
obtained. In the experiment, fibre to sugar ratios of 1/5, 1/7, 1/10, 1/15, 1/20, 
1/30 (wt/wt) were chosen. The tensile stress-strain curves indicated that this 
parameter had larger effect on the tensile strength than other parameters such 
as fibre diameter and processing temperature. The fibre-to-sugar ratio 1/5, 
which had the highest fibre content, resulted in the largest stiffness, and the 
highest ultimate strength. On the contrary, the ratio 1/30 gave the lowest 
ultimate strength (Fig.4.9).  
 
 
Fig.4.9. Stress-strain curves of fibrous matrices with different fibre–to-sugar ratios 
The fibre in the matrix started breaking during extension, followed by the 
bonding points when the tensile strength at the bonding points was larger than 
that of the fibre. Otherwise, the break would occur firstly at the bonding points. 
During the tensile test, the two phenomena could happen in the same samples 
(Fig.4.10).  
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Fig.4.10. Possible matrix breaking modes, matrix prepared by a) 1/5(wt/wt) fibre/sugar, b) 
1/10 (wt/wt) fibre/sugar, c) 1/20 (wt/wt) fibre/sugar, d) 1/30 (wt/wt) fibre/sugar 
By optimising the processing parameters, the optimum conditions to prepare 
the fibrous matrices were obtained: Fibre length: 1.5 mm; fibre diameter: 50 
μm; processing temperature: 62 ºC; heating time: 30 mins. Matrices with 
different fibre-to-sugar ratios showed different densities and pore sizes.  
4.2.5 Fibrous samples with different fibre/sugar ratios 
Four matrices were prepared under the fibre/sugar ratio of 1:5, 1:10, 1:20 and 
1:30 (wt/wt), which were respectively marked as PCL-5, PCL-10, PCL-20 and 
PCL-30.  
 
4.2.5.1 Densities of the matrices 
The samples density was calculated based on the mass and the dimension of 
dry samples. The density results were shown in Table 4.1.  
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Table 4.1. Densities of different matrix samples 
Samples Density (g/cm3) 
PCL-5 0.0208±0.0007 
PCL-10 0.0126±0.0008 
PCL-20 0.0074±0.0005 
PCL-30 0.00600±0.0006 
 
4.2.5.1 Morphology of fibrous matrices      
4.2.5.1.1 Optical microscopy 
The optical microscopy images of the four matrices with different densities are 
shown in Fig.4.11. PCL films (thickness 0.85 ± 0.03 mm) were prepared by 
hot pressing. PCL-5 was the densest one, and PCL-30 was the least dense one. 
The pores in PCL-10, PCL-20, PCL-30 were easily observed.  
 
Fig.4.11. Digital photo of the PCL matrices produced from different fibre/sugar ratios 
4.2.5.1.2 Scanning electron microscopy 
 As evidenced in the scanning electron microscopy (SEM) images in Fig.4.12, 
the fibres in the matrices appeared uniformly and randomly distributed 
showing no preferential orientation.  They were bonded with each other at the 
contact points. Such an inter-fibre bonding stabilises the fibrous architecture 
and the porous network.  
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Fig.4.12. SEM images of PCL matrices produced at different fibre/sugar ratios in the view of 
front and side, a) and a’) are front and side view of PCL-5, b) and b’) are PCL-10, c) and c’) 
are PCL-20, d) and d’) are PCL-30.  Scale bar = 250 μm 
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Among the four different matrices, PCL-5 was the densest one. Both small and 
large pores existed in the matrix structure. Similar surface morphology was 
also found for the sample PCL-10. For PCL-20 and PCL-30, matrices were 
more or less loose. Fibre end could be found even in the cross-section of PCL-
30, indicating weak bonding between fibres.  
4.2.5.1.2 Micro-computed tomography 
X-ray micro-computed tomography (μ-CT) is a non-invasive and non-
destructive technique to obtain precise quantitative and qualitative information 
about 3D micro-architectures. Here this technique was employed to explore the 
3D structure of the fibrous matrices. The μ-CT images indicated that the matrix 
contained two types of pores: randomly oriented small pores arising from fibre 
accumulation and larger pores due to the sugar template. All fibrous matrices 
had an excellent porous structure (Fig.4.13). All pores in the fibrous matrices 
were well interconnected, without any dead-end pores. Such an excellent pore-
interconnectivity may facilitate the transport of nutrients and the formation of 
neo-tissues.  
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Fig.4.13. μ-CT images of the four fibrous matrices (isometric view of whole, isometric and 
front view of magnified central part), scale bar =250μm. 
Unlike the conventional nonwovens in which the pores are oriented along the 
X-Y plane (matrix surface), the pores in the prepared matrices showed no 
preferential orientation, as proved by the randomly obtained 2D images of 
micro-CT results in different directions (i.e. x-y, x-z, and y-z), which are 
shown in Fig.4.14. This is possibly because of the use of short fibres in the 
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matrix preparation which enables the fibres to orient in different directions. 
Short fibre with small aspect ratio reduced the fibre-fibre entanglement.  
 
Fig.4.14. 2D cross-section images of a) PCL-5, b) PCL-10, c) PCL-20 and d) PCL-30 in the 
order of x-y, y-z, and x-z directions from left to right, scale bar=500μm. 
4.2.5.2 Pore structures  
By changing the fibre/sugar ratio for the matrix preparation, the pore structures 
of fibrous matrices were changed in a controlled way. As shown in Fig.4.15, 
with a change of the fibre/sugar ratios from 1:5 to 1:30 (wt/wt), the average 
pore size increased from 150 μm to 1000 μm. This increase in pore size led to 
an increase of porosity from 73% to 99%, but a decrease in surface-to-volume 
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ratio, from 4.1 cm-1 to 0.4 cm-1. These four matrices all had very good pore 
interconnectivity, above 95%. These porous characteristics constitute the main 
advantage of this template-aided fibre-bonding technique over the conventional 
nonwoven and template leaching techniques. The conventional nonwovens 
have a lower degree of bonding across the fabric thickness direction and very 
limited space to adjust the pore size and porosity, while the conventional 
template-leaching techniques typically result in low pore-interconnectivity.  
 
Fig.4.15. Pore size, porosity, pore interconnectivity and surface-to-volume ratio of the four 
fibrous matrices. 
4.2.5.3 Stability and mechanical properties 
To prove the pore stability, the fibrous matrices were immersed in water and 
stirred mechanically for 1 day. No obvious structural change was observed 
after the treatment. However, for lab-made needle-punched nonwoven fabric 
and non-bonded nonwovens having a similar porosity, lots of fibres were 
detached from the matrices during the test, indicating the weak ability to 
maintain the porous structure.  
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The mechanical property of as-prepared matrices was shown in Fig.4.16. The 
fibre/sugar ratio had an influence on both tensile and compression strengths. 
PCL-5 has the largest ultimate tensile strength (6.7 MPa) and the smallest 
compression strength (0.13 MPa). PCL-30 with the highest porosity showed 
the smallest tensile strength (0.75 MPa) and the highest compression strength 
(0.64 MPa). Higher porosity could give larger space for compression, but 
reduces the tensile strength.  
 
Fig.4.16. Mechanical properties of four different fibrous scaffolds, a) in elongation mode, and 
b) in compression mode 
In comparison, the tensile strength of needle-punched nonwoven fabric was 
direction dependence (Fig.4.17). In the machine direction, the nonwoven web 
had good strength, but the tensile strength along the width direction was very 
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weak, much lower than the fibrous matrices prepared in this work. The needle-
punched nonwoven had a high bulk density (0.27g/cm3), similar to PCL-5 
(0.208 g/cm3), but the strength was much lower than PCL-5. The lab-made 
nonwoven had similar density and porosity to PCL-30, but not inter-bonded, 
had hardly any strength. 
 
Fig.4.17. Comparison of tensile stress-strain curves between the fibrous matrices and normal 
nonwoven matrices, in which PCL-5(1) and PCL-5(2) are in elongation mode tested in two 
different directions. PCL-30(1) and PCL-30(2) are also tested in two different directions. 
Nonwoven 1 is needle-punched nonwoven. Its tensile strength was also tested in two directions 
(machine and width). Nonwoven 2 is lab-made non-bonded nonwoven fabric.  
4.2.5.4 Water contact angle, hydraulic permeability and water binding ability 
Water contact angle of the matrices was measured to detect the hydrophilicity 
or hydrophobicity of the matrices. Increasing the density of fibrous matrices 
reduced the water contact angle (Fig.4.18 a). This is probably due to the 
wicking function existing in the low density matrices. Hydraulic permeability 
of matrices is an important characteristic for tissue engineering, because an 
excellent permeability can allow the exchange of nutrient and metabolic 
wastes, and hence regulate cell migration deep into the fibrous scaffolds.  For 
the different fibrous matrices, the hydraulic permeability values were in the 
range of 2×10-8~10×10-8 m4N-1s-1 (Fig.4.18b), which were between the 
reported woven tissue scaffold (~1×10-15 m4N-1s-1) [121] and nonwoven tissue 
scaffold (~5×10-6 m4N-1s-1) [421]. This suggests that the as-prepared matrices 
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should be good for nutrient and waste exchanges inside the matrices, and thus 
good for cell in-growth. Water bonding ability is also crucial for tissue 
engineering applications. With good water bonding ability, the matrices can 
hold enough nutrients to support cell growth. Fig.4.18 c shows that these 
fibrous scaffolds have high water binding capacity. They can hold as high as 
1200 weight percentage of water comparing to their original weight.  
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Fig.4.18. Water contact angles, hydraulic permeability and water binding capability of matrix 
samples (PCL-5, PCL-10, PCL-20 and PCL-30) 
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4.2.6 Cytotoxicity test 
The cytotoxicity was determined by growing fibroblasts in the extract of the 
scaffolding materials. The cell viability obtained was higher than 90% for all 
the samples, including PCL pellets (raw material), as-extruded PCL fibres, 
PCL fibrous matrices and PCL 2D films, and there was no significant 
difference among the samples tested (p>0.05) (Fig.4.19), indicating that all the 
tested PCL samples were non-toxic to cells.  
 
This suggests that in the processing of fibrous matrices, from fibre extrusion 
and fibre cutting to 3D structure formation, no extra toxic components are 
introduced. In other words, all the as-prepared matrices are suitable for further 
biological study.  
 
Fig.4.19. Cell viability of fibroblasts growing in the extract of the scaffolding materials 
(p>0.05) 
4.2.7 Comparison of dynamic and static seeding methods 
On the base of the equipment availability, the cell seeding methods, such as 
shaking seeding using orbital shaker, rotating seeding using blood roller and 
small vials and stirring seeding using spinner flask, have been trialed. In the 
experiment, the influence of speed on the seeding efficiency was examined. 
Cells used in all the related experiments were CHO cells.  
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4.2.7.1 Shaking seeding method using orbital shaker 
The speed of orbital shaker was set at 0, 50, 75, 100, or 125 rpm. Seeding 
density is 5×104 cells/matrix (because at low seeding density like 1×104, 
seeding efficiency couldn’t be detected correctly, which may result in large 
experimental errors for MTS assay since there was almost no colour developed 
when the cell number was low. Another reason for the high seeding density is 
that the high seeding density is often required in many circumstances, and it is 
believed that static seeding methods are mainly limited to high seeding density. 
The seeding volumes varied at 50, 100, 200, 500, and 1000μl. 
The seeding efficiency was calculated using equation (4.1).  
ሺΨሻ ൌ      
   
ൈ ͳͲͲ  (E4.1) 
It changed when different seeding volumes or different shaking speeds were 
applied.  
As shown in Fig.4.20, the influence of seeding volume on the seeding 
efficiency is not apparent.  The volume 200 μl gave the least fluctuating 
condition. But the effect of shaking speed on the seeding efficiency was great 
(Fig.4.21). At speed 50 rpm, the seeding efficiency was the highest, which 
proved that lower speed led to better cell adhesion. This is similar to that was 
concluded from the stirring seeding method.  
 
Fig.4.20. Relationship between seeding volume and seeding efficiency 
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Fig.4.21. Influence of shaking speed of orbital shaker on seeding efficiency 
4.2.7.2   Rotating seeding method using blood roller 
Here, roller having different speeds was firstly trialled and seeding density of 
5×104 cells/matrix was used. The volume in one 25 ml centrifuge tube is 2 ml, 
which can just cover the whole matrices.  
The cell number was measured by MTS, and seeding efficiency was then 
calculated according equation (4.1).  
The seeding efficiency varied with the speed, and the best seeding efficiency 
was found at the speed of 37 rpm (Fig.4.22). Lowering the speed improved cell 
attachment.  
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Fig.4.22. Influence of rotating speed of blood roller on seeding efficiency 
4.2.7.3 Stirring seeding method using spinner flask 
The speed of spinner flasks was set in the range between 50 rpm and 80 rpm 
based on the previous results on shaker and blood roller which indicated lower 
speed was better for cell attachment. Seeding density of 1×106 cells/ml was 
used. Because this method requires a huge volume of media to ensure the 
sufficient contact between media and samples, if seeding density was lower, 
e.g. 5×104 cells/matrix, the actually cell density within the seeding media was 
just 5×103 cells/ml. With such a low cell density, the number of cell attaching 
on the surface might be very small. Therefore, a cell density of 1×106 was 
used. The seeding volume was fixed at 110ml. With such a medium volume, 
the matrix can be merged into the media easily.  
Fig.4.23 indicates the seeding efficiency of the stirring seeding method.  With 
a high seeding density (1×106), the seeding efficiency was not higher than 5%. 
This seeding method could give a good cell distribution. Because this method 
consumes a huge volume of media (110 ml), it was not considered a good 
seeding method to seed cells into 3D porous scaffolds.  
 
Fig.4.23. Influence of stirring speed of spinner flask on seeding efficiency 
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4.2.7.4 Comparison between static and dynamic seeding methods  
Among these dynamic seeding methods, the shake seeding using blood roller 
gave the highest seeding efficiency.  Therefore, rotate seeding was chosen to 
further compare with static seeding method. PCL-10 samples were seeded with 
CHO cells by the standard static seeding method and the rotate seeding method 
at the optimised conditions. The cell morphology and cell number at various 
time-courses were recorded.  
The confocal images of CHO on matrices after the static seeding and the 
dynamic seeding were shown in Fig.4.24. CHO cells looked healthy in the 
fibrous matrix after either static or dynamic seeding. The cells distributed on 
the fibre surfaces also looked uniform. Cells were growing on the fibre surface 
along the fibre direction.  
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Fig.4.24. Confocal microscopic images of CHO cells seeded by static and dynamic methods. 
From top to bottom, images were taken with different magnifications. The bottom images were 
taken under white light.  
SEM images in Fig.4.25 also reveal the healthy growth state of the cell seeded.  
There is no much difference observed among the SEM images.  
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Fig.4.25. Morphology of dynamic seeded (a, c, e) and static seeded (b, d, f) CHO cells, a & b 
are 3 days, c & d are 7 days, e& f are 14 days.  
The difference between static and dynamic seeding methods can be found after 
14 days of cell growth. After two weeks of cell culture, the MTS assay was 
conducted on the fibrous matrices and the results are shown in Fig.4.26.  
Initially, the cells number showed no obvious difference. With longer time of 
cell growth, cells seeded by the static method became confluent, and then died 
in some parts, while for dynamic seeding, the cells still kept growing because 
of more uniform distribution within the fibrous matrix. After 7 days of culture, 
the cells number for the dynamically seeded samples was higher. This trend 
was maintained until 14 days of cell culture, and on the 14th day, the cell 
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number in the dynamically seeded was larger than that by static seeding 
method.  
 
Fig.4.26. Comparison of cell number in fibrous matrices between dynamic seeding and static 
seeding methods 
According to the above experiment, dynamic seeding is good for long-term 
culture study due to uniform cell distribution, and static seeding is much easier 
to conduct, although it has problems of cell arrangements in the scaffolds. Due 
to the limitation in the equipment availability, the consumption of the culture 
media and the possibility of scale-up study (rotary vials) for dynamic seeding 
methods, however, classical static seeding method was mainly used in the 
following part.  
4.2.8 Cell seeding efficiency  
Seeding efficiency reveals the ability of cells to attach on a scaffold material. 
The seeding efficiencies of both cell lines on the fibrous matrices are listed in 
Table 4.2. The PCL-5 had the largest seeding efficiency for both fibroblast and 
CHO cells. The matrices having a smaller mean pore size showed larger cell 
population. More cells were trapped by fibres, and less penetrated into the 
wells. The seeding efficiency for fibroblasts was larger than that of the CHO 
cells. This might be because fibroblasts were larger than CHO cells in size. 
This assisted in the cell attachment on the fibres, but not on the wells. 2D PCL 
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film showed lower seeding efficiency than the commercial 2D culture plate. 
Because 2D culture plate was surface-treated by plasma better for cell culture 
study, while 2D PCL film used here received no surface treatment.  
Table 4.2 Seeding efficiency of CHO and fibroblast cells on different fibrous 
matrices  
x Seeding efficiency on the Petri dish is 93.6% for CHO and 93.9% for 
fibroblast 
4.2.9 Cell morphology  
At different time intervals, the cell-matrix composites were taken out, and 
treated for SEM observation and confocal microscopy observation.  
4.2.9.1 SEM  
The morphologies of CHO cells growing in the PCL fibrous matrices are 
shown in Fig.4.27. The cells adhered and spread well on the surface of PCL 
fibres. Rounded cells, indicative of non-viable or unhealthy cells were not 
observed, further demonstrating the conducive environment for cell culture. 
Live CHO cells mostly maintained a spindle-shape even though some cells 
with elliptical and polygonal morphologies were observed. The cells spread 
and proliferated randomly around the fibres. They wrapped around the fibre 
Samples CHO (%) Fibroblast (%) 
 Matrix Well Media Matrix Well Media 
PCL-5  18.3 32.0 49.7 47.8 37.7 14.5 
PCL-10  13.5 71.1 15.4 43.7 44.8 11.6 
PCL-20 9.6 46.5 43.8 26.5 63.0 10.5 
PCL-30  3.7 47.9 48.4 14.7 75.1 10.3 
PCL film  3.9 39.2 57.0 12.8 78.5 6.1 
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surface and grew along the fibre axis without directional preference.  From the 
very beginning, some of CHO cells were seeded inside the scaffolds due to the 
fabulous pore structures, cells distributed not only on the surface of scaffolds, 
but also inside it. After some time, cells on the surfaces could also grow along 
the fibre length direction to fibres inside the matrices. This phenomenon 
resulted in the random distribution of CHO throughout the whole matrices.   
The cell morphology on the fibrous scaffolds varied over time. After 3 days of 
seeding, CHO cells cultured on PCL-20 proliferated throughout the matrix, 
indicating that the matrices are suitable for the growth of CHO cells (Fig. 
4.27a and 4.27a’). On the 7th day of culture, the cells covered more surfaces 
of the fibres and they thickened to anticipate rounding up for mitosis (Fig. 
4.27b and 4.27b’), persumbly because of the ability of CHO cells to change in 
response to contact with other cells in the population [423-424]. With an 
increase in the culture time, the cell population increased dramatically (Fig. 
4.27c&4.27c’, 4.27d-4.27d”). As a consequence of the adaptive processes, 
cells shape changed. Viable cells were obviously in a highly asymmetric 
(bipolar) form, toward spindle-like shaped and orientated along the fibre 
direction due to a process called contact guidance [295, 303, 425]. Cell growth 
on other fibrous matrices showed a similar tendency. 
For comparison, CHO cells were also cultured on 2D culture plates in the same 
conditions and their morphology on the 14th  day of culture is shown in Fig. 
4.27e. CHO cells appeared flattened, well spread, but not as elongated as those 
cultured on 3D PCL matrices. Such differences in cell morphology and cell 
spread should derive from the apparently different culture environment 
between 2D film and 3D fibrous structure [426-427]. 
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Fig.4.27. CHO cells in fibrous scaffolds (PCL-20) after a) 3 days, b) 7 days, c) 14 days, and d) 
21 days of culture. e) CHO cells after 14 days of growing on PCL film under the same culture 
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condition. (Cells were fixed with OsO4, and images were taken from front or back of samples. 
All scale bar = 50 μm. 
Fig.4.28 displays morphology of fibroblasts cultured on PCL-20. The arrows 
point to the cells attached to multiple fibres close to the inter-fibre bonding 
sites or where fibres came in close proximity (overlapping fibres). Dehydration 
and gold coating before the SEM observation are the main causes of the cracks 
visible in the SEM images, especially for fibroblasts layers. Within 7 days of 
the culture, fibroblasts adhered well and showed a healthy morphology. 
Especially, cells were observed growing along the fibre axis and bridging 
between adjacent fibres (Fig.4.28b & 4.28b’). At day 14, the number of 
bridging cells increased. At the 21st day, layered fibroblasts were observed. 
These results suggest that fibroblasts attached, spread and grew very well on 
the 3D fibrous scaffolds during the culture period and that they could form 
layers spanning the entire scaffold surface with time. By comparison, no 
layered cell morphology could be seen on the PCL film.   
Fibroblasts grew on the fibre surfaces when there were enough spaces at the 
early culture day. With the time increasing, fibroblasts could bridge between 
fibres while the distance was short enough for their branch. This kind of branch 
of fibroblast made it possible to form an entity where pores were small and 
also allowed it to grow inside the matrices.  
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Fig.4.28. Fibroblast cells on fibrous scaffolds (PCL-20) after a) 3days, b) 7 days, c) 14 days, 
and d) 21 days of culture. e) Fibroblast cells after 14 days of growing on PCL film under the 
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same culture condition. (Cells were fixed with OsO4, and images were taken from front or back 
of samples. All scale bar = 50 μm. 
4.2.9.3 Confocal microscopic images  
Fig.4.29 shows the confocal microscopy images of the CHO cells growing in 
the fibrous matrices. They either grew randomly on the fibre surface 
(Fig.4.29a), or they grew orderly along the fibres (Fig.4.29b), all of them 
maintained elliptical, polygonal or spindle-like shape showing their healthy 
state. In Fig.4.29d, an image with lower magnification proved the cell 
distributed uniformly on the fibres in the matrices.  
 
Fig.4.29. Confocal microscopic images of CHO cells on PCL fibrous matrix (PCL-10). The 
cells were fluorescently stained in red for the actin filaments and in blue for the nuclei. a) 
showed cells distribute randomly, b) showed cells ranged orderly along the fibre, c) is the 
magnified images indicated clearly cell shape, d) is image with long magnification verified cell 
distribution in the matrices.  
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Fibroblast grew nicely on the PCL matrices were also be proved by confocal 
microscopic images in Fig.4.30.  Fibroblasts wrapped the fibre surface and 
grew along the length direction, which resulted in cell migration happening 
(Fig.4.30a). Fibroblasts also bridged when the distances between fibres were 
compatible to their sizes (Fig.4.30a’), similar conclusions could also be drawn 
from SEM images.  
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Fig.4.30. Confocal microscopic images of fibroblasts on PCL fibrous matrix (PCL-10). The 
cells were fluorescently stained in red for the actin filaments and in blue for the nuclei. a)-a”) 
are images with high magnification. b)-b”) are images with low magnification, in which a) 
showing cell growing along the fibre, a’) indicating cells can bridge between fibres, a”) 
demonstrated one whole fibroblasts cell with clear shape; b) is image presenting nuclei only, 
b’) is image expressing actin filaments only, b”) is images stacked by b) and b’) scale 
bar=50μm 
4.2.10 Cells penetration inside the matrices 
4.2.10.1 Confocal microscopic slices 
Laser confocal microscopy makes it possible to focus on different z position of 
samples, to scrutinise cell migration inside the samples. As shown in Fig.4.31 
for CHO cells, and Fig.4.32 for fibroblasts, throughout the thickness of 320 
μm, there were red colours and green colours at different layers indicating the 
presence of cells on different level. Since low magnification was used to give a 
general view of the cell distribution, cell cytoskeleton and nuclei are not well 
distinguishable in these images.  
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Fig.4.31. Confocal microscopic cross-section slices of CHO cells on PCL-10 at various z 
positions (the image were taken every 40 μm throughout the whole scaffold thickness nearly 
300 μm) (PCL-10 after 21 day culture of CHO cells) Scale bar = 250 μm 
 
Fig.4.32. Confocal microscopic cross-section slices of CHO cells on PCL-20 at various z 
positions (the image were taken every 40 μm throughout the whole scaffold thickness nearly 
300 μm) (PCL-10 after 21 day culture of CHO cells) Scale bar = 250 μm 
4.2.10.2 micro-CT 
Confocal microscopy has a limitation to collect clear images over 300 μm in 
depth. To confirm cell growth throughout the whole thickness of the matrix 
samples, micro-CT was used. As evident in the reconstructed micro-CT image 
in Fig.4.33a, many OsO4-stained cells (red spots) were observed on the 
surface of fibres (green) inside the 3D scaffolds. In contrast, a micro-CT image 
of the PCL fibrous matrix without containing any cells was also included (Fig. 
4.33b), but no red spots can be seen in the matrix. 
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Fig.4.33. micro-CT images of 3D scaffolds with and without cells inside 
4.2.11 Cell proliferation  
 
Fig.4.34. MTS assay of CHO and fibroblasts on fibrous matrices 
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Fig.4.34a summarizes the mean number of CHO cells growing on the fibrous 
matrices over 21 days of culture. Because of the low seeding efficiency, the 
culture number initially on 2D control should be higher than that on the 3D 
matrices. This is true for the fibroblasts. The fibroblast cells on the 2D control 
after 3 days of culture showed a higher number than those in the 3D matrices 
(Fig.4.34b). However, for the CHO cells, it showed a reverse trend. The low 
CHO number on the 2D control in the early days came from the uneven 
distribution of the CHO cells in the culture plate. Despite the high seeding 
efficiency for tissue culture plate (TCP), most of the CHO cells preferred to 
stay on the edge area of the TCP well (see Fig.4.35). This led to the occurrence 
of cell confluence in this area just within three days of culture.  
The higher cell numbers in the 3D matrices than on the 2D control was 
maintained for the whole culture period. The CHO cells in the matrices grew at 
a similar rate during the culture period. However, the cell number on the 2D 
PCL film and the culture plate was stabilized after 2 weeks of culture, 
indicating that the cell growth rate slowed down from day 14 of culture. 
Because of the contact-inhibitive nature, the CHO cell growth is surface area 
dependent. Larger surface area in scaffold should result in more cells to grow. 
This could be the main reason as to why the 2D controls accommodated fewer 
cells than the 3D fibrous matrices.  
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Fig.4.35. CHO cells cultured on 2D plates for three days 
The sample PCL-5 had the highest surface area (265.7 cm2), the lowest 
porosity (73.19%) and the smallest pores (119.6 μm) among the fibrous 
matrices. It also showed higher seeding efficiency and larger cell number in 3 
days of cell culture than the other matrices. The results that longer culture time 
resulted in decreased cell growth rate could be attributed to two reasons: the 
growing cell population reduced the pore size, which adversely led to inhabited 
mass transfers of nutrients and waste, and the cells were confluent in some 
areas of the matrix. Scale bar=50μm 
By comparison with PCL-5, PCL-10 provided larger pores (size above 200 
μm) for the cell growth. This also facilitated the nutrient and waste exchange, 
allowing cell growth at a steady rate. In the first week, the cell number in PCL-
5 was higher than that of in PCL-10. However, the cell number in both 
matrices on the day 14 became very similar. Longer culture resulted in higher 
cell number in PCL-10 than PCL-5. This suggested that smaller pores could 
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provide more opportunities for the fibroblasts to attach to scaffold, but larger 
pore could provide larger space for the cells to grow over time. PCL-20 and 
PCL-30 contained larger pores, respectively about 800 μm and 1000 μm. The 
mean cell number on PCL-30 was much less than that on PCL-20 after 21 days 
of culture, which could come from the reduced overall surface area of the 
fibrous matrix. These results indicated that pore size played an important role 
in the cell growth.  
The MTS assays performed on the fibrous matrices revealed fibroblasts 
proliferation on the 3D PCL matrices (Fig.4.34 b). Within the 21 days of the 
culture period, the number of fibroblasts continuously increased in the fibrous 
matrices. Comparing with the 2D tissue culture plates, the 3D matrices had less 
cell numbers at day 3 and day 7, due to the low seeding efficiency. However, 
the cell population on the matrices increased continuously with time and 
became comparable to 2D tissue culture plates in two weeks, and then 
dramatically larger by day 21. The 2D PCL film showed the lowest cell 
number among the sample groups after 21 days of culture. This can be 
explained in that the 3D fibrous matrices have a larger surface area than 2D 
films or well, allowing the cells to spread on the fibre surface. The 3D porous 
structure also facilitates the cell uptake and exchange of nutrients and disposal 
of waste. 
Again, the porosity, pore size and surface area of the fibrous matrices affected 
the fibroblasts growth. The matrix PCL-5 yielded the highest cell number. This 
trend was maintained for the whole three-week culture period. This is different 
from what was observed for the CHO cells, in which the cell growth rate 
levelled off from day 14. Fibroblasts are large flat cells with the size about 
30~100 μm and the cell thickness about 3~4 μm. In this case, cells growing on 
fibre surface had relatively smaller influence on pore volume hence the media 
and waste exchange compared to the CHO cells. As a result, sensibly larger 
cell population can be achieved on the matrix with a larger surface area, and 
PCL-5 disk has the largest cell population after three weeks of culture. It is 
reasonable to predict that longer culture period would lead to more fibroblasts 
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growing in the fibrous matrices, and the inhibited mass transfer will still 
happen once the cells take up certain pore volume.  
4.3 Conclusion 
 
Stable fibrous matrices with different pore porosities, and pore sizes were 
successfully produced by the combined hot-press and particle-leaching method. 
The influences of bonding temperature, fibre diameter, fibre/sugar ratio on the 
formation of fibrous structures were examined. Through controlling the 
fibre/sugar ratio, four matrices with different structures were obtained.  
 
The SEM and micro-CT observations revealed that these fibrous matrices had 
excellent porous structures with small pores formed by fibre assembly, and 
large pores due to template particles. These structures were highly porous (over 
80% porosity). The pores inside the matrices were well interconnected and no 
dead pores were found even in the dense areas. Moreover, the pore structure 
had no preferred orientation.  
 
These fibrous matrices also had good mechanical properties compared to 
nonwoven fabrics. They were stable due to the inter-bonded fibrous 
characteristic. They also had excellent permeability to culture media showing 
their potential for use in tissue engineering.  
Both static seeding and dynamic seeding methods were used to seed CHO cells 
on the matrices. It was found that cells could grow on the fibrous porous 
matrices by either static seeding or dynamic seeding method. Although 
dynamic seeding method provided high seeding efficiency and high level of 
uniformity on cell distribution, it is limited to large scales of seeding. Static 
seeding has been used instead in this study.  
The as-prepared fibrous matrices were biocompatible and conducive to cell 
growth, which was proved by culturing CHO and fibroblast cells on them. By 
using micro-CT and confocal microscopy, the cell migration and growth inside 
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the fibrous matrices were clearly proved. It was also found that the pore 
characteristics and surface area played an important role in mediating the 
growth of CHO cells and fibroblasts inside the matrices differently. The 
integration of large surface area and smaller pores was suitable for the growth 
of fibroblasts. Smaller pores could provide more opportunities for the 
fibroblasts to attach to scaffold, but larger pore could provide larger space for 
the cells to grow on a long term basis. The scaffold-making approach 
developed allows the choice of different fibres and the control of pore size and 
porosity, and fibrous scaffolds with different pore characteristics can be 
produced to suit different cell lines for many different biomedical applications. 
Since the developed fibrous matrices show better mechanical performance and 
more stable pore structure than the conventional nonwoven scaffolds, they 
should have better performance in tissue engineering applications.       
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C H A P T E R  F I V E  
Nano-structured surface in 3D fibrous 
scaffolds and its cell culture performances 
In this chapter, the influences of nano-structured fibre surface in the 3D fibrous 
matrices on the cell culture performances are presented. An electrostatic self-
assembly method was used to load silica nanoparticles on PCL fibrous 
matrices. Osteoblasts were seeded onto the scaffolds to examine cell 
proliferation and cell differentiation performance.  
5.1 Experimental Procedure 
In this chapter, only matrix PCL-10 (porosity >90%, mean pore size 200 μm) 
was used. Silica nanoparticles were synthesised from TEOS according to the 
Stober method. The detailed method was introduced in Chapter 3 already. Then 
these obtained silica nanoparticles were coated on the PCL fibrous scaffold 
surfaces by electrostatic layer-by-layer self-assembling method. After the 
NaOH surface treatment, PCL surface could form abundant carboxylic groups, 
with a negative charge. Since silica nanoparticles had a positive charge, 
electrostatic assembly was possible. PAA/SiO2 was used in the following 
double electric layers to control the content of nano-SiO2. The silica 
nanoparticle coatings were controlled in 0 layer, 1 bilayer, 3 bilayers and 5 
bilayers.  
5.2 Results and Discussion 
5.2.1 Silica particles and size distribution  
Fig. 5.1 shows a typical SEM image of silica nanoparticles synthesised and the 
histogram of the particle size distribution. The synthesised silica nanoparticles 
ranged from 50~70 nm in size.  Due to the dynamic light scattering (DLS) 
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measurement used water as solvent, and the reflection of particles in water 
resulted in relatively larger size. Sizes obtained based on SEM images also 
were a little larger than the real size due to the gold coating.  
 
Fig.5.1. a) SEM images of synthesised silica nanoparticles, b) histogram of particle size 
distribution measured from SEM image, and c) histogram of particle size distribution obtained 
by DLS.  
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5.2.2 Nanoparticle assembly and surface morphology  
The fibre morphologies before and after self-assembly with silica nanoparticles 
are presented in Fig.5.2. Before self-assembly, there were no particular 
structures found on the fibre surface (control sample, PCL fibrous matrix, 
Fig.5.2a). When assembling with one layer of silica nanoparticles, particles 
can be observed clearly around the fibre surface (Fig.5.2b). After coating with 
three and five layers of nano-silica, the nanoparticles covered the entire fibre 
surface homogeneously, and some parts even formed an aggregated structure 
(Fig.5.2c and 5.2d).  
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Fig.5.2 SEM images of control (a and a’), 1 bilayer (b and b’), 3 bilayers (c and c’) and 5 
bilayers (d and d’) self-assembled fibre samples. The scale bars for images a-d are 10 μm, and 
for images a’-d’ are 200 nm.  
5.2.3 Surface chemical components  
To confirm the surface components, ATR FTIR spectra were recorded and 
shown in Fig.5.3. Most of the main band characteristics of PCL were observed 
in the spectra, suggesting a very thin layer of silica nanoparticles was deposited 
on the PCL substrate. For the fibre coated with 1 layer silica, the difference 
was not so distinct. After silica nanoparticle surface modification, the band 
peaks at 800 cm-1, 1101 cm-1, 3360 cm-1 arose from Si-O-Si symmetric 
stretching vibration, Si-O-Si asymmetric stretching vibrations, and Si-OH 
stretching [428-429]. With increasing silica nanoparticle layers, the peak 
intensity increased indicating more silica nanoparticles coated on the PCL 
surface.  
 
Fig.5.3. ATR-FTIR spectra of control and surface modified samples 
Surface chemical components of the treated fibrous matrix were detected by X-
ray photoelectron spectroscopy (XPS) technology. As shown in Fig.5.4, the 
survey spectra reveal that silica nanoparticles are successfully assembled on 
the surface. For comparison, XPS spectrum of the pristine control samples is 
also included, but only has O and C peaks (Fig.5.4a). When the fibre surface 
was treated by NaOH solution, a new peak with the binding energy of 490 eV 
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appeared, corresponding to Na 2s (Fig.5.4b). When a thin layer of PAA/SiO2 
was assembled on the fibre surface, new peaks with binding energies of 153 
and 102 eV, attributed to Si 2s and Si 2p respectively, appeared which 
confirmed the formation of SiO2 on the surface (Fig.5.4c).  
 
Fig.5.4. XPS spectra of PCL fibrous samples a) non-treated, b) treated with NaOH solution, c) 
treated with both NaOH and thin layer of nano-SiO2 
The high resolution XPS C1s spectra of the fibrous matrices are shown in Fig. 
5.5.  Curve fitting the spectrum revealed that the pristine control samples had 
four components (Fig.5.5a), -CH2-(284.56 eV), -CH2-C=O (285.05 6eV), -
CH2-O (285.936 eV), and -C=O (288.598 eV). After NaOH treatment, the 
group –O-C=O was changed to –COOH and -CH2-OH, as indicated by the 
binding energy shift in the range of 287~289 eV.  When PAA/SiO2 layers were 
assembled to the surface, a huge increase in –C-OH (285.993eV) was detected.  
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Fig.5.5. High resolution XPS C1s spectra of a) Pristine control sample, b) NaOH treated 
sample, c) nano-SiO2 modified sample 
5.2.4 Atomic force microscope 
After surface modification, the surface roughness of PCL fibres was measured 
by AFM. Only one layer of silica presented a roughness value (RMS) at 24 nm, 
and with increasing bilayer number, surface roughness increased to 33 nm and 
37 nm. This rough surface compared to the smooth surface of pristine samples 
(3 nm) would improve osteoblast cell attachment, and might assist in further 
cell growth performance.  
 
Fig.5.6.  AFM images of control and surface modified samples. a) pristine sample, b) 1 bilayer 
modified sample,c) 3 bilayers modified sample, d) 5 bilayers modified sample. 
5.2.5 Surface wettability  
As known from literature, cell adhesion, spreading and growth require the 
scaffold surface having suitable hydrophilicity [430]. Since silica nanoparticles 
are hydrophilic, applying silica nanoparticles on PCL fibre surface could 
improve the surface wettability. With an increase in the silica nanoparticle 
layer, from 0, to 1, 3 and 5, the water contact angle decreased from 78, to 52, 
37, and 28 degree, responsively (Fig.5.7a~5.7d), suggesting the enhanced 
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water wettability. Fig.5.7e shows the contact angle could be stable in a very 
short time, no more than 0.3 s.  
 
Fig.5.7. Surface water contact angle before and after surface coating, a) control sample, b) 1 
bilayer, c) 3 bilayers, and d) 5 bilayers coating samples; e) water contact angle changing with 
contact time.   
5.2.6 Cytotoxicity  
Cytotoxicity study was conducted on all the as-prepared samples. Results were 
given in Fig.5.8. All the samples provided over 90% cell viability, no matter 
how many layers were applied. This indicates that silica surface treatment is 
not toxic to cells, and thus suitable for further cell culture study.   
 
Fig.5.8. Cell viability of fibroblasts growing in the extract of the scaffolding materials, bar 
chart indicates the mean cell number, and the line chart displayed cell viability. Values shown 
are the means of three measurements on individual specimens. Error bars show ± standard 
deviation (p>0.05).  
Fibroblast cells attached and spread very nicely on the tissue culture plates 
(TCP) for all tested samples (Fig.5.9). These images suggested that even in the 
presence of extract of silica nanoparticles solution, fibroblasts can still sustain 
  
-131- 
a thinly spread healthy state, illuminating the nontoxic feature of PCL matrices 
and surface silica nanoparticles coated PCL matrices.  
 
Fig.5.9. Cell morphology of fibroblasts growing in the extract of scaffolds after culture for 
three days, a) control, b) 1 bilayer, c) 3 bilayers, and d) 5 bilayers; The scale bar for images a-d 
are 500 μm, and for images a’-d’ are 100 μm.  
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5.2.7 Osteoblast cell culture 
MTS assay was applied to measure the mean cell number at different culture 
time (1 day, 3 days, 7 days), referring to the cell proliferation on different 
samples (Fig.5.10). At the very early stage, i.e. day 1, the mean cell number 
was in the order of 5 bilayers> 3 bilayers> 1 bilayers> 3DC, which was an 
evidence that surface roughness affected cell attachment. The higher the 
surface roughness, the higher was the number of adhered cells.  After three 
days of culture, cell number on the three treated samples was dramatically 
higher than that on the control pristine sample. But the difference is not 
statistically significant (at the 5% level) among the three treated samples.  A 
further 4 days culture offered a clear trend of variability among different 
samples. Samples with one layer of silica enhanced cell division greatly. Cell 
number was nearly two times more than other samples. Surface nano-textured 
structure was believed to enhance cell attachment and adhesion, but probably 
would prohibit the cell proliferation [431]. That could be the reason why 
samples with three and five bilayers had relative fewer cells on day 3 and day 
7.  If only the cell attachment is considered, samples with five layers of silica 
nanoparticles are better. For cell proliferation, samples with one bilayer silica 
coating were better than others.  
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Fig.5.10. Mean cell number changes of hFOB 1.19 on different scaffolds as a function of time. 
Values shown are means ± standard deviation. * p<0.05 versus 3DC at day 3, † p<0.05 versus 
3DC at day 7.  
5.2.8 Cell morphology  
Cell morphology was recorded by laser scanning confocal microscopy (LSCM) 
after a certain culture period. Cells were fluorescently stained with nuclei 
shown in blue colour and actin filaments in red colour in these images. The 
osteoblast cells maintained a polygon shape on control samples, but on silica 
treated samples, at day 1, osteoblasts tended to become round, and their size 
was a little smaller than that on the control samples. At day 3 and day 7, more 
spread osteoblast appeared, as shown in Fig.5.11. The changes in surface 
topography and roughness may hold vital clues to cell activity, especially cell 
attachment [308]. Nano-structured surface can enhance the cell elongation and 
spread because the cells can recognise the nano-scale topography [138, 302, 
432]. In addition, there were fewer cells on the control pristine samples than on 
silica nanoparticle coated samples.  
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Fig.5.11. Confocal images of hFOB 1.19 on scaffolds for culture 1, 3, and 7 days (from left to 
right), a) control, b) 1 bilayer, c) 3 bilayers, d) 5 bilayers (from top to bottom). The cells were 
fluorescently stained in red for the actin filaments and in blue for the nuclei. Scale bar = 100 
μm. 
SEM images of cells on different substrates confirmed the results obtained 
from confocal microscopy. PCL pristine surface has no reactive groups on the 
surface for osteoblast attachment (Fig.5.12a and 5.12e). At day 3, the cells still 
kept a round shape as just seeded. At day 7, cells attached to the surface, but no 
actin filament was observed. In contrast, the surface assembled with silica 
nanoparticles gave cells nano-scaled rough surface to attach and spread 
(Fig.5.12b, 5.12c, 5.12d). The actin filaments are exhibited in Fig.5.12c’ and 
5.12d’, which is another evidence showing the biocompatibility of silica 
nanoparticles coating. With 7 days of culturing, the osteoblast cells tended to 
be elongated comparing to 3 days of culturing (Fig.5.12 f-h). 
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Fig.5.12. Cell morphology of hFOB 1.19 on scaffolds after 3 days and 7 days of culture, a) 
control-3days, b) 1 bilayer-3days, c) 3 bilayers-3days, d) 5 bilayers-3days, e) control-7days, f) 
1 bilayer-7days, g) 3 bilayers-7days, h) 5 bilayers-7days. Scale bar = 2 μm. 
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5.2.9 Alkaline Phosphatase activity   
The synthesis of alkaline phosphatise during cell cultures was also assayed, 
which was an early indication to bone formation. ALP activity also reflects the 
overall osteoindustivity and cell differentiation. To measure the 
osteoindustivity of the silica nanoparticles coated PCL fibrous scaffolds, ALP 
activity of the osteoblasts that were cultured on those samples was quantified. 
Samples with 1 layer of silica nanoparticles were tested, and the 2D tissue 
culture plate (TCP) and the 3D fibrous matrix without the surface modification 
were used as controls.  
After three days of culture, the osteoblasts growing on the silica treated 
samples showed significant increase in the ALP activity, as evidenced in 
Fig.5.13. By comparison, the ALP activity of osteoblasts on 3D and 2D 
controls was lower. Longer time of culture leads to lower ALP activity. At day 
7, both silica treated samples and 2D/3D control samples had a low ALP 
activity, while silica treated samples were still much more than that on control 
samples. Another peak appeared near 10 day and 14 days. This tendency for 
ALP activity was also described by other researchers [433]. ALP could reach 
the first peak just after seeding, but with time, its quantity reduced until another 
peak appeared. The nearly 3-fold increase in ALP activity observed in the 
osteoblasts growing on the silica-treated samples after 14 days of culture was 
an indication that this special surface-treated scaffold had osteoinductivity in 
vitro.  
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Fig.5.13. Alkaline phosphate content of hFOB 1.19 on 1 bilayer coating and control samples as 
a function of time (3 days, 7 days, 10 days, 14 days), *p <0.05 versus 3D control samples and 
2D TCP at corresponding day, † p<0.05 versus results on day 7.  
The higher ALP activity for the silica nanoparticle treated fibrous matrices 
could be explained by three factors. First, 3D environment could provide better 
nutrient and waste exchange for osteoblasts, which might help with increasing 
the ALP activity. Although the ALP activity here is similar to 2D control, the 
cell number on 3D control was dramatically different to that on 2D control. 
The seeding efficiency was 17.32% of cells attached on the 3D control, but 
93.52% for 2D tissue culture plates. Second, the hydrophilic and nano-scale 
surface characteristics enhance the cell attachment, thus the cells initially 
attached to the silica treated samples were much higher in number than that on 
3D control samples. It was tested that the cell number attached on the treated 
scaffold was 26.4% of the original seeded cells, while only 17.32% of original 
cells attached on the 3D control. The large cell numbers might have higher 
ALP activity in the same environment. Third, the silica nanoparticles 
assembled can enhance the osteoinductivity[434]. Si is one of the components 
composing bone, Si-O-Si, and Si-OH groups existing in SiO2 nanoparticles 
could help the formation of bioactive CaP on the substrate surface. In addition, 
PCL fibrous matrices with self-assembled silica nanoparticle surface coating 
could form uniform hydroxyapatite layers after immersing in simulated body 
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fluid (SBF) for 7 days, and the hydroxyapatite layer became thick and 
continuous after exposing to SBF for 21 days (Fig.5.14).  
 
Fig.5.14. Formation of apatite on the silica nanoparticle coated PCL fibrous matrices surface 
after immersing into 1×SBF for 7 days. a) & a’) pristine control sample, b) & b’) silica treated 
samples just after self assembly, c) & c’) silica treated samples after immersing in 1×SBF for 3 
days, d) & d’) silica treated samples after immersing in 1×SBF for 21days.  
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ALP activity was also demonstrated visually by staining the ALP by Naphthol 
AS-MX phosphate and diazonium salt. All the ALP generated was stained to 
pink to red colour. The cells can further be nucleus stained by Mayer’s 
hematoxylin, showing blue colour in the images.  
Although some osteoblasts with dark nucleus stained existed, stained ALP was 
really hard to be found in 3D control samples, even at day 3 (Fig. 5.15), at 
which point it was proved previously to have the largest ALP content for 3D 
control samples. As comparison, the stained ALP could be observed for 
nanoparticle treated samples at every time point: day 3 (Fig.5.15), day 7 
(Fig.5.16), day 10 (Fig.5.17), day 14 (Fig.5.18). The pink colour with a darker 
centre distributed evenly throughout the whole samples. Quantitative 
differences among different time intervals at least indicated much more ALP 
activity in silica-treated samples than in 3D control samples.  
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Fig.5.15. Stained ALP of hFOB 1.19 on 1 bilayer coating and control samples at day 3, a) & 
a’) control sample with ALP stain only, b) & b’) silica treated sample with ALP stain only, c) 
& c’) control samples with ALP and nucleus stain together, d) & d’) silica treated samples with 
ALP and nucleus stain together.  
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Fig.5.16. Stained ALP images of hFOB 1.19 on 1 bilayer coating and control samples at day 7, 
a) & a’) control sample with ALP stain only, b) & b’) silica treated sample with ALP stain 
only, c) & c’) control samples with ALP and nucleus stain together, d) & d’) silica treated 
samples with ALP and nucleus stain together.  
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Fig.5.17. Stained ALP images of hFOB 1.19 on 1 bilayer coating and control samples at day 
10, a) & a’) control sample with ALP stain only, b) & b’) silica treated sample with ALP stain 
only, c) & c’) control samples with ALP and nucleus stain together, d) & d’) silica treated 
samples with ALP and nucleus stain together.  
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Fig.5.18. Stained ALP images of hFOB 1.19 on 1 bilayer coating and control samples at day 
14, a) & a’) control sample with ALP stain only, b) & b’) silica treated sample with ALP stain 
only, c) & c’) control samples with ALP and nucleus stain together, d) & d’) silica treated 
samples with ALP and nucleus stain together.  
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5.3 Conclusions 
Silica nanoparticles were assembled on PCL fibrous porous scaffolds. The 
surface morphology and wettability could be controlled by the coating layers. 
Cytotoxicity study using fibroblasts demonstrated that all the samples 
including the pristine control and the silica-treated samples were nontoxic to 
cells and suitable for tissue engineering application.  
MTS results and SEM images suggested that the nano-structured surface can 
effectively enhance the cell attachments, and cell proliferation was much more 
active for the silica-treated 3D PCL fibrous scaffold compared to the non-
treated 3D control samples. ALP activity in these silica-treated 3D PCL fibrous 
scaffolds was also higher than that on control samples, revealing better 
osteoconductivity and osteoindustivity.  
These results suggested that nano-structured silica coating on PCL surfaces 
exhibited much improved cell attachments, cell division and proliferation and 
cell differentiation. These fibrous scaffolds with thin nano-structured surface 
had potential applications in bone tissue engineering.  
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C H A P T E R  S I X  
Deposition of apatite on inter-bonded 3D 
fibrous scaffolds and its effect on cell 
performances 
Bone-like apatite was deposited on the fibre surface of 3D inter-bonded fibrous 
matrices via immersing in the simulated body fluid (SBF). Oxygen or nitrogen 
plasma was used to treat PCL surface before the deposition, which was found 
to speed up the CaP nucleation and the formation of bioactive apatite. Two 
osteoblast cell lines: human fetal osteoblast cells (hFOB1.19) and osteoblast-
like cells (Saos-2) were used to examine the influence of apatite coating on 
osteoblastic cell responses. The cell morphology, cell proliferation and ALP 
enzyme activity for cell differentiation were found to be affected by the apatite 
coating dramatically.  
6.1 Experimental Procedure 
In this chapter, only PCL-10 (porosity >90%, mean pore size 200 μm) was 
used as matrix sample.  
 
The PCL-10 samples were firstly pre-treated by vacuum plasma to activate the 
fibre surface, followed by immediately immersing them into 1×SBF or 
10×SBF at physiological pH condition (7.4) and 37 ° C for apatite deposition. 
After that, the fibrous sample were thoroughly washed with MilliQ water and 
dried overnight at room temperature. hFOB 1.19 and Saos-2 cells were then 
seeded and cultured on the matrix.  
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6.2 Results and Discussion 
6.2.1 Plasma treatment 
X-ray photoelectron spectroscopy (XPS) measurement was used to identify the 
surface component changes before and after plasma treatment. The survey 
spectra are shown in Fig.6.1. Before plasma treatment, PCL matrix only had C, 
O and Si peaks. When the sample was treated with N2 plasma, a weak N peak 
appeared.  
 
Fig.6.1. XPS survey spectra of a) pristine PCL matrix and b) after N2 plasma treatment  
The atomic contents of the fibrous matrices are listed in Table 6.1. For the 
pristine PCL, it contained 73.99% carbon (Table 6.1). The carbon content 
decreased after the plasma treatment, and the C/O ratio decreased for plasma 
treatment. N2 plasma introduced N onto the surface, and the surface N content 
increased a lot after N2 plasma treatment. 
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Table 6.1. Elemental contents of the fibrous matrices before and after plasma treatment 
Elements Untreated After treatment 
C 73.99 70.98 
O 23.54 24.72 
N 0.602 1.568 
Si 1.861 2.728 
C/O 3.143 2.871 
 
Fig.6.2 shows high resolution C1s and N1s spectra, in which all the studied 
fibrous samples exhibit three main components corresponding to the aliphatic 
carbon bonds (–C–C– or –C–H), carbon single bonded to oxygen (–C–OH or –
C–O–), and carbonyl functional groups (–C–O-) located at approximately 
285eV, 286eV, and 289eV, respectively. The samples showed similar peaks, 
suggesting that the plasma treatments had a very small influence on the surface 
chemical components.  
The N1s peaks at 399.90eV and 402.26eV indicated the formation of –
CH3CONH2 groups after the N2 plasma treatment.  
Thus, the XPS analyses confirmed that the plasma treatments lead to slightly 
different surface chemistry, which may affect the wettability and deposition of 
CaP. 
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Fig.6.2. Curve-fitted XPS spectra of C1s and N1s, a) pristine control sample, b & c) N2 plasma 
treated samples 
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6.2.2 Surface morphology  
As shown in Fig.6.3, without plasma treatment, the fibre surface shows no 
apatite-like particles after soaking in SBF for three days. For the plasma treated 
samples however, particle like structure formed on the fibre surface after 
immersing in the SBF solution at the same condition. This suggested that the 
plasma activated PCL surface showed improvement in the apatite nuclei 
forming and deposition ability.  
 
Fig.6.3. Surface morphology of PCL fibres after soaking in SBF solution for 3 days, a & a’) 
pristine control matrix, b & b’) N2 plasma treated sample. 
Fig.6.4 shows the surface morphology of the PCL fibrous matrices after 21 
days soaking in SBF. For the untreated pristine PCL samples, the surface 
looked similar to that of the samples soaked for 3 days, and there were no 
apatite-like particles found on the surface. For the nitrogen plasma treated PCL 
fibre matrix, thicker particles were observed, and the particles were hard to be 
recognised due to the intensive agglomeration.  
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Fig.6.4. Surface morphology of PCL fibres after soaking in SBF solution for 21 days, a & a’) 
pristine control sample, b & b’) N2 plasma treated sample. 
From the above experiments and results, N2 plasma could give a good apatite 
deposition. Therefore, in the following study on using 10×SBF solution to 
deposit apatite, N2 plasma was still used to pre-treat the PCL fibre matrices.  
10×SBF has higher ion concentration that can speed up the formation of apatite 
on the substrate surface. As shown in Fig.6.5, within 4 hours of immersing the 
fibre matrix in the solution, apatite particles could be observed on the surface, 
the level of which was similar to that of samples soaked in 1×SBF for three 
days. When the plasma treated fibrous matrix was immersed in the solution for 
one day, a thick apatite layer was generated on the fibre surface, which was 
even better than soaking in 1×SBF for 21 days. The high concentration SBF 
was effective in formation of apatite layers.  
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Fig.6.5. SEM images of the PCL matrices after N2 plasma treatment and soaking in 10× SBF 
for 4 and 24 hours. a & a’) soaking for 4hrs, b & b’) soaking for 24hrs. 
6.2.3 Apatite formation  
The SEM EDX curves of the PCL fibre matrix after socking in the SBF 
solutions are shown in Fig.6.6. The peaks Ca and P clearly appeared in the 
curves, which was a proof of the CaP formation.  For the 1×SBF treated 
matrix, the peaks for both Ca and P were very sharp and clear, similar to the 
results from literature on chitosan substrates [435]. While for 10×SBF, peaks 
showed a little difference. This was because 10×SBF usually can not exactly 
form bone-like apatite, which has been proposed as an issue in the literatures 
[436]. This result also suggested that that apatite formed from 1×SBF was 
dramatically different from that formed 10×SBF.  
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Fig.6.6. SEM-EDX scanning results of the apatite treated PCL fibre samples, a) soaking in 
1×SBF solution, b) soaking in 10×SBF solution.  
The CaP on PCL fibre surface was also characterised through calculating the 
ion concentration changes in the SBF solution. Fig.6.7 provides the calcium 
and phosphate ions concentrations after immersing the fibrous samples. Both 
concentrations decreased greatly with time for the treatment using 10×SBF. 
However, the trend for the 1×SBF treatment was not obvious. This could be 
due to the low ion concentration, and the uneven fibrous structures.  
 
  
-154- 
 
Fig.6.7. Ca and P ion concentration changes in 1×SBF and 10×SBF solutions as a function of 
time  
6.2.4 Water contact angle  
Because the matrices had macro-pores insides them, water drops might be kept 
in the pores or on the fibres. To eliminate the difference, films with exactly the 
same treatment were used for water contact angle (WCA) testing after plasma 
treatment. Water contact angle changed from about 80º to nearly 45º after 
plasma treatment (Fig.6.8), which indicated that surface had a good water 
wettability. This would assist in the whole surface contact and reaction with 
SBF solution.  
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Fig.6.8. Surface water contact angles before and after N2 plasma treatment, a) control sample, 
b) N2 plasma treated sample.  
Water contact angle results for matrix samples undertaken different soaking 
times in 1×SBF or 10×SBF are exhibited in Fig.6.9. After 21 days of soaking 
in SBF, a layer of apatite was deposited on the fibre surface, resulting in 
decrease in the water contact angle, from 106 to 55º. For the samples soaking 
in 10×SBF (24 hours), a decrease trend was also obtained.  Different contents 
of apatite formation on the surface resulting from variable soaking times and 
soaking concentrations made the initial variety of WCA among these samples.  
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Fig.6.9. Water contact angles of the PCL matrices as a function of soaking time, a) 1×SBF, b) 
10×SBF.  
6.2.5 Cytotoxicity study  
The cytotoxicity results are shown in Fig.6.10. All the samples had a very good 
compatibility to fibroblast cells. 3 days’ culture resulted in the cell number 
rising from the original number (1×104) to above 3×104 with the cell viability 
higher than 95%. These positive results confirmed that the samples with apatite 
on the surface were non-toxic to cells, and were suitable for tissue engineering 
application.  
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Fig.6.10. Cell cytotoxicity results using fibroblast cells, the bar shows mean live/dead cell 
number after 3 day culture; the line indicates the mean cell viability (p>0.05).  
Fig.6.11 further shows the healthy state of fibroblast cultured on the extract of 
different samples. From the images of low magnification, it can be seen that 
the cells spread uniformly on the surface of TCP. From higher magnification 
images, the cells are observed to interact with each other and maintain a 
polygon shape, indicating their happy growing state.  
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Fig.6.11. Fibroblast morphology after cultivation for 3 days in the extract media of different 
samples, a) Control, b) O2 plasma treated, c) N2 plasma treated.  
6.2.6 Cell morphology, distribution and migration  
6.2.6.1 Light microscopy 
Under normal light microscopy, the cells can be distinguished from the 
polymer when the samples were stained with dyes, and the low magnification 
also provides information on the cell distribution and migration. As 
demonstrated in Fig.6.12, the influence of apatite on the hFOB1.19 and Saos-2 
become apparent only after 7 days of culture. Without the apatite layer, the 
hFOB1.19 was hard to attach to the PCL fibre surface. There was very small 
number of cells found on the matrix. With the help of a thin layer of apatite, 
more hFOB1.19 could be observed. The hFOB1.19 cells on both the control 
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and the apatite coated samples looked very healthy in terms of their shapes. In 
contrast, the difference between apatite and no-apatite coated samples for Saos-
2 was very small. This is mainly because Saos-2 cells have much higher 
growth and proliferation rate than the hFOB1.19 cells. Saos-2 cells grew not 
only on the matrix surface, but also inside the matrix. The cells had no 
preference growth orientation along the fibres, and they all looked very healthy 
as well.  
 
Fig.6.12. Morphology of hFOB1.19 and Saos-2 cells grown on PCL fibrous matrices after 7 
days of culture, a &a’) hFOB1.19 on control, b & b’) hFOB1.19 on apatite treated samples; c 
& c’) Saos-2 on control samples, d& d’) Saos-2 on apatite treated samples. Cells were stained 
with 1% toluidine blue in 2% borax and 0.04% methylene blue. The scale bar for images a-d is 
500 μm, and for images a’-d’ is 100 μm. 
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6.2.6.2 Laser confocal microscopy (CLMS) 
Fig.6.13 shows the morphology of the cells growing on the PCL fibrous 
matrices. In the early days, both hFOB1.19 cells and Saos-2 cells were not easy 
to be found.  The cells also had small sizes but no elongation (Fig.6.13 a-1 & 
b-1). At day 3, both hFOB1.19 and Saos-2 cells were found to start elongating 
along the fibre length direction (Fig.6.13 a-2& b-2). This phenomenon became 
clearer at day 7 (Fig.6.13 a-3). For the area with many bonded fibres, the cells 
elongated less (Fig.6.13 b-3). Longer culture time led to huge amounts of cells 
covering on the fibre surface (Fig.6.13 a-4 and b-4).  By comparison, less 
hFOB1.19 cells were found on the control sample. For Saos-2 cells, the cells 
covered most of fibre surfaces. The enhancement of Saos-2 cells growth with 
apatite was not observed visually.  
Cells-hFOB1.19 have a similar shape to the Saos-2 cells. In biologics, they 
both are classified as osteoblasts. Saos-2 cells have exactly the same 
characteristic as osteoblasts and they are often called osteoblast-like cells.  
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Fig.6.13. Morphologies of hFOB1.19 and Saos-2 cells in different culture periods, a1~3) 
hFOB1.19 on apatite treated samples after 1 day, 3 days, 7 days and 14 days of culturing; c) 
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hFOB1.19 on control samples 14 days of culturing; b-1~3) Saos-2 on apatite treated samples 
after 1 day, 3 days, 7 days and 14 days of culturing; d) Saos-2 on control samples after 14 days.  
6.2.6.3 Scanning electron microscopy (SEM) 
SEM images in Fig.6.14 and Fig.6.15 exhibit the cell morphology of 
hFOB1.19 and Saos-2 on PCL fibrous samples as a function of culturing time.  
For hFOB1.19 cells (Fig.6.14), at day 1, the cells seemed to dislike growing on 
the surface of PCL fibre, they just attached to the surface, showing similar 
phenomenon on apatite coated surface.  At day 3 and day 7, cells could spread 
on the surface, but they tended to crouch and the cells were still small in 
number. In comparison, more cells were observed to spread on the apatite 
coated surface, and the cells were more easily found. With two weeks of 
growth, more hFOB1.19 cells were found on the surface, showing healthy 
cells-matrix interaction.  
For Saos-2 cells (Fig.6.15), at day 1 and day 3, the cells were found to scatter 
on the fibre surface. The cells attaching to the untreated samples were very low 
in number. One week later, more Saos-2 cells distributed on the fibre surface.   
Saos-2 cells had a tendency to orient along the fibre length direction on the 
apatite treated samples, but not on the untreated control samples. After two 
weeks of growth, Saos-2 cells covered most of the fibre surfaces, cells on the 
apatite coated surface grew with an orientation along the fibre length direction.  
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Fig.6.14. hFOB1.19 cultured on PCL fibrous samples at different culturing times, a-1~4) on 
control samples after 1 day, 3 days and  7 days, and 14 days of culturing; b-1~4) on the apatite 
treated samples after 1 day, 3 days,  7 days and  14 days of culturing; scale bar = 10 μm 
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Fig.6.15. Saos-2 cultured on PCL fibrous samples at different culturing times, a-1~4) on 
control samples after 1 day, 3 days and 7 days, and 14 days of culturing; b-1~4) on the apatite 
treated samples after 1 day, 3 days, 7 days and 14 days of culturing; scale bar = 10 μm 
6.2.7 Cell proliferation  
The cell proliferation was measured by MTS assay. The culture time was set at 
day 1, 3, 7, and 14. The changes of live cell number at different time periods 
are shown in Fig.6.16.  
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When Saos-2 and hFOB1.19 were firstly cultured on these scaffolds,  more 
hFOB1.19 cells stayed on the matrix surface than Saos-2 cells, and the apatite 
coated surface contained more cells than the untreated control samples.  At day 
3, cell number did not change much for the Saos-2. For hFOB1.19, however, 
the cell number on the apatite-coated surface was nearly double that on non-
treated pristine sample (Fig.6.16b). This tendency sustained for at least two 
weeks. The enhancement effect of the apatite layer to Saos-2 cell growth was 
clear for a long time. As seen in Fig.6.16a, at day 14, the cell number on the 
apatite-coated samples was much higher than that on the non-treated pristine 
one. Saos-2 cells were more populous than hFOB1.19, mainly because of their 
high growth speed.  
 
Fig.6.16. Proliferation of osteoblastic cells on PCL matrices with or without apatite coating  
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6.2.8 Alkaline phosphate activity 
ALP activity can be calculated by ALP experiment results shown in Fig.6.17 
quantitatively and Fig.6.18-Fig. 6.25 qualitatively.  
Cells hFOB1.19 were cultured at 34 ºC for the first three days to obtain enough 
cells. Then these hFOB1.19 cells-scaffold composites were moved to the 39 ºC 
incubator for best cell differentiation, at which time, the day was set as zero. 
To make the same, for Saos-2 cells, although the beginning temperature was 37 
ºC, and the cell proliferation temperature was unchanged, they also allowed 
proliferating for three days. For the following days, it was counted at 3 days, 7 
days, 10 days, and 14 days, and at every interval, the ALP content was 
measured and calculated.  
As indicated in Fig.6.17 a, ALP activity for hFOB1.19 is variable with 
culturing time. At the first three days, the ALP activity was high, and then 
decreased at day 7. At day 10, the content increased again and reached the 
highest value. All scaffold samples showed a similar trend.  
Comparing to the control samples, the apatite coated fibrous samples expressed 
an improved ALP activity at day 3, 10, 14. At day 7, there was no distinct 
difference between the control samples and the apatite coated 3D samples. In 
this study, there was not much difference between 2D control samples and 3D 
control samples in terms of ALP activity.  
Fig.6.17b shows the ALP results for Saos-2 cells, which are quite different 
from those obtained on hFOB1.19 cells. The ALP contents of Saos-2 were 
much higher than that on the hFOB1.19, even for 1 day culture, the content 
was 100 times higher. Another difference for Saos-2 was that the peaks of ALP 
activity appeared at day 7. Only one peak existed in all the tested groups. There 
was no statistically significant difference between the apatite coated and the 
non-coated samples at day 7, day 10 and day 14. The apatite improvement of 
ALP activity was only found at day 3. High proliferation rate of Saos-2 was the 
main reason for this phenomenon.  
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Fig.6.17. ALP activity of Saos-2 and hFOB1.19 on different samples 
By staining the cells with dye, ALP enzyme could be observed visually. This 
assisted in understanding the difference between sample groups.  
Figs.6.18 to 6.25 show all stained ALP images. Samples were firstly stained by 
naphthol AS-MX phosphate/N, N dimetylformamide (DMF) solution and 0.6 
mg/ml diazonium salt for ALP enzyme, then all the samples were further 
stained by Mayer’s hematoxylin for cell nuclei. Pink to red colour represented 
ALP generated by cells. The dark blue colour was from cell nuclei.  
At day 3, there was already some ALP observed in the apatite coated samples 
grown with hFOB1.19. When looking at the images of control samples 
(Fig.6.18 c and c’), some cells were observed on the matrices, but no ALP 
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(Fig.6.18a and a’). These results were in accordance with that from ALP 
content mentioned previously: apatite might have a good effect on the cell 
differentiation at the early stage.  
For the Saos-2 cells at day 3, the influence of apatite on ALP activity was 
evident (Fig.6.22). Cells or ALP enzyme was found to distribute throughout 
the matrix, which was different to the untreated pristine samples.  
At day 7, the ALP activity of hFOB1.19 was very low. There were only several 
red spots in the matrices, for both control and the apatite coated samples 
(Fig.6.19).  
For Saos-2, the ALP activity was much higher than that of hFOB1.19. The 
matrices had red colour on some fibres. Such a good ALP activity maintained 
for all the tested time intervals (Fig.6.23 & Fig.6.24), and nearly the whole 
matrices looked red after 14 days of culture (Fig.6.25) 
Longer culturing time gave an easy observation of hFOB1.19 cells on the 
matrices. The ALP activity, however, was still very low and not much red 
colour was shown (Fig.6.20& Fig.6.21). This could be attributed to two 
factors: hFOB1.19 had really low cell proliferation rate, even after 14 culturing 
days, therefore not enough cells were grown on the matrices, and hFOB1.19 
cells were hard to differentiate at 39 ºC.  
The results on ALP contents and stained ALP images suggested that ALP 
activity could be enhanced by apatite coating all the time for hFOB1.19 cells, 
but only at the early stages for Saos-2 cells.  
  
-169- 
 
Fig.6.18. Images of hFOB1.19 stained with alkaline phosphate on PCL fibrous samples at day 
3, a) & a’) control sample with ALP stained only, b) & b’) apatite treated sample with ALP 
stained only, c) & c’) control samples with ALP and nucleus stained together, d) & d’) apatite 
treated samples with ALP and nucleus stained together. 
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Fig.6.19. Images of hFOB1.19 stained with alkaline phosphate on PCL fibrous samples at day 
7, a) & a’) control sample with ALP stained only, b) & b’) apatite treated sample with ALP 
stained only, c) & c’) control samples with ALP and nucleus stained together, d) & d’) apatite 
treated samples with ALP and nucleus stained together. 
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Fig.6.20. Images of hFOB1.19 stained with alkaline phosphate on PCL fibrous samples at day 
10, a) & a’) control sample with ALP stained only, b) & b’) apatite treated sample with ALP 
stained only, c) & c’) control samples with ALP and nucleus stained together, d) & d’) apatite 
treated samples with ALP and nucleus stained together. 
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Fig.6.21. Images of hFOB1.19 stained with alkaline phosphate on PCL fibrous samples at day 
14, a) & a’) control sample with ALP stained only, b) & b’) apatite treated sample with ALP 
stained only, c) & c’) control samples with ALP and nucleus stained together, d) & d’) apatite 
treated samples with ALP and nucleus stained together. 
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Fig.6.22. Images of Saos-2 stained with alkaline phosphate on PCL fibrous samples at day 3, 
a) & a’) control sample with ALP stained only, b) & b’) apatite treated sample with ALP 
stained only, c) & c’) control samples with ALP and nucleus stained together, d) & d’) apatite 
treated samples with ALP and nucleus stained together.  
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Fig.6.23. Images of Saos-2 stained with alkaline phosphate on PCL fibrous samples at day 7, 
a) & a’) control sample with ALP stained only, b) & b’) apatite treated sample with ALP 
stained only, c) & c’) control samples with ALP and nucleus stained together, d) & d’) apatite 
treated samples with ALP and nucleus stained together. 
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Fig.6.24. Images of Saos-2 stained with alkaline phosphate on PCL fibrous samples at day 10, 
a) & a’) control sample with ALP stained only, b) & b’) apatite treated sample with ALP 
stained only, c) & c’) control samples with ALP and nucleus stained together, d) & d’) apatite 
treated samples with ALP and nucleus stained together. 
  
-176- 
 
Fig.6.25. Images of Saos-2 stained with alkaline phosphate on PCL fibrous samples at day 14, 
a) & a’) control sample with ALP stained only, b) & b’) apatite treated sample with ALP 
stained only, c) & c’) control samples with ALP and nucleus stained together, d) & d’) apatite 
treated samples with ALP and nucleus stained together. 
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6.3 Conclusions 
A thin layer of apatite was deposited on the PCL fibre surface by pre-treatment 
of fibre with N2 plasma and soaking in SBF solution. The plasma pre-treatment 
sped up the apatite formation. The apatite formation was confirmed by SEM 
and EDX, and the apatite coating made the fibre surface more hydrophilic.  
These apatite-coated samples were proved to be biocompatible to fibroblast 
cells with no cytotoxicity. They also improved the cell attachments because of 
the increased surface roughness and wettability. The apatite coating improved 
the cell proliferation, because the apatite surface was more bioactive for cells 
to grow than pristine PCL surface. This good cell differentiation was also 
indicated by the increase in the ALP activity. In summary, apatite was 
successfully applied on PCL 3D fibrous matrices, and this coating was proved 
to effectively enhance the adhesion, proliferation and differentiation of 
osteoblast cells.  
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C H A P T E R  S E V E N  
Inter-bonded 3D fibrous scaffolds with 
antibacterial surface coating and cell growth 
performances  
In this chapter, 3D fibrous scaffolds were surface coated with antibacterial 
agents, silver and polyhexamethylene biguanide hydrochloride (PHMB). The 
cytotoxicity of the coated fibrous matrices was studied. The antibacterial 
activity was confirmed, and the compatibility to fibroblast cell growth was 
examined.   
7.1 Experimental Procedure 
PCL fibrous matrices PCL-10 (porosity >90%, mean pore size 200 μm) were 
used. The antibacterial agents (Ag nanoparticles) were coated on the surface by 
an electroless plating method. Briefly, two solutions separately containing Ag+ 
source and the reducing agent were mixed together to initiate the silver-mirror 
reaction in the presence of the fibrous matrices. The silver generated was 
deposited onto the fibre surface. Separately, PHMB was coated on fibre surface 
by the layer-by-layer electrostatic assembly technology. To do this, PAA 
abundant with –COOH groups was applied onto the fibre surface, followed by 
assembling positively charged PHMB under pH 8.0. Then another negatively 
charged PAA was introduced, followed by the PHMB again. 
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7.2 Results and Discussion 
7.2.1 Electroless plating of silver  
7.2.1.1 Electroless plating 
The plating time was studied from 2 minutes to 40 minutes and the optical 
microscopy images of the coated fibrous matrices are shown in Fig.7.1. It was 
found that 10 minutes of plating was enough to finish the reaction and also 
avoided the aggregation of silver particles on the fibre surface, although these 
precipitations could be washed away by ethanol or distilled water.   
 
Fig.7.1. Photographs of PCL matrices with silver coated surfaces. The scale bar=100μm. 
Silver nanoparticles show distinct surface Plasmon absorption from the visible 
to the near infrared region [437]. As shown in Fig 7.2 a~c, the white fibrous 
sample after 2 minute treatment becomes yellow. Longer plating time made the 
sample become brown and even grey eventually. The dark brown colour 
indicated the formation of silver nanoparticles. The SEM images shown in Fig 
7.2 d~f indicates that a fine nano-silver coating evenly covers the entire fibre 
surface. Higher magnification image illustrated that the deposited Ag was in 
the form of nanoparticles.   
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Fig.7.2. Photographic and SEM images of PCL matrices, a) uncoated PCL matrix; b & c) PCL 
matrices coated with silver nanoparticles at different plating times (low & high); d) untreated 
PCL matrix; e & f) Ag-coated PCL matrices in low and high magnification.  
TEM images in Fig.7.3 indicate that a very thin layer of Ag coating is formed 
on the PCL fibre surface. The thickness of the Ag coating was around 100~120 
nm, after 5 minute Ag plating treatment.  
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Fig.7.3. TEM images of Ag-plated PCL matrices. The silver coating layer is around 100~120 
nm in thickness.  
7.2.1.2 Particle-size and distribution  
Based on the SEM images, the Ag particle size was calculated. Fig.7.4a 
provides the particle size result measured from SEM images. The mean particle 
size was about 75.04 nm with a standard deviation of 25.74 nm. The 
distribution of Ag nanoparticle size fitted the Gaussian distribution (R2 = 
0.97).  
The particle size was verified by DLS. Samples were dissolved in 
dichloromethane, and the solution was then tested. Fig.7.4b shows a typical 
testing result. The mean particle size measured by this method was near 200 
nm, which was much larger than that measured from SEM images.  
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Fig.7.4. Particle size distribution histograms tested by a) SEM image and b) DLS (dynamic 
light scattering)  
7.2.1.3 Silver crystalline  
X-ray diffraction (XRD) patterns of the electrolessly plated Ag nanoparticles 
on the PCL matrix are shown in Fig. 7.5. The peaks at 2θ = 38.32°, 44.04°, 
64.64° and 77.42° were assigned to the (111), (200), (220), and (311) reflection 
lines of Ag particles, respectively [438-439].  
 
Fig.7.5. XRD pattern of Ag coated PCL matrix 
7.2.1.4 Ultraviolet visible (UV-Vis) absorption 
 
Fig.7.6. UV-Vis spectra of Ag solution released from the coated fibrous samples with single 
layer coating as a function of soaking time  
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Fig.7.6 shows the UV-Vis spectra of Ag nanoparticles released from the coated 
PCL fibrous matrix, with the maximum absorption peak at about 420 nm, 
which is consistent with the absorption of silver nanoparticles [440]. Since the 
release of silver nanoparticles is time dependent, the peak increased gradually 
with the increase in the immersion time.  
7.2.1.5 Antibacterial properties 
Fig.7.7 gives the antibacterial ratio of different samples. All the samples 
demonstrated strong antibacterial properties. For the sample with 10 min Ag 
plating and washed with ethanol and water before use, more than 99% bacteria 
were killed within 3hr. With increasing the plating time, a high percentage of 
bacteria were killed.  
At the same treatment condition (10 mins double layers coating), the unwashed 
samples had a high antibacterial ratio compared to the washed samples because 
washing removed some silver nanoparticles off the matrix, which decreased the 
antibacterial property of the matrix. Similarly, when increasing the plating time 
from 10 mins to 30 mins, more particles were assembled on the fibre surface, 
leading to stronger antibacterial effect. Plating more layers of Ag also could 
improve the bacterial inhibition function, because more Ag ions would be 
released from the increased surface area.  
 
Fig.7.7.  Antibacterial efficacy of different sample groups as a function of time (Escherichia 
coli, E.coli)  
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The Ag particle coating changed the E.coli surface from smooth to irregular as 
indicated in literatures [441-442]. Here the Ag particles on the PCL fibre 
surface damaged the normal biological function (Fig.7.8).  
 
Fig.7.8. Effects of nanoparticles on Escherichia coli (E.coli), a) after contact with the Ag-
coated PCL fibrous matrix for 7 hours, cell surface was surrounded by Ag particles; b) E.coli 
cells had an irregular surface (cellular shrinkage).  
7.2.1.6 Cytotoxicity  
Fig.7.9 shows the cytotoxicity testing results of the Ag-plated fibrous matrices.  
Without any sterilization treatment, the scaffolds showed more than 90% 
fibroblast cell viability after 5 days of cell culture. This result was quite similar 
to that of the control matrix. This suggests that the silver coating has very low 
toxicity to human mammalian cells and the silver nanoparticles coated fibrous 
matrices can be used for tissue scaffolding applications.  
  
-185- 
 
Fig.7.9.  Cytotoxicity test results by culturing fibroblasts in extract liquids from the Ag-plated 
fibrous samples and control samples (p>0.05) 
7.2.1.7 Culture of fibroblasts  
Cell culture test was conducted on the Ag coated PCL matrix. As shown in 
Fig.7.10a, after 1 day of cell culturing, although the number of cells on the 
matrix is slightly lower than 2D control due to the static seeding limitation, the 
mean viable cell number on the Ag-coated matrix is equivalent to the 3D PCL 
control matrix. After 3 days and 7 days of culture, the cell number in the Ag-
coated fibrous matrix nearly had no changes with time, which was abnormal 
when comparing to the 3D control and 2D control samples (Fig.7.10b&c).    
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Fig.7.10.  MTS results of fibroblasts cultured on PCL matrices and nAg-anchored PCL 
matrices 
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This result suggested that the Ag-coated reduced the cell growth. To improve 
the cell growth on the Ag-coated fibrous matrix, the sample was pre-coated 
with a thin layer of cellulose acetate using a dip coating method. The cell 
culture result was also included in Fig.7.10. It was shown that a thin layer of 
polymer was still not able to improve the cell growth much.   
7.2.2 Electrostatic assembly of PAA-PHMB  
7.2.2.1 Confirmation of PHMB  
To verify the assembly of PHMB on the 3D PCL scaffolds, the samples were 
stained with a dye (Eosin). Due to the reaction between PHMB and the dye, 
red colour would be developed when the dye molecules interacted with PHMB.  
More dye-PHMB interaction led to deeper colour. Fig.7.11 inset image shows 
the PCL fibrous matrices having different layers of PHMB stained by Eosin 
dye. Without PHMB layer, no absorption peak appeared in the range of 
500~570 nm. With increasing the PHMB assembling layers, the matrices had 
stronger absorption peak at 540 nm.  
 
Fig.7.11. Visible spectra of the stained fibre samples with different PHMB layers  
PHMB coatings were confirmed by FTIR. As shown in Fig.7.12 the vibration 
peaks at 3375 cm-1, 1625 cm-1, and 1575cm-1 are corresponding to NH, NH2 
and NH4+, when 5 layers or more layers of PHMB are assembled onto PCL 
fibres.   
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Fig.7.12. FTIR spectra of PCL fibrous samples before and after PHMB assembling 
7.2.2.2 Water contact angle  
Since the matrices had macro-pores, water drops might be kept in the pores or 
on the fibres. To eliminate the difference, films with exactly the same 
treatment were used for WCA testing. It was assumed that contact angle on 
films can reflect the water wettability of fibrous matrices.  
Water contact angle of PHMB coated samples were measured on the PCL film 
with exactly the same treatment method. Results are shown in Fig.7.13.  
Without any treatment, the PCL film was hydrophobic with a mean contact 
angle of 78.0º. When one layer of PHMB was introduced on the surface, 
contact angle decreased to 67.9º. Increasing the PHMB layers on the surface 
lowered the contact angles. When the coating was 7 bilayers of PHMB, the 
contact angle reached as low as 52.7º, which was ideal for tissue scaffold 
applications [443].  
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Fig.7.13. Water contact angles of different layers of PHMB coated films 
7.2.2.3 Washing durability of PHMB coatings 
Fig.7.14 shows the Visible absorption of the PHMB coated fibrous samples 
before and after sterilising process (washing with 70% ethanol and distilled 
water for several times, detailed process was described in chapter 3).  The 
PHMB peak was still very high after sterilising treatment. The inset digital 
photo shows the colours before and after sterilising treatment. 
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Fig.7.14. Visible spectra of the PHMB-coated samples before and after sterilising treatment, 
Inserted images were digital photos of the corresponding samples.  
7.2.2.4 Antibacterial properties  
The antibacterial results of the PHMB coated fibrous samples are provided in 
Fig.7.15. The initial seeding number of bacteria was 7.575×106, while after 4hr 
culturing and growth on pristine control sample, the number increased to 
1.87×109, which was regarded as no bacterial killing property. For the fibrous 
sample containing 1 layer of PHBM coating, although there was a certain 
reduction of E.coli bacteria (The reduction rate was 71.88% and 80.13% 
respectively), it was still not enough for the self-disinfection purpose. Some 
bacteria were still found on the surface after 5 hours of incubation. When more 
layers of PHMB were assembled on the surface, the retarding rate of bacterial 
could reach 99.99%, as indicated in Fig.7.15. Especially for 7 layer coating, 
most of plates showed no living E.Coli.  
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Fig.7.15. Bacterial growth and antibacterial rate of fibrous matrices having different layers of 
PHMB treated samples after 4hrs contact 
Although the 3, 5 and 7 bilayers of PHMB assemblies made it possible to kill 
all bacteria in 5 hours, it was still necessary to investigate the long-term 
antibacterial efficacy. At the first half hour, the bacteria on the control samples 
were recovered from the liquids and adjusted to the environments. There was 
no increase in logarithm value. In contrast, the bacteria on the PHMB treated 
samples (7 bilayers) were killed immediately when they contacted with PHMB 
coated surface, which was tested in 10 mins. There were no bacteria on the 
PHMB-treated fibre surface. With time, bacteria on the control samples 
propagated quickly, while no changes happened on the PHMB treated samples. 
It proved that with PHMB on the surface, no bacteria grew.  
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Fig.7.16. Bacterial growth as a function of time 
7.2.2.5   Cell cytotoxicity  
The cytotoxicity study was done using fibroblast cells according the method 
mentioned in Chapter 3. The extract media was used. The cell viability and the 
cell growth morphology after 3 days culture are shown Fig.7.17 and Fig.7.18. 
All the samples tested proved no toxicity to cells, with cell viability of more 
than 95%, and cell morphology sustaining in a healthy polygon shape.  
 
Fig.7.17. Cell viability results of the fibrous samples with different layers of PHMB (p>0.05) 
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Fig.7.18. Cell growth morphology, a) & a’) on control samples, and on the PHMB assembled 
fibrous samples with b) & b’) 1 layer PHMB coating, c) & c’) 1 bilayer PHMB/PAA coating, d) 
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& d’) 3 bilayers PHMB coating, e) & e’) 5 bilayers PHMB coating and f) & f’) 7 bilayers 
PHMB coating 
7.2.2.6 Cell growth  
A simple 7 day culture of fibroblast was conducted for evaluating the cell 
culture adaptability. MTS assay was used to identify the real viable cell 
number after 7 day culture. The cell number data is given in Fig.7.19. 
Although there were little differences in the mean cell number after 7 days 
culture, the cell number showed no differences between the pristine samples 
and the PHMB assembled samples. When taking into consideration of different 
layers, 7 bilayers of PHMB coating had less cell number compared to samples 
coated with fewer PHMB layers (Fig.7.19).  
 
Fig.7.19. Mean cell number of fibroblasts on different samples after 7 days of cell culturing  
Confocal microscopy images provided another proof of fibroblasts growth 
state. As shown in Fig.7.20, in one week of cell culture, it was hard to observe 
separate cells from these images. Cells already grew into multiple layers on the 
fibre surface.  
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Fig.7.20. Confocal microscopic images of fibroblasts after 7 days of cell culture, a) pristine 
fibre sample, and the fibrous sample with b) 1 PHMB layer, c) 1 PHMB/PAA bilayer, d) 3 
PHMB/PAA bilayers, e) 5 PHMB/PAA bilayers, f)  7 PHMB/PAA  bilayers.  Scale bar = 100 
μm 
Fig.7.21 shows the SEM images of the fibrous sample after 7 days of cell 
culture. For the untreated pristine samples, due to the hydrophobic surface, the 
cell attachment on the fibre surface was not uniform. Some surface parts 
contained much less cells compared to other parts. For the samples having 1 
layer of PHMB coating, the cells covered the entire fibre surface. The fibrous 
samples with 1 bilayer, 3 bilayers, and 5 bilayers, showed a similar tendency. 
With increasing PHMB layers, cells seemed to not grow as usual. In addition, 
cells grew not only on the fibre surface, but also between the fibres.  
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Fig.7.21. SEM images of fibroblasts after 7 days of culturing on fibrous matrices, a) pristine 
fibre sample, and the fibrous sample with b) 1 PHMB layer, c) 1 PHMB/PAA bilayer, d) 3 
PHMB/PAA bilayers, e) 5 PHMB/PAA bilayers, f) 7 PHMB/PAA bilayers.  Scale bar = 100 
μm 
7.2.2.7 Cell proliferation  
Cell proliferation study was conducted on 7 bilayers of PHMB coated samples, 
which had the best antibacterial properties and cell effectiveness.  
The samples with 7 layers of PHMB assembly had similar number of cells 
compared to the control sample in the first three days, and even after a longer 
culture period.  The cell growth speed on both samples was increased until 7 
days, after which the cell number reduced (Fig.7.22).   
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Fig.7.22. Fibroblast number on the control and the PHMB assembled (7 bilayers) samples.  
SEM images in Fig.7.23 reveal the cell morphology of fibroblasts on the 
fibrous samples after 3 and 7 days of cell culture. On day 3, very few cells 
were observed on the matrices. After 7 days of culture, fibroblasts could form 
multiple layers around the fibres of control samples. However for the PHMB 
treated fibrous matrices, fibroblasts were found to be in bunches and existed 
mainly on the boundary between fibres, rather than on the fibre surfaces.  
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Fig.7.23. SEM images of fibroblasts after 3 and 7 days of culture, a) pristine fibre sample-3 
days’ culture, b) pristine fibre sample-7 days’ culture, c) fibrous sample with 7 PHMB/PAA 
bilayers-3 days’ culture, and d) fibrous sample with 7 PHMB/PAA bilayers-3 days’ culture. 
Scale bar = 50 μm 
7.2.3 Comparison  
Electroless plating provided a quick method to assemble a thin silver 
nanoparticle layer on the surface of PCL matrices, which could be achieved in 
10 minutes. The content of silver on the surface was dependent on plating time 
and coating layers. In contrast, the procedure for PHMB/PAA electrostatic 
self-assembly on PCL fibrous matrices was much complicated and time-
consuming, but the content of PHMB could be controlled by changes of layers.  
In the view of antibacterial properties, silver coating was more effective than 
PHMB coating. Silver killed 99.99% of original seeded bacterial in 4 hours, 
while for PHMB coating, only samples with larger number of layers (3 bilayers, 
5 bilayers & 7 bilayers) had relative good bacterial killing ability.  
Although samples treated with the two methods showed no difference in cell 
toxicity study, the cell growth experiment indicated that silver treated samples 
were only good for short time cell culture (1 day), but PHMB treated samples 
could provide good environment for cell growth till 14 days.  
7.3 Conclusion 
Two antibacterial agents, silver and PHMB were applied to the PCL fibrous 
matrix respectively by electroless plating and layer-by-layer electrostatic self-
assembling methods. Antibacterial experiment indicated that these treatments 
were effective for killing bacteria. For cell culture, the samples coated with 
silver nanoparticles were proved to be good for short time, e.g. 1 day, culture, 
longer culture time would result in death of cells. The cells on the PHMB 
assembled fibrous samples showed much better growth performance. The 
layers of PHMB influenced cell growth mainly in terms of cell number rather 
than cell morphology. Seven bilayers of PHMB coating gave a small cell 
population after 7 days of culture, and the cell maintained not only on the 
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surface but also on the fibre-junction area. Cell growth speed was higher in the 
first two weeks, and it slowed down afterwards on PHMB treated samples as 
well as on control samples. The PHMB may be a good antibacterial candidate 
for self-disinfection tissue scaffolds.  
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C H A P T E R  E I G H T  
Summary and Outlook 
8.1 Conclusions 
In this thesis, a new scaffold fabrication method combining fibre melt 
processing with particle leaching technique has been developed, which has 
great potential for tissue engineering. The scaffolds prepared not only have the 
basic characteristics of fibrous scaffolds, but also provide stable mechanical 
properties with controlled and interconnected pores which make them an 
excellent candidate for tissue engineering scaffolds.  
Based on this novel 3D scaffold, surface techniques were used to improve 
surface roughness, surface bioactivity and surface antibacterial properties.  The 
surface modified 3D scaffolds revealed enhanced cell performances. The main 
conclusions from this PhD study are highlighted below.  
1) 3D inter-bonded fibrous scaffolds were fabricated by combining melt-
bonding of nonwoven with a particle leaching process. The melt procedure 
ensures good mechanical properties and stability of the 3D scaffolds, and the 
use of short fibres facilitates to form 3D structure with isotopic pores. The 
particle leaching technique allows controlling the pore size and porosity. The 
resulting 3D structure was demonstrated to be an excellent candidate for in 
vitro cell culture.  
2) Layer-by-layer electrostatic coating was used to uniformly generate a thin 
layer of silica nanoparticles on the PCL fibrous matrices. This coating 
technique allows good control of the nanoparticle layers on the fibre surfaces. 
This coating not only changes the surface roughness and water wettablity, but 
also provides a profound benefit for cell attachment, proliferation and 
differentiation.   
3) Fibrous scaffold has also been modified with apatite to enhance the 
osteoblasts bioactivity. PCL fibres could be activated by vacuum plasma 
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treatment and subsequently immersing into SBF solution. The coating resulted 
in enhanced proliferation rates for bone cells and alkaline phostatase formation.  
4) Antibacterial agents have also been introduced to the surface of 3D fibrous 
scaffold by electroless plating of Ag or layer-by-layer coating of PHMB. The 
antibacterial coating showed non toxicity but only a short term cell 
biocompatibility for Ag, while maintaining normal cell function till 14 days for 
PHMB.  
This research has shown that 3D inter-bonded fibrous scaffolds with functional 
surface have great potential for biomedical applications.  
8.2 Suggestion for Future Work  
This research opens up a new avenue of using 3D fibrous matrices with 
stabilised porous structure and nano-structured surface for tissue scaffolding 
applications. However, many questions remain to be answered.  For example, 
the materials selection, the large-scale and uniform dynamic seeding of cells, 
the gene expression of silica nanoparticles treated surface, the possibility of 
integrating  nano-tomography, bioactive surface and antibacterial properties 
into one step coating, effect of growth factor and  most importantly, the in vivo 
applicability and the long-term effect to tissue and organ after implantation.  
Tackling the following technical hurdles may form the focus of further studies.  
1) The main material used in this study, polycaprolactone (PCL), is a 
thermoplastic polymer. There are many other kinds of polymers, such as 
natural and nondegradable polymers, that need to be examined.  The relevant 
cell culture experiments should also be conducted.  
2) Dynamic seeding gives better efficiency and cell distribution than static 
seeding method for cell culture. This seeding method was not used due to the 
lack of facility. It should be performed in future studies.  
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3) The effect of silica nanoparticles on the gene expression is still not clear, 
although they are nontoxic to cells. What’s more, the in vivo experiment on 
animal is necessary before clinical trials. The apatite coated samples face 
similar challenges that may be tackled.  
4) For antibacterial surface treatment, more experiments are needed to examine 
the generality of the antibacterial activity. That is to say, when it imparts the 
sterilising property, it may simultaneously induce biological responses to 
human mammalian cells, resulting in the failure of the whole system. This 
aspect requires further study.  
5) The possibility of growth factor induction into the 3D inter-bonded fibrous 
scaffolds, the influence of different growth factors on scaffold performance 
both in vitro and in vivo, and the delivery mechanism of the growth factor are 
also critical issues to be examined.  
6) In the long term, in vivo implantation experiment is necessary before any 
clinical trials on human body can be contemplated.   
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